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ABSTRACT 
The death of monocyte and macrophage cells in the atherosclerotic plaque is thought 
to be due principally to the toxicity of oxidised LDL (oxLDL). This makes an important 
contribution to the development of the lipid core of advanced plaque and also to the overall 
stability of the plaque. 
Under inflammatory conditions in which IFNy is present, human monocytes and 
macrophages produce the partially reduced pteridine 7,8-dihydroneopterin (78"l\TP). This 
molecule has been shown to be a very efficient free radical scavenger and to protect some cell 
types from damage during incubation with reactive oxygen species. The possibility of 78NP 
reducing loss of cell viability of monocytes and macrophages in the atherosclerotic plaque 
was examined in this research. 
THP-l and U937 monocytes and THP-l macrophage-like cells were incubated with 
AAPH or oxidised LDL, and loss of cell viability and total reduced thiols measured. In 
monocytes, both AAPH and oxLDL caused concentration-dependent reduction in viability. 
The loss of reduced thiols was also proportional to AAPH and oxLDL concentration, except 
in U937 monocytes with oxLDL, where the levels dropped suddenly. Viability loss in THP-l 
macrophage-like cells was found to be small and not dependent on the concentration of the 
AAPH or oxLDL. 
The development of apoptotic features, including nuclear morphological changes, 
caspase enzyme activation and phosphatidylserine exposure was examined in monocytes 
incubated with oxLDL. Both cell types had characteristics typical of apoptosis, with the 
exception of low levels of caspase enzyme activity in U937 monocytes, which decreased 
even further during incubation with oxLDL. Evidence is presented that this may be due to the 
oxidation of the crucial cysteine residue on the caspase enzymes. 
During incubations with AAPH, 78NP significantly reduced cell viability and thiol 
loss in U937 cells and decreased cell viability loss by a small amount in THP-l monocytes 
when the incubations were carried out in EBSS media. 78NP had a similar effect in U937 
cells with oxLDL, but no protective effect was observed in THP-l monocytes. 78NP had no 
effect on viability loss with AAPH or oxLDL in THP-l macrophage-like cells. The protective 
effect of78NP may be dependent on its ability to inhibit thiolloss. 
xv 
All three cell types were shown to produce 78NP after stimulation with IFNy. 
However, inclusion ofIFNy did not in most cases prevent cell viability loss during exposure 
to oxLDL. 78NP was found in inflammatory material, but only at levels a hundred-fold less 
than those required to provide an antioxidant effect. 
78NP is able to protect cells from viability loss generated by free radicals and the 
reactive oxygen species in oxLDL in some circumstances. However, since the levels in vivo 
are likely to be far lower than those required for antioxidant activity, the evidence presented 
does not SUppOlt the hypothesis that 78NP would be able to protect monocyte and 
macrophage cells from cell death in the atherosclerotic plaque. 
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INTRODUCTION 1 
INTRODUCTION 
PURPOSE OF THIS STUDY 
Oxidised low density lipoprotein (oxLDL) has been hypothesised to be central to the 
development of atherosclerosis. Tissue culture studies have shown that oxLDL can elicit 
many of the cellular responses that appear during the development of atherosclerotic plaque 
(Chisholm III and Chai, 2000). One of the key features of advanced plaque is an acellular 
lipid core, thought to be fonned from macrophage cells that have undergone cell death 
(Martinet and Kockx, 2001). In tissue culture oxLDL is cytotoxic to monocytes and 
macrophages via a range of mechanisms (Bjorkerud and Bjorkerud, 1996). 
Monocyte and macrophage cells have a number of cellular defence mechanisms 
which allow them to function in inflammatory environments. Some of these protective 
responses are activated by the T cell-synthesised cytokine interferon-y (IFNy) (Wachter et ai., 
1992). 7,8-Dihydroneopterin (78NP), a pteridine synthesised from GTP, is hypothesised to be 
part of this response. 78NP can function as an antioxidant, scavenging a range of free radicals 
(Sherr, 1994). It has been shown to protect some cell types from oxidative damage, and has 
been reported to both enhance and reduce apoptosis (Baier-Bitterlich et ai., 1995; 
Schobersberger et aI., 1996; Gieseg et al., 2001). Pteridines may also affect cell viability 
through influencing the cells' signalling pathways and gene expression (MUff et ai., 1994). 
Atherosclerotic plaques are known to be sites of inflammation (Galle et ai., 1999A), 
suggesting that the macrophages present may be synthesising 78NP. This thesis will examine 
the process of oxLDL-mediated cell death using two monocyte-like cell lines and one 
macrophage-like cell type and explore the possible inhibition of cellular death by 78NP. 
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MACROPHAGES AND THE GENERATION OF ANTIOXIDANTS: 
7,8-DIHYDRONEOPTERIN AND INTERFERON-y 
INTERFERON-Y 
2 
The interferons are a family of cytokines, carrying messages between cells as part of 
the immune response. IFNa and IFN~ are type I interferons, which induce resistance to 
viruses (Mueller et al., 1991; Johnson et al., 1994; Kuby, 1997). 
IFNy is the only type II interferon. It has a dimer structure, and is much more 
plurifunctional than the other interferons, carrying out antiviral, anticellular, antiparasitic and 
immunoregulatory activities. It is produced by Th1 lymphocytes, cytotoxic T cells and NK 
cells activated by microorganisms or antigen, and binds to receptors on monocytes, 
macrophages, Tor B cells (Takikawa et al., 1988; Johnson et al., 1994). Once bound to the 
cell-surface receptors, it activates the Janus tyrosine kinases, which phosphorylate Stat 
factors 113, 91 and 84, These can then form a complex and activate various genes (Johnson et 
al., 1994). 
IFNy enhances the Th1 type immune response by increasing inflammation via 
macrophages, which are then better able to ingest and kill invading, infected or cancerous 
cells (Kuby, 1997; Widner et al., 2000), IFNy primes the respiratory burst and induces 
expression oftheMIlC II antigen, MIlCI, FcR, IL-1, IL-15, TNFa, platelet activation factor, 
adhesion molecules, proteases and iNOS, and enhances the production of complement factors 
B, C2 and C1-inhibitor (Faltynek et at., 1988; Billiau and Dijkmans, 1990; Kuby, 1997; 
Musso et al., 1999). 
Since it is part ofthe cytokine network, IFNy's production is modulated by many 
other endogenous factors, such as interleukins, other interferons and lymphotoxins (Billiau 
and Dijkmans, 1990). Anti-inflammatory cytokines diminish its effects. Histamine, Fe2+ ions, 
Fe3+ ions, transferrin and metalloporphyrins containing iron or zinc reduce IFNy effects in 
THP-1 monocytes (Weiss et al., 1992; Weiss et al., 1993B; Gruber et al., 2000). 
To counter some of the inflammatory effects, IFNy also increases production of 
molecules which can act as antioxidants. It induces the degradation of heme to bilirubin 
(Christen et at., 1994), transiently induces ceruloplasmin secretion in U937 cells and 
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enhances it in peripheral blood monocytes and THP-1 monocytes, which produce higher 
constitutive levels (Mazumder et at., 1997). Pteridines are also produced (Huber et at., 1984), 
and metabolism of tryptophan is increased (Wachter et at., 1992). 
PTERlDINES: BACKGROUND 
Pteridines were first described in 'Nature' in 1889. They are pyrazino-pyrimidine 
compounds, ubiquitous and essential for many cell functions in plants, bacteria, non-
mammals and mammals (Woell et at., 1993; Walter et at., 2001). Their synthesis is 
stimulated by interferons, in particular IFNy. IFNu, IFN~, TNFu, TNF~, IL-1, IL-2, IL-6, 
GM-CSF, LPS, lectins~ PMA, zymosan and Ca2+ ionophore A23471 can also increase the 
production, but not by as great a degree as IFNy. Some of these cytokines are able to act in 
synergy with IFNy and enhance its effects (Troppmair et at., 1988; Meyer et at., 1992; 
Werner-Fehnayer et at., 1993). 
Pteridines can be either conjugated, with a relatively complex side chain, such as folic 
acid and riboflavin, or unconjugated, with a less complex side chain at position 6, including 
biopterin and neopterin (Wachter et ai., 1989). The unconjugated pteridines can be grouped 
into three classes by oxidation state: fully reduced tetrahydrobiopterins, partially reduced 
dihydropterins and aromatic pterins such as neopterin and biopterin (OettI and Reibnegger, 
2002). 
The biosynthetic pathway begins with the cleavage of the purine GTP by GTP 
cyclohydrolase I to fonn 7,8-dihydroneopterin triphosphate (Figure 1) (Wachter et at., 1992). 
7,8-dihydroneopterin triphosphate is a precursor to folic acid and riboflavin in 
microorganisms. Higher animals and mammals synthesise pteridines instead (Wachter et at., 
1989). 
GTP cyclohydrolase I is a d5 symmetric toroid-shaped decamer, with ten active sites 
at the interface of three adjacent subunits, and an essential Zn2+ ion bound to conserved 
cysteine and histidine residues at each active site. The reaction is complex, with ten proposed 
steps. The sequence begins with the opening of the imidazole ring of GTP, and continues 
with a carbohydrate rearrangement and ring closure (Schramek et at., 2002). 
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GTP cyclohydrolase I is the only enzyme in the pathway modulated by IFNI' and 
other cytokines, without which its levels are low and rate-limiting. The rate-limiting part of 
the reaction is associated with the rearrangement of the carbohydrate side chain. IFNy also 
increases the levels of GTP itself (Kojima et al., 1992). Once GTP cyclohydrolase I is 
activated, the levels of the other enzymes in the pathway determine the identity of the final 
products (Werner et al., 1990). This will vary between cell types (Wachter et al., 1992). 
If 6-pyruvoyl tetrahydropterin synthetase, which metabolises 7,8-dihydroneopterin 
triphosphate, is active at high levels, the main product will be 5,6,7,8-tetrahydrobiopterin. 6-
Pyruvoyl tetrahydropterin synthetase generates 6-pyruvoyl-tetrahydropterin, and sepiapterin 
reductase reduces it to 5,6,7,8-tetrahydrobiopterin, which can be metabolised to biopterin and 
7,8-dihydrobiopterin (Walter et al., 2001). 
If6-pyruvoyl tetrahydropterin synthetase levels are low, the 7,8-dihydroneopterin 
triphosphate is likely to be metabolised by less specific enzymes (Wachter et ai., 1992). 
Aldoses can convert 7,8-dihydroneopterin triphosphate to 7,8-dihydrofolic acid (Spoettl et 
ai., 1999/2000). Phosphatase activity results in 7,8-dihydroneopterin (78NP) (Wachter et al., 
1992). Humans and other primates are the only species in whose body fluids 78NP has been 
detected (Wachter et al., 1989). 
78NP is oxidised to two different products, depending on the oxidant. HOCI or acidic 
iodine solution oxidises 78NP to neopterin by the loss of hydrogen at C7 and N8 (Gieseg et 
ai., 2000B; Widner et al., 2000). The other product is 7,8-dihydroxanthopterin, which comes 
about through loss of the trihydroxypropyl side chain at position 6. This may occur by a 
retro-aldol reaction, which could be initiated by the abstraction of a hydrogen atom from the 
central hydroxyl group on the side chain (Murr et al., 1994; Widner et al., 2000; Duggan et 
al., 2002). It is formed by peroxyl radicals and hydrogen peroxide (Gieseg et al., 2000B). 
Neopterin and 7,8-dihydroneopterin are found in reasonably constant proportions in 
human body fluids, with a ratio of neopterin: total neopterin (where the 78NP has been 
oxidised to neopterin) of 1:3 in urine and 1:2 in serum from venous blood samples. There are 
higher 78NP levels in blood from arteries and in cerebrospinal fluid (Werner-Felmayer et al., 
1990). Pterins are cleared only by the kidneys (Widner et al., 1999), which is why the overall 
levels in urine are higher than those in serum (Mueller et al., 1991). 
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Figure 1: The biosynthesis and metabolism of7,8-dihydroneopterin. Adapted from Spottl et al., 
1999/2000 and Widner et at., 2000. 
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The production of 78NP and neopterin conelates closely with IFNy serum 
concentration and activation of cell-mediated (Th1) immunity. As neopterin is very 
fluorescent, the determination of its levels in body fluids is a valuable diagnostic tool in 
conditions associated with increased activation of the cellular immune system (Hoffman et 
ai., 1996). 
Examples in which an increase is found in serum include autoimmune diseases, such 
as rheumatoid arthritis, ulcerative colitis, Crohn's disease, autoimmune thyroiditis (Wachter 
et al., 1989), rejection of transplanted organs including liver, renal, cardiac, pancreatic and 
bone manow transplants (Mueller et al., 1991) and viral, bacterial and protozoal infections, 
(Huber et al., 1984; Wemer-Felmayer et ai., 1990; Strohmaier et ai., 1996), including malaria 
(Plasmodiumfaiciparum) (Facer, 1995), hepatitis (Woell et ai., 1993) and HIV (Fuchs et ai., 
1989; Griffm et ai., 1991; Moriuchi et ai., 2000). Increases are also found in diabetes mellitus 
type I, inflammatory diseases such as sarcoidosis, celiac disease, multiple sclerosis and 
aseptic meningoencephalitis, cancers including gynecological, genitourinary tract, lung, 
gastrointestinal, pancreatic and hematological neoplasias (Wachter et ai., 1989), alcoholic 
liver disease, bum patients (Facer, 1995), pregnancy (Widner et ai., 1999), in breastfeeding 
women with silicone breast implants (Levine et al., 1996) and long-term hemodialysis 
patients with immune activation due to the interaction of the blood with the membrane (Fuchs 
et al., 1988). Increased levels are measured in the cerebrospinal fluids of neurodegenerative 
patients with AI7.heimers, Huntington's or cerebral infection, such as Lyme neuroboneliosis 
(Sattler et ai., 1999; Spoettl et ai., 1999/2000). 
The rise in neopterin levels does not necessarily occur in every patient. In cancer, the 
frequency of elevated neopterin varies from 18% of patients with breast cancer to 100% in 
some hematological neoplasias (Mun et ai., 1999). Some studies also show increases in 
neopterin which are very small, although apparently still statistically significant. It is not 
clear whether this rise would be physiologically important. For example, in a study of 
Hodgkin's disease and non-Hodgkin's lymphomas, the highest increase found was I. I-fold 
(Denz et ai., 1992), yet the increase was still said to be predictive of the cancer. 
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Higher levels of neopterin are generally related to poor prognosis (Facer, 1995), 
correlating with more rapid progression and earlier death (Baier-Bitterlich et ai., 1997). A 
decline is found in the remission of cancers (Murr et ai., 1999). 
POSSIBLE ROLES OF PTERIDINES IN VIVO 
Some pteridines have been assigned biological roles, usually as enzyme cofactors. 
Tetrahydrofolate is a cofactor in thymine synthesis and in the conversion of homocysteine to 
methionine (Wachter et ai., 1989; Widner et ai., 2002). Pterin is a component in the 
molybdenum cofactor of nitrate reductase, sulphite oxidase and xanthine oxidase (Wachter et 
ai., 1989; Spoettl et ai., 199912000). 5,6,7,8-Tetrahydrobiopterin is a cofactor of aromatic 
amino acid monooxygenases, etherlipidoxidase (Werner-Felmayer et ai., 1990; Mueller et ai" 
1991; Woell et ai., 1993) and nitric oxide synthase isofornlS (Werner-Felmayer et ai., 1993; 
Walter et ai., 2001), as well as having a role in cell differentiation and proliferation (Walter et 
ai.,2001), 
The role of 78NP and neopterin is much less certain. Several ideas have been put 
forward and tested, but it is not yet proven whether any of them actually occur in vivo. The 
most often explored possible roles for 78NP and neopterin concern their pro- or anti-
inflammatory effects. This type of function would make sense, given that they are generated 
by monocytes and macrophages under inflammatory conditions. They may be able to 
modulate those conditions, protecting the macrophage itself, or enhancing its cytotoxicity. 
These effects are most often due to their pro- or antioxidant activities. 
For example, 78NP could act as an extra- or intracellular antioxidant to protect the 
cell against its own oxidants. A similar level of IFNy is required for maximum 78NP release 
as well as maxinlum reactive oxygen species production, and the timecourse to 78NP and 
hydrogen peroxide secretion is similar. The protection would also extend to other oxidants 
that are produced in inflammation, such as those of neutrophils. Inflammatory sites have high 
concentrations of superoxide and HOCI, as well as hydrogen peroxide (Nathan, 1986). 78NP 
may be one of the many safeguards in place to ensure the process does not get out of hand. 
This is the possibility investigated in the research of this thesis. 
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78NP might also improve macrophage immune function, as well as protecting the 
celL The antioxidants glutathione, N-acetylcysteine, vitamin E and vitamin C stimulated 
phagocytosis, increased superoxide production and improved migration and chemotaxis in 
vitro> Vitamins E and C increased levels of adherence (Tillinghast and Newell, 1987; Del Rio 
et al., 1998). Also, the ratio of neopterin and 78NP can influence the balance between 
superoxide and NO. This is crucial to the development of peroxynitrite. At the right pH, 
neopterin will increase its toxicity by enhancing the nitration of tyrosine (Shen, 1994). 
It has been proposed (but not tested) that these pterins may function to increase the 
macrophage's arsenal against invaders by inhibiting some of the foreign enzymes. Neopterin 
is an intermediate in the folic acid pathway, which is part of microorganisms' , but not 
animals', metabolism. Neopterin might therefore inhibit folate synthesis. At least two 
enzymes in the pathway use dihydro substrates, so neopterin, the oxidised form, may inhibit 
them, or at least dilute the pool of available substrate (Nathan, 1986). 78NP may have a 
similar function, as it seems able to competitively inhibit methyl group metabolism enzymes, 
such as dihydrofolate reductase and dihydropteridine reductase, which recycle the pterin 
cofactors used for forming tetrahydroderivatives. 78NP must first be tautomerised to the 
7,8(6H)-dihydro derivative by Fe3+ (Fuchs et al., 1990). 
Many studies have been carried out showing that pterins can interfere with a redox 
balance, sometimes within cells and sometimes in purely chemical systems. Their exact effect 
depends on their structure, concentration and the system they are in. The same amount of a 
pterin can have the opposite effect in a different system. 
PTERIDINES AS PRO- AND ANTIOXIDANTS, OR REDOX MODULATORS 
In general, aromatic pterins such as neopterin act in a pro-oxidant, pro-inflammatory 
fashion, and partially reduced pterins such as 78NP and fully reduced pterins such as 5,6,7,8-
tetrahydrobiopterin are antioxidants and anti-inflammatory, except at very high 
concentrations or in cell types which do not produce them themselves. 
Neopterin's prooxidant effect was shown when it enhanced chloramine-T and 
hydrogen peroxide-mediated chemiluminescence in a luminol assay at concentrations 
between 2.0nM and 200llM (Murr et al., 1994; Baier-Bitterlich et al., 1995). In a solution of 
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tyrosine, nitrite and hydrogen peroxide, 200llM neopterin enhanced 3-nitrotyrosine fonnation 
(Widner et al., 1998). Neopterin also sensitised DNA to photodamage through the fonnation 
ofpterin radicals (Oettl and Reibnegger, 2002). 
Any apparent antioxidant activity of neopterin has so far been found to be due to 
inhibition of the enzyme generating the oxidative stress, rather than a chain-breaking or 
scavenging activity (Oettl and Reibnegger, 2002). Neopterin inhibited superoxide generation 
by the NADPH oxidase enzyme, by competing with NADPH (Kojima et al., 1993) and by 
non-competitive, reversible inhibition of the xanthine oxidase enzyme (OettI et al., 1997; 
Watanabe et al., 1997; Oettl and Reibnegger, 1999). The inhibition of xanthine oxidase may 
be related to the fact that pterin fonns part of the enzyme's cofactor (Wachter et al., 1989; 
Spoettl et al., 1999/2000). Concentrations in vivo are not likely to be high enough to inhibit 
these enzymes (Kojima et al., 1993), 
78NP, a partially reduced pterin, has mainly scavenger and protectant properties. It 
has been shown to scavenge superoxide in xanthine/xanthine oxidase or NADPH cytochrome 
P450 reductase systems, with an lCso of 3.85!lM (Shen, 1994; Oettl et al., 1997). The ICso 
was 0.161lM for 78NP in a glucose/glucose oxidase system generating hydrogen peroxide and 
78NP also scavenged hydrogen peroxide-mediated chemiluminescence (Murr et al., 1994; 
Shen, 1994; Baier-Bitterlich et al., 1995). Hydroxyl radicals generated using a chloramine 
system were quenched by 50% by 78NP (Oettl and Reibnegger, 2002). EPR spectroscopy 
showed 78NP was as effective at scavenging DPPH as Trolox, and more effective than 
Trolox with ABTS+ (Oettl et al., 2000A). Using AAPH to generate peroxyl radicals, 78NP 
reduced the radical level to 11 %. The rate constant for the 78NP reaction was 107 M-1 S-I, 
which is close to a-tocopherol (Oettl et al., 1997). 78NP could also scavenge peroxynitrite as 
measured by EPR spectroscopy (Oettl et al., 2000A). 
78NP inhibited peroxyl and hydroxyl radical-mediated protein hydroperoxide 
fonnation on bovine serum albumin completely at 200IlM. It could also degrade prefonned 
protein hydroperoxides on BSA (Duggan et al., 2002). 78NP at 200llM inhibited 3-
nitrotyrosine fonnation in a solution of tyrosine, nitrite and hydrogen peroxide at any pH 
(Widner et al., 1998), 
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78NP's antioxidant capacities have also been tested in LDL oxidation. Between 1 ~ 
and lOIlM 78NP could prevent the oxidation of linoleate and LDL with AAPH and Cu2+, 
increasing the lag phase of lipid peroxidation, and diminishing the consumption of vitamin E. 
78NP appeared to be acting as a chain-breaking antioxidant, effectively competing with 
vitamin E for the lipid peroxyl radical. It was suggested that it was unlikely the 78NP was 
acting to directly scavenge the peroxyl radicals, as it had a similar efficiency of protection 
with Cu2+ (Gieseg et al., 1995). 
The fully reduced 5,6,7,8-tetrahydrobiopterin has even more impressive antioxidant 
properties than 78NP, although it is not known if it has an antioxidant function in vivo. It 
inhibits luminol-dependent chemiluminescence in all enzyme or chemical systems examined. 
It was able to scavenge superoxide and hydroxyl radicals, DPPH and hydrogen peroxide 
more efficiently than established aritioxidants like ascorbate and glutathione (Kojima et al., 
1993; Shen, 1994; Kurobane et al., 1995). 
5,6,7,8-Tetrahydrobiopterin is very readily oxidised in air (auto oxidation) (Arai et al., 
1998) and is a strong reducing agent, reducing ferric to ferrous ions, which gives it a pro-
oxidant ability to enhance Fenton reactions. Mass spectroscopy has shown that 5,6,7,8-
tetrahydrobiopterin and iron ions are able to form complexes (Oettl and Reibnegger, 2002). 
78NP is less prone to autooxidation than the fully reduced tetrahydrobiopterins. 
However, it is still sensitive to oxidation, especially with transition metals. Hydroxyl radical 
formation was illustrated by the hydroxylation of salicyclic acid in solutions of 500llM 78NP 
without another radical generator, as ferric ions were reduced to ferrous. Other dihydropterins 
yielded different degrees of hydroxylation, dependent on their redox potential and structure. 
Superoxide was thought to be formed from dissolved oxygen by auto oxidation of trace 
metals, with subsequent production of hydroxyl radicals through Fenton reactions. The 
addition of chelated ferric ions increased the hydroxyl radical yield ten-fold, possibly due to 
iron binding by the 78NP. The side chain at position 6 was important here (Oettl et al., 
2000B). 
Hydroxyl radicals were also shown to be formed dose-dependently in HEPES with 
200IlM-5mM 78NP by ESR spectroscopy, using the spin trap nitrone compound DMPo. A 
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reduced signal was found in chelexed HEPES, supporting the theory advanced above 
(Wirleitner et at., 2001). These same properties are responsible for the fact that 5mM 78NP 
has been shown to enhance chemiluminescence (Oettl and Reibnegger, 2002). 
78NP can also reduce ferric to ferrous ions in heme proteins, both in hemoglobin and 
myoglobin, at concentrations as low as 40JlM. This allows molecular oxygen to bind and 
78NP then supports the cleavage 0 f the porphyrin ring, to produce carbon monoxide and non-
heme iron. The reduction of iron is a potent electron-generating system (Horejsi et at., 2002). 
78NP may have a role in reducing the Fe3+ of transferrin, elevated in IFNy-induced anaemia, 
which is necessary for iron binding (Fuchs et ai., 1991; Denz et at., 1992). 
78NP may also have its own ion binding capacity, although this has proved difficult 
to demonstrate so far (Oettl, personal communication, 2002). The previously described work 
with LDL oxidation suggests it may not bind Cu2+, since it had no effect on the propagation 
rate ofthe oxidation with Cu2+ (Gieseg et ai., 1995). Other pteridines, including 5,6,7,8-
tetrahydrobiopterin and the pteridine carboxaldehyde thiosemicarbazones, are able to chelate 
iron. The pteridine carboxaldehyde thiosemicarbazones inhibit enzymes in this way. Amino 
and hydroxyl groups were found to be important for this property (Hochmann et at., 1973). 
78NP's dual role in radical scavenging and fonnation under different conditions was 
well illustrated in an experiment in which, in a phosphate buffer with low iron concentrations, 
78NP enhanced superoxide fonnation over a time period of hours. However, in organic 
buffer, with a high iron concentration, a reduction in superoxide production was found after 
ten minutes (Oettl and Reibnegger, 2002). 
To summarise, 78NP and neopterin are both redox active compounds which can act as 
pro- or antioxidants depending on the circumstances, although 78NP is usually an antioxidant 
and neopterin usually a prooxidant. They are likely to be able to modulate the redox balance 
in cells and in the oxidative microenvironment of the inflammatory site. 
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1·'l:''C'l:)£'"rC' ON CELL VIABILITY AND ApOPTOSIS 
The effect of the pterins on cell viability parallels their effect on radicals and reactive 
oxygen species. Neopterin may enhance or not affect cell viability loss, and 78NP reduces 
viability loss, except at high concentrations. This implies the existence of a relationship 
between cell death and changes in the cellular redox balance. 
Neopterin seems able to enhance apoptosis, but not cause it itself. Neopterin at 
200J.1M enhanced the toxicity of chloramine-Tat pH 7.5 towards Escherichia coli and 
Staphyiococcus aureus (Weiss et ai., 1993A; Murr et ai., 1994), increased cell damage on B-
16 melanoma cells by UV-A irradiation (Murr et ai., 1999) and, at 1mM, enhanced apoptosis 
in the rat alveolar epithelial L2 cell1ine induced by IFNy and TNFa through the production 
of NO (Schobersberger et al., 1996). These cells do not produce 78NP or neopterin 
themselves. This is likely to explain the discrepancy with neopterin up to 1mM slightly 
decreasing TNFa-induced apoptosis in U937 monocyte cells (Baier-Bitterlich et ai., 1995). 
78NP can also inhibit apoptosis in different cell types. In U937 cells undergoing 
TNFa-induced apoptosis, 78NP was a potent inhibitor up to a concentration of 300J.1M 
(Baier-Bitterlich et ai., 1995). 78NP up to 1mM inhibited apoptosis in Jurkat T cells by anti-
Fas antibodies (Wirleitner et ai., 1998). 
High concentrations of 78NP cause or enhance apoptosis, much as they augmented 
oxidative stress. In the rat alveolar epithelial L2 cell line, 78NP at concentrations up to 1mM 
increased apoptosis induced by IFNy and TNFa through the production of NO 
(Schobersberger et al., 1996). 5mM 78NP superinduced apoptosis ofU937 cells with TNFa, 
by boosting radical production (Baier-Bitterlich et ai., 1995) and also caused apoptosis in a 
rat pheochromocytoma cel11ine (Enzinger et al., 2001), PC12 cells (Enzinger et at., 2002), 
human neuronal NT2IHNT cells (Spoett1 et ai., 1999/2000) and Jurkat T cells, which could 
be abrogated by antioxidants (Baier-Bitterlich et ai., 1996A; Wirleitner et at., 1998; 
Wirleitner et at., 2001). 
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78NP can protect cells from viability loss due to oxidative damage. It shielded red 
blood cells from haemolysis initiated by AAPH and HOCI, and U937 cells from HOCI and 
Fe-mediated damage. Effects mediated by hydrogen peroxide could only be partially reduced 
(Oieseg et al., 2000B; Gieseg et ai., 2001). 
In line with its strong antioxidant capability in chemical systems, 5,6,7,8-
tetrahydrobiopterin can also protect cells and whole animals from oxidative damage. 
It protected endothelial cells from cumene hydroperoxide-induced cell viability loss, bringing 
them back up to control levels by ImM (Kurobane et al., 1995). It was able to shield linoleic 
acid from air oxidation (Kojima et al., 1993). 5,6,7,8-Tetrahydrobiopterin had a protective 
effect in free radical-induced injury in developing paw edema, gastric ischemia reperfusion 
injury, adriamycin cardiotoxicity and carbon tetrachloride heptatoxicity in mice (Arai et al., 
1998). 
EFFECTS ON GENE EXPRESSION AND CELL SIGNALLING 
Part of the pterins' possible influence on inflammation may occur through alteration 
of the cells' patterns of gene expression, either directly or more indirectly via cell signalling. 
Neopterin inhibited hypoxia-induced erythropoietin gene expression and formation in HepG2 
cells (MUff et ai., 1999) and induced proto-oncogene c-fos expression (Schobersberger et ai., 
1996) via effects on cytokines and second messengers, mostly mediated by reactive oxygen 
speCles. 
Both neopterin and 78NP are able to enhance the effects of second messenger cGMP. 
Together, they induced c-fos in NIH 3T3 fibroblasts (MUff et ai., 1999). Another study also 
looking at fibroblasts, with a transfected c-fos construct, showed 78NP and cOMP causing 
significant transcription activation of the construct. Antioxidant activity may be important, as 
BHT and BHA could also have this effect (Ueberall et al., 1994). 
Neopterin activated iNOS in rat vascular smooth muscle cells at 1O~ (Hoffmann et 
ai., 1998). In human vascular smooth muscle cells, neopterin had an additive effect on iNOS 
expression if stimulated with LPS. 78NP had no effect, and neither of them changed the 
induction by IFNy (Schobersberger et ai., 1995). Conversely, another study showed that if 
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IFNy or TNFa mediated the iNOS stimulation, neopterin would decrease the activation 
(Hoffmann et al., 1998). Neopterin cannot stimulate iNOS in the rat alveolar epithelial cell 
line L2 (Schobersberger et al., 1996). 
The iNOS activation occurs through a modulation of the redox-modulated signalling 
pathways which induce it, so the pterin's pro- and antioxidant properties are important. 
Oxidative stress activates NFKB, for which the iNOS gene has two putative binding sites. 
Neopterin increased nuclear uptake ofNFKB through inducing TNFa, which in turn induced 
free radical production and caused the release ofNFKB from IKB (Hoffman et al., 1996). 
Neopterin could also activate NFKB in Jurkat cells (Barak and Gruener, 1991; 
Schobersberger et al., 1996). 
78NP at 200jlM was able to induce an increase in IFNy secretion by Jurkat T cells, in 
what would be a self-amplifying feedback loop (Baier-Bitterlich et al., 1996B). But if 
hydrogen peroxide, which also induces it, was present, 200jlM 78NP decreased secretion, 
whereas 5mM superinduced it, in another example of its biphasic effects (Baier-Bitterlich et 
ai., 1996B). Extra IFNy might result in proinfiammatory events. 
Pterins could also affect signalling by influencing another second messenger: Ca2+. 
When pterins were added to THP-l cells, a rapid transient increase in Ca2+, lasting for around 
one minute, was found. 78NP was the most efficient pterin, requiring only 10nM for a 
significant change. 100nM 5,6,7,8-tetrahydrobiopterin and IjlM neopterin had the same 
effect. The increase was blocked by lanthanum ions, showing the involvement of an inducible 
calcium channel activated by the pteridines (Woell et al., 1993). In another investigation, 
using alveolar epithelial cells, neopterin was found to abolish an ATP-stimulated intracellular 
Ca2+ release (Hoffmann et al., 2002). 
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CELL DEATH: APOPTOSIS AND NECROSIS 
Cell death is commonly divided into two categories: apoptosis and necrosis. In a 
certain situation, a cell's loss of viability is assigned to one or the other, depending on the 
appearance of certain features. 
Necrosis, sometimes called oncosis, was the earliest form of cell death described. It is 
usually associated with a sudden or high level of damage to the cell, and the death is said to 
be accidental (Ueda and Shah, 1994). Necrosis is characterised by swelling and rupture of 
internal organelles, which prevents further ATP production, followed by plasma membrane 
lysis and the release of denatured protein, DNA fragments, lysosomal contents and other cell 
debris into the extracellular space (Lelli Jr. et ai., 1998). The cell is killed by the disruption of 
the ion homeostasis (Bomer and Monney, 1999). 
Apoptosis (programmed cell death) is a rapid, efficient and highly regulated process 
involved in physiological as well as pathological conditions (Verhaegen, 1998; Rizzo et ai., 
1999). It is an essential process for development and maintenance of homeostasis during 
embryogenesis, cell growth and immune regulation as well as elimination of damaged, 
mutated or infected cells in eukaryotic organisms (Takano et aI., 2001). 
The significance of apoptosis can be illustrated by examples of the consequences of 
its deregulation. An imbalance between cell death and survival is found in the pathology of a 
range of diseases including atherosclerosis (Geng et ai., 1997). Oncogenic transformation is 
associated with a decreased susceptibility to respond to apoptotic stimuli (Rizzo et al., 1999), 
whereas excessive apoptosis results in acute organ failure and chronic diseases involving the 
loss of post-mitotic cells (Kroemer and Reed, 2000). 
Apoptosis is identified by a combination of biochemical and morphological changes, 
which are commonly, but not uniformly, found. The inter-relationships of the constellation of 
features, and their precise roles, vary with stimuli and cell type. 
The biochemical changes which occur are involved with the regulation of the process 
and mark the three phases of apoptosis: initiation or induction, decision or execution (the 
commitment to apoptosis) and degradation (the carrying out of apoptosis) (Kroemer and 
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Reed, 2000; Cannody and Cotter, 2001). Biochemical changes also alert surrounding cells to 
the cell's situation (Vissers et al., 1999). 
Most of the well-known morphological events centre around the nucleus, which 
shrinks, condenses and undergoes pyknosis (margination) (Alcouffe et al., 1999; Yuan et al., 
2000). The chromatin are cleaved in a process characterised by double-stranded DNA 
fragmentation (Reid et al., 1993A). The mitochondria and the lysosome are also involved in 
early events, but no physical changes are seen in these organelles until further on (Verhaegen, 
1998). In the later stages, the endoplasmic reticulum is vacuolated (Reid et al., 1993B) and 
the cell shrinks due to vesicles being formed at the endoplasmic reticulum, fusing to the 
plasma membrane and being released extracellularly (Samali et al., 1996). This stage is seen 
with a scanning electron microscope as blebs, which form at the membrane (Reid et ai., 
1993B). These become apoptotic bodies, which are later phagocytosed (Lelli Jr. et ai., 1998). 
If phagocytosis does not eventuate, . a process known as secondary necrosis, in which the 
membranes of apoptotic bodies lyse and release their contents, as in necrosis, will occur 
(Skepper et al., 1999). 
THE INITIATION PHASE 
This stage of apoptosis involves the direct effect of the stimulus. The first step in the 
pathway may be the engagement of a receptor at the cell surface. These receptors are called 
'death receptors'. The best characterised death receptors are F as (CD9S1 Apo-l), 1NFR 1 
(p55ICDI20a), DR3 (TRAMP/Apo-3), DR4, DRS (TRAIL-2/APO-2) and DR6 (Cannody 
and Cotter, 2001). These interact with apoptotic machinery in the cytosol. 
Fas is a member of the TNFa-receptor family, produced by CD8+ T lymphocytes 
(Geng et al., 1997). It crosslinks with anti-Fas antibody or its natural ligand FasL (Samali et 
ai., 1996). FasL is a type II membrane protein of 37kDa, and is also part of the TNFa family 
(Kiener et ai., 1997; Griffith et al., 1999). Other death receptor ligands include TRAIL 
(TNFa-related apoptosis inducing ligand), another TNFa family member, which binds to 
DR4 and DRS (Suliman et ai., 2001). 
The ligation ofFasL or other ligands results in crosslinking of the intracellular death 
domains of the receptors and the start of apoptotic signalling. This may occur either through 
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recruitment of a set of signalling proteins which activate caspase enzymes and begin an 
enzyme cascade (Geng et ai., 1997; Dai and Krantz, 1999; Artier et ai., 2000), or through 
activation of other modulators such as reactive oxygen species, glutathione efflux, ceramide 
or the Bcl-2 family. Both these pathways are thought to lead to changes in the mitochondria, 
which will result in caspase activation if this has not already occurred. The ability of the 
death-inducing signalling complex (DISC) to activate caspase-8 may be the deciding factor 
(Carmody and Cotter, 2001; Partheniou et ai., 2001). 
It is also possible for the receptor/ligand step to be skipped, and apoptotic signalling 
to be directly activated by the stimulus given to the cell, if it is taken up by the cell or affects 
its oxidative environment 
THE EXECUTION PHASE 
CASPASES 
Of the fourteen caspase enzymes that have been identified, twelve are found in 
humans (Hampton and Orrenius, 1997; Lin et ai., 2000). The enzymes are called caspases 
based on their specificity for cleavage after aspartic residues and their active site cysteine at 
amino acid 163, contained in a common sequence QACRG (Kubo et ai., 1997; Mohr et ai., 
1997; Vissers et ai., 1999). The cysteine mediates nucleophilic attack on the target substrate. 
It must be reduced to function and can be regulated by the glutathione ratio. The basic amino 
acids which surround the cysteine lower the pKa to allow the reaction to proceed at 
physiological pH (Boggs et ai., 1998; Liu et ai., 2001; Hampton et al., 2002B). 
Caspases are present in the cytoplasm in an inactive proform with aN-terminal 
domain, a large subunit of around 20kDa and a small one of around 10kDa. Once apoptosis is 
underway, they are processed by proteases, often other caspases, to the active form, in which 
the large and small subunits form a heterodimer, and dimers form tetramers. A cascade is set 
in motion, in which the caspase enzymes are activated in a certain order (Hampton and 
Orrenius, 1997; Mohr et ai., 1997; Thornberry and Lazebnik, 1998). 
There are two classes of caspase in apoptosis: one that cleaves other caspases, the 
initiator caspases, including caspase-1 (also known as ICE, interleukin-1~ converting 
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enzyme), -2 (also known as Nedd-2 and ICH-l), -8 (FLICE (FADD-like ICE), MACH), -9, -
10, and -13, with long prodomains, and the effector caspases that cleave other proteins and 
have short pro-domains. These are caspases-3 (CPP32, apopain, Yama), -6 (Mch2) and -7 
(Lap3, Mch3, CMHl) (Van den Dobbelsteen et ai., 1996; Kubo et al., 1997; Pardhasaradhi et 
al., 1997; Stennicke and Salvesen, 1997; Thornberry and Lazebnik, 1998). Caspases-4 and-5 
also have long prodomains, placing them in the initiator caspase category, but evidence for 
their precise role in apoptosis is sti11lacking, although they can cleave caspase-3 in vitro (Lin 
et al., 2000), 
The caspase cascades are well characterized. There are two main initiator cascades, 
activated by different apoptotic inducers (Bomer and Monney, 1999). Caspase-8 is activated 
by DISC at crosslinked intracellular death domains of cell surface death receptors such as Fas 
or other TNF a family members, and then activates the caspases-3, -6 and -7. DISC is made 
up of the receptors, the receptor ligand, an adapter molecule, the Fas-associated protein with 
a death domain (FADD), and caspase-8 (Dai and Krantz, 1999). 
Alternatively, caspase-9 is activated in the cytosol through AP AF -1 (apoptotic 
protease activating factor-I), a 130kDa protein with an NH2-tenninal caspase recruitment 
domain (CARD). A complex is fonned with APAF-l, cytochrome c from the mitochondria 
(also called APAF-2 in this situation), ATP and procaspase-9 (Uu et al., 1996; Zou et ai., 
1999; Ishisaka et al., 2001). Caspase-9 will also activate the caspases-3, -6 and -7. This 
mechanism is mitochondrial-dependent, since cytochrome c release is required (Artier et al., 
2000). 
The effector caspases undertake the disassembly of the cell and are therefore 
responsible for many of the morphological changes. The details of how this takes place are 
unclear, as not all substrates have been identified, and those that have been were discovered 
in an unsystematic fashion, so that their relationship to cell death is not always understood 
(Thornberry and Lazebnik, 1998; Cannodyand Cotter, 2001). Since proteolysis is 
irreversible, effector caspase activation is seen as a point of commitment to apoptosis. 
Caspases may carry out the disassembly themselves, for example through cleavage of 
lamin proteins, which contributes to nuclear condensation (Thornberry and Lazebnik, 1998; 
Zou et ai., 1999; Umeda et al., 2001). They may also activate other proteins that execute 
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disassembly, such as the nuclease DFF40/CAD (Woo et al., 1998; Borner and Monney, 1999; 
Umeda et ai., 2001). 
The caspase enzymes also inactivate proteins that prevent apoptosis, including 
DFF45IICAD, an inhibitor ofDFF40/CAD, anti-apoptotic members of the Bcl-2 family and 
proteins involved in DNA activities such as repair (poly (ADP-ribose) polymerase, P ARP, 
and DNA-P~s), mRNA splicing (UI-70K), mRNA processing and translocation to the 
cytoplasm (small nuclear ribonucleoprotein-Ul, snR.l\TP-Ul) and replication (replication 
factor C). These cleavages have the effect of maintaining NADH and ATP levels, which, if 
depleted, would lead to necrosis (Sumimoto et al., 1994; Palomba et al., 1996; Samali et al., 
1996; Leist and Nicotera, 1997; Thornberry and Lazebnik, 1998; Virag et al., 1998; Kroemer 
and Reed, 2000; Virag and Szab6, 2001). 
Caspases affect cell signalling by amplifying the kinase activity of MEKKI and that 
of the p38 and JNK MAPK pathways, which are pro-apoptotic (Widmann et ai., 1998; 
Aoshiba et al., 1999; Umeda et al., 2001). The cleavage of anti-apoptotic proteins including 
Raf-l, Cbl and Cbl-b and Akt shuts down the anti-apoptotic ERK and PI3K-Akt pathways 
(Widmann et ai., 1998). 
MITOCHONDRIA 
The mitochondria have been given a central position in the execution phase, as the 
pathways from different stimuli seem to converge there and trigger key changes, which may 
be committal events. These include the release of proteins, the loss of membrane potential, 
and the disruption of the membrane, also known as MMP, mitochondrial membrane 
permeability. MMP affects viability by disrupting electron transport and energy metabolism 
(Kroemer and Reed, 2000; Carmody and Cotler, 2001). 
If the outer membrane becomes more permeable, the gradient is reduced. Proteins 
normally in the intermembrane space, such as some procaspases (-2, -3, -7, -9), adenyl ate 
kinase 2, heat shock proteins 10 and 60, and catabolic enzymes such as arginase sulphite 
oxidase move into the cytosol. 
The release of cytochrome c results in a breakdown of electron flow, generating 
reactive oxygen species, specifically superoxide, and reducing the supply of ATP (Liu et ai., 
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1996; Cai and Jones, 1998; Green and Reed, 1998). It then triggers caspase activation as part 
of AP AF-l (Stridh et ai., 1998; Ishisaka et ai., 2001). 
Apoptosis-inducing factor (AIF), which cleaves procaspase-3 also enters the cytosol. 
It is imported to the nucleus, where it induces peripheral and 'dot' chromatin condensation 
and DNA fragmentation (Marzo et ai., 2001). SmaclDIABLO (second mitochondria-derived 
activator of caspases/direct lAP binding protein with low pI) binds to and inhibits inhibitor of 
apoptosis proteins, which would otherwise sequester caspases (Cuvil1ier and Levade, 2001). 
If the inner membrane becomes more permeable, the gradient is completely disrupted, 
resulting in small solutes such as Ca2+ and glutathione flowing out, and water and sucrose 
flowing in, causing swelling (Kroemer and Reed, 2000). Gradient loss may also be under 
redox control, as reactive oxygen species are reported to oxidise cardiolipins in the inner 
mitochondrial membrane, leading to disruption of the potential (Lizard et ai., 2000). 
The mechanisms of increase of pC1meability and protein release, which are often 
thought to be linked, are debated by a number of authors. Two main processes are put 
forward as possibilities: the opening of a pore, and the rupture of the outer membrane. 
Pore formation may occur via an ANT (in the inner membrane), VDAC (in the outer 
membrane) or Bax-formed channel, or by a multiprotein ensemble, called the permeability 
transition pore complex. This would include proteins in the inner and outer membranes at a 
point where the two membranes contact, such as ANT, VDAC, Bax, Bcl-2, cyclophilin D, 
creatine kinase or hexokinase II (Kroemer and Reed, 2000). There may be redox-sensitive 
sites on the pore (Lizard et ai., 2000; Liu et ai., 2001). 
A pore would allow for equilibration of ions across the membranes, dissipating the 
gradient and uncoupling the electron transport chain, providing a plausible mechanism for 
that part of the process (Green and Reed, 1998). However, the pore complex suggested above 
would only allow movement of solutes of up to 1.5kDa, making cytochrome c and AIF too 
big (Carmody and Cotter, 2001). 
Solving this dilemma, three mechanisms for the rupture of the outer membrane, which 
would release proteins, have been put forward. Pore opening may allow water and solutes to 
enter the matrix, causing rapid osmotic changes (Carmody and Cotter, 2001), or closure of 
VDAC may cause mitochondrial hyperpolarization (Suen et ai., 2001), or a hyperpolarization 
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of the inner membrane may cause the increased export of protons to the intennembrane 
space, an increase in osmolality and the entry of water (Green and Reed, 1998). 
The lack of adequate answers for how mitochondrial changes occur is emphasised by 
the fact that these changes may occur in any order. Some examples show cytochrome c 
release and caspase activation appearing to lead to membrane potential loss, whereas other 
cells undergo very rapid loss of potential, which might therefore contribute to the following 
protein release (Cai and Jones, 1998; Green and Reed, 1998; Stridh et ai., 1998; Cannody 
and Cotter, 2001; Liu et ai., 2001). 
THE LYSOSOME 
Oxidative conditions and the build-up of substances indigestible by lysosomal 
enzymes promote lysosomal degradation (Hellquist et ai., 1997). This is a similar process to 
the rupture of the mitochondrial membrane, since the destabilisation of the lysosomal 
membrane results in the destruction of the membrane's proton gradient and leakage of 
hydrolytic cathespins, DNases and perhaps iron into the cytosol (Fossel et ai., 1994; Bolton et 
ai., 1997; Brunk et ai., 1997; Yuan et ai., 2000). Consequences of this include reactive 
oxygen species generation (Keller et ai., 1999). 
In spite of the prevailing opinion of lysosomes as sturdy organelles which break down 
late in cell death, several studies have shown leakages of cathespin enzymes and other 
markers from lysosomes early in apoptosis, before mitochondrial and nuclear changes (Brunk 
et ai., 1997; Yuan et ai., 2000). In these cases lysosomal disruption may playa role in the 
initiation or commitment phases of apoptosis. 
THE DEGRADATION PHASE 
PHOSPHA TIDYLSERINE EXPOSURE 
The major classes of phospholipid are usually asymmetrically distributed across 
membranes. The inward-directed ATP pump aminophospholipid translocase/flippase and the 
outward directed pump floppase are believed to maintain the asymmetry (Kagan et ai., 2000). 
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An early feature of apoptosis, designed to mark the cells for recognition and removal 
by phagocytes, is the exposure of phosphatidylserine on the cell surface. Certain conditions, 
including ATP depletion, Ca2+ influx or fodrin cleavage, activate a third enzyme, a 
phospholipid scramblase, and inhibit the flippase, which allows for the loss of asymmetry 
(Kagan et al., 2000; Yu et al., 2000). The process is still partially unexplained. Along with 
phosphatidylserine, phosphatidylethanolamine is also an aminophospholipid, and so both 
would be expected to be exposed on the surface of the cell (Kagan et al., 2000). 
The involvement of oxidative stress in the pathway may explain this anomaly. In 
paraquat-treated 32D cells, keratinocytes with cumene hydroperoxide and HL-60 cells with a 
lipid-soluble peroxyl radical generator, phosphatidylserine was the only phospholipid 
oxidised (Kagan et al., 2000). Cytochrome c, for example, has been shown to preferentially 
oxidise phosphatidylserineover other phospholipids (Kagan et aI., 2000). Furthermore, in 
neutrophils treated with PMA, NADPH oxidase activity was necessary for phosphatidylserine 
exposure, but myeloperoxidase was not. Adding hydrogen peroxide could also induce 
exposure (Hampton et al., 2002C). 
Another possibility is that phospholipid tumover, altered during apoptosis, may also 
contribute to the flipping of phosphatidylserine. In U937 cells, Jurkat cells and HL-60 cells, a 
dramatic early increase in phosphatidylserine biosynthesis is found, whereas the increase in 
phosphatidylethanolamine and sphingomyelin is small, and phosphatidylcholine levels 
decrease (Yu et al., 2000). 
DNA DEGRADATION 
There are three parts of DNA degradation in apoptosis: single strand nicks, large 
DNA fragments of 50-200kbp and fmally cleavage at intemucleosomal regions to generate 
nuc1eosome size fragments of 180-200bp. This last stage is observed with the popular DNA 
laddering technique on agarose gels (originally considered the hallmark of apoptosis), and the 
first stage is seen with the TUNEL method. TUNEL labels DNA breaks with dUTP-biotin 
transferred to the free 3'-end ofthe cleaved DNA (Bustamente et al., 1995; Samali et al., 
1996). 
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A range ofCa2+/Mg2+-dependent endonucleases are activated to carry out this process 
(Reid et al., 1993A). A slight lowering of intracellular pH may be important (pardhasaradhi 
et al., 1997). Specific proteins identified include the nuclease DFF40/CAD, which cleaves 
DNA into intemucleosomal fragments (Bomer and Monney, 1999), DNA fragmentation 
factor (DFF) and p21-activated kinase 2 (PAK2) (Woo et al., 1998). These are all activated 
by caspases. Another contributor, AlF, comes from the cytosol by a caspase-independent 
mechanism (Marzo et al., 2001). 
BLEBS: FORMATION OF APOPTOTIC BODIES 
Bleb fOlmation is related to perturbations in cytoskeletal organisation. Proposed 
mechanisms include a rise in cytosolic free Ca2+, ATP depletion and changes in the G-
actinIF-actin ratio. Since monomeric actin has four thiol groups, three of which are masked in 
the presence of physiological concentrations of A TP, the depletion of glutathione is also 
considered necessary for bleb formation (Lemasters et al., 1987; Mirabelli et al., 1988). 
MODULATORS OF THE RESPONSE 
There are many other molecular participants in the apoptotic process. Exactly how 
many ofthese are active at once is uncertain, as studies tend to measure only a few. They 
may, however, all be important in most circumstances. The efiects of modulation are seen on 
caspases and the mitochondria, and may also have an effect on initiation in some cases. The 
role of modulators may be very fundamental, or simply a fine-tuning of the process. Their 
inactivation often partially prevents apoptosis. Many modulators affect others, in what can be 
a very complicated network of cross-regulation. 
CALCIUM IONS 
A rise in Ca2+ ions is seen to occur relatively early in apoptosis in many cell types 
(Escargueil-Blanc et al., 1997). The ions are released by the opening of channels in the 
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endoplasmic reticulum by inositol triphosphate, or in an uncontrolled manner by oxidative 
damage to the mitochondria or endoplasmic reticulum (Halliwell and Gutteridge, 1999). 
The Ca2+ may be involved in signalling and the opening of the mitochondrial 
membrane pore (Halliwell and Gutteridge, 1999). Caspase activation may indirectly require a 
rise in Ca2+ (Skepper et al., 1999). Ca2+ also stimulates a range ofCa2+.dependent enzymes 
including phospholipases, the endonucleases involved in DNA fragmentation and proteases 
such as calpains (Escargueil et aI., 1992). 
In some cell types, depleting extracellular Ca2+, buffering the intracellular Ca2+ or 
blocking the Ca2+ rise can prevent apoptosis (Ueda and Shah, 1994; Escargueil-Blanc et al., 
1997). However, Ca2+ influx is not always required (Sumimoto et al., 1994), and in some 
cells, a transient elevation of Ca2+ by ionophores inhibits apoptosis (Lotem and Sachs, 1998; 
Aoshiba et al., 1999). 
A Ca2+ peak and Ca2+ -dependent proteases may also be features of necrosis, which 
can be partially blocked by protease inhibitors (Escargueil-Blanc et al., 1994; Escargueil-
Blanc etal., 1997). 
LIPIDS 
Lipids may act as signalling molecules to modulate apoptosis. The neutral 
sphingolipid ceramide and arachidonic acid, a polyunsaturated fatty acid, can induce 
apoptosis (Rizzo et al., 1999). Ceramide may act by disrupting the electron transport chain at 
cytochrome b-cl/cytochrome c (Green and Reed, 1998) or amplifying caspase-8 activity by 
increasing TRADD recruitment to the DISC complex (De Nadai et aI., 2000). It may regulate 
protein phosphorylation by acting directly on protein kinase C~ (which is involved in NFKB 
regulation) and MAPK (Hannun and Obeid, 1995). 
The activation ofthe transcription factors peroxisome proliferator-activated receptors 
(PP ARs) by prostaglandins in human monocytes and macrophages results in caspase-3-
mediated apoptosis, through interference with the anti-apoptotic NFKB signalling pathway, 
by inhibition of the transcription of its p65/RelA subunit (Chinetti et al., 1998). 
Lipids might also abrogate apoptosis. Sphingosine I-phosphate can directly inhibit 
caspase-3, and can counteract cytochrome c and SmacIDIABLO's effects, possibly by halting 
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their release from mitochondria. Sphingosine 1-phosphate's generation would also reduce 
apoptosis as ceramide concentration would be lowered (Cuvillier and Levade, 2001). 
BCL-2 FAMILY 
The bel-2 family of genes has a role in the regulation of apoptosis. Bel-2, Bag-I, Bel-
w, Mcl-1, AI, adenovirus Elb 19K, Ced-9 and Bcl-xl enhance survival in several cell types 
, 
against different apoptotic inducers, and Bax, along with Bad, Bak, Mak, Bok, Bid, Bik, Bim 
and Bcl-xs have the opposing function. The ratio of protective to apoptotic proteins 
determines the family's overall effect (Okada et al., 1998; Mizuno et al., 1999; Cannodyand 
Cotter, 2001). 
The family has a similar structure to channel-forming colicins, with 7 a-helices joined 
by flexible loops (Green and Reed, 1998). Bax, Bid, Bim and Bak, as dimers or oligomers, 
fonn ion-conducting channels in the mitochondrial outer membrane. Their effect is reduced if 
they fonn complexes with anti-apoptotic family members. They also form pores in the 
membranes of the endoplasmic reticulum and nucleus. Bim, which is attached to 
microtubules, is released if the cell is under stress, and the others migrate from the cytosol 
(Zamzami et al., 1995; Meilhac et al., 1999; Kroemer and Reed, 2000; Carmody and Cotter, 
2001). The effect of these pores may be to induce mitochondrial membrane permeability and 
cytochrome c release from the mitochondria, intervene in Ca2+ signalling by encouraging 
Ca2+ release from the endoplasmic reticulum and modulate nuclear transport (Harada et al., 
1997B; Meilhac et al., 1999; Kroemer and Reed, 2000; Carmody and Cotter, 2001). 
The family'S pro-apoptotic effect is dependent to some extent on caspases. Bid is 
cleaved by caspase-8 to induce it to go to the membranes, and caspase-1 digests Bcl-xl, 
stopping its anti-apoptotic effect (Kroemer and Reed, 2000). Bcl-2 may be cleaved during 
apoptosis by caspase-3, going from 28kDa to a 23kDa pore-forming pro-apoptotic version 
(Chen et al., 2000; Varela et al., 2001). 
As well as forming complexes, Bcl-2 is said to be an antioxidant, preventing lipid 
peroxidation, and being associated with an increase in intracellular GSH (Lizard et al., 1998). 
The antioxidant properties may be indirect, since by preventing cytochrome c release and 
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superoxide production, change in cell redox status via GSH is reduced (Cai and Jones, 1998; 
Cannody and Cotter, 2001). 
REDOX MODULATION 
Oxidative mechanisms may have a central role in apoptosis, perhaps as a point of 
convergence of stimuli into a main signalling pathway. Many cell types display an increase in 
reactive oxygen species as part of activation, proliferation and differentiation as well as death 
(Lizard et al., 2000). Examples of parts of apoptosis influenced by redox modulation include 
caspase activation, the Bcl-2 family, blebbing, phosphatidylserine exposure, lysosome 
degradation, death receptor activity and pore opening and gradient disruption in 
mitochondria. 
The first indication that oxidative effects might be involved came when it was found 
that oxidants, such as oxLDL, caused apoptosis accompanied by increased ROS production 
(Dirnmeler et al., 1997). The idea was supported by the fact that some non-oxidative agents 
caused apoptosis involving oxidative stress. Examples of this type of apoptosis include that 
induced by TNFa, Fas, honnone and growth factor deprivation, cytokines, glucocortocoids, 
etoposide and epipodophyllotoxin, an inhibitor oftopoisomerase II (Bustamente et al., 1995; 
Yang et al., 2000; Galan et al., 2001; Takano et at., 2001). 
The apoptotic agents may increase ROS by upregulating endogenous oxidants, and so 
do not have to be oxidants themselves. The mitochondria are usually pinpointed as the key 
source. Others are NADPH oxidase in phagocytes, the catabolism of purine nuc1eotides and 
the metabolism of fatty acids (Takano et ai., 2001). 
ROS, being reactive and non-specific, do not seem the ideal way to mediate the highly 
controlled changes of apoptosis. However, many kinases, phosphatases and transcription 
factors are redox responsive (Cannody and Cotter, 2001). Some selectivity can also be 
provided. For example, the surrounding protein environment can enhance the reactivity of 
hydrogen peroxide with certain cysteine residues (Hampton et al., 2002B). 
The induction of oxidative stress by an apoptotic agent does not prove that ROS 
mediate apoptosis. They may be merely a consequence of damage, rather than a cause of 
death (Cannody and Cotter, 2001). Further evidence for a role for ROS is given by 
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antioxidants that have been able, in some cases, to inhibit apoptosis. Since the oxidative 
burden occurs eady rather than late, antioxidants are likely to affect early events (Bustamente 
et al., 1995). Antioxidants which are able to prevent or reduce apoptosis under certain 
circumstances include N-acetylcysteine, GSH and vitamins E and C together, vitamin C 
alone, dehydroascorbic acid, r-tocopherol, BHT, SOD and catalase (Lotem et al., 1996; Niu 
et al., 1996; Shanna et al., 1996; Dimmeler et al., 1997; Asrnis and Wintergerst, 1998; Galle 
et al., 1999B; Li et al., 1999; Siow et al" 1999; Lizard et al., 2000; Takano et al., 2001). 
Some anti-apoptotic factors, such as Bcl-2, act by reducing ROS generation (Galan et al., 
2001). Apoptosis sometimes occurs in the presence of antioxidants. Reactive oxygen species 
are therefore not a universal, essential trigger (Davis et al., 2000; Galan et ai., 2001). 
Since both ROS and antioxidants may play pro- and anti-apoptotic roles, their 
importance may be in the way they change, or modulate, the redox environment, which is 
likely to affect signalling pathways, rather than their pro- or antioxidant properties per se. We 
can, however, conclude that oxidants have a tendency to cause apoptosis, and antioxidants a 
tendency to prevent or delay it. 
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LOW DENSITY LIPOPROTEIN 
Low density lipoprotein (LDL) is part of a lipoprotein system for the controlled 
transport and metabolism oflipids in the bloodstream. LDL is the main carrier of cholesterol, 
delivering it to peripheral cells. Increased levels correlate with an increased risk of 
atherosclerosis (Esterbauer et at., 1988B; Meilhac et al., 1999). 
Lipoproteins are spherical structures, made up of protein embedded in a monolayer 
surface of polar phospholipids and cholesterol around a core of neutral cholesterol esters and 
triglycerides. They also contain antioxidants, including a-tocopherol, r-tocopherol, 
carotenoids and ubiquinol-l 0 (Stocker, 1994; Meyer et aZ., 1995). The structure is quite fluid, 
so the phospholipids can quickly change places (Laggner, 1987). 
LDL is characterised by its density, size, Mr, chemical composition, structure and 
protein (Esterbauer et at., 1992). LDL's buoyant density range is 1.063-1.090glmL, and it is 
between 2.2-3.0 x 106 Daltons and 200-500A in size (Laggner, 1987; Meyer et al., 1995). 
LDL has the highest proportion of cholesterol esters of the lipoproteins, making up 
about half its mass (Laggner, ] 987). Of the fatty acids, around half are polyunsaturated fatty 
acids (PUPAs), mainly linoleic acid, with minor amounts of arachidonic acid and 
docosahexaenoic acid, although this will vary between donors (Esterbauer et aZ., 1992). 
The only protein component ofLDL is apolipoprotein BlOO, a large lipid-binding 
protein of alternating a-helical and f3-sheet structure. ApoBI00 has 4536 amino acids and a 
Mr of 512,000. Details of protein folding and lipid-protein interactions are still obscure 
(Laggner, 1987; Meyer et at., 1995). 
The range oflipophilic antioxidants also varies with donor. On average, each LDL 
has 6 a-tocopherol molecules, Ih y-tocopherol, 1/3 ubiquinol-lO and f3-carotene (more than 20 
different carotenoids have been reported), and lito oxycarotenoid (Esterbauer et al., 1992). 
LDL is taken up by the cell via the LDL receptor or by non-specific endocytosis 
(Brown and Goldstein, 1976). LDL interacts with the LDL receptor based on ionic attractions 
between clusters of basic atnino acids and the acidic amino acids ofthe receptor. Divalent 
cations, preferably Ca2+, are also required. They bind at eight sites to negatively charged 
residues, mostly glutamate and aspartate. Most of these sites are on apoB, although some 
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weak binding sites are found on phospholipids (Pifat et at" 1992). LDL can also be taken up 
as an immune complex by Fe-gamma receptors. Autoantibodies and immune complexes have 
been found in patients with coronary artery disease, peripheral vascular disease and 
atherosclerotic lesions (Huang et ai., 1997). 
ATHEROSCLEROSIS 
Atherosclerosis is a multifactorial, complex pathological process. In most cases, it is 
the underlying cause of coronary artery disease (YUi-Herttuala, 1998). It involves the 
accumulation of intra- and extracellular lipids (from LDL), monocyte/macrophage infiltration 
and foam cell formation, the proliferation of smooth muscle cells, and the accumulation of 
connective tissue components, forming a plaque. 
Major risk factors for atherosclerosis therefore include hyperlipidemia (Nishio et at., 
1996) and white blood cell count. White blood cell count also predicts cardiovascular events 
such as myocardial infarction or thrombotic stroke, and their severity (Schmitz and Lackner, 
1993; Belch, 1994). 
This outline of atherosclerotic development will trace the influence of oxLDL, as well 
as the role of monocytes and macrophages, inflammatory conditions and antioxidants. 
The first theory on the mechanism of atherogenesis was published in 1852. 
Rokitansky's incrustation hypothesis proposed that fibrin deposition and secondary lipid 
accumulation were the most important events in atherosclerosis development. In 1856, 
Virchow postulated lipid deposition in the arterial wall was in fact the primary event and 
provided morphologic evidence of inflammation. An association with monocytes, 
macrophages and foam cells was found in rabbit lesions in 1913, but not in humans until 
Stary's work in 1987. Goldstein demonstrated the macrophage scavenger receptor pathway in 
1979 (Schwartz and Valente, 1995). In 1986, Ross put forward the now prevalent 'response 
to injury' hypothesis, an integrated model of atherogenesis involving the cells of the immune 
system and inflammation, as well as lipids (Jang et at., 1993). The first reports on LDL were 
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in the 1970s. By the late 1970s and early 1980s, oxidised LDL had become a topic of 
discussion , and was found to inhibit growth and cause cell injury. By the end of the 1980s, 
oxLDL was shown to affect growth factor and cytokine production (Chisholm [II and Chai, 
2000). 
There is still considerable dehate about oxidative aspects of the theory, and many 
more details have been added since Ross' paper, however the basic sequence of events in 
atherogenesis seems to have become widely accepted. 
INITIATION 
The arterial lesion is initiated at the endothelium, a selectively permeable barrier 
hetween tissue and the blood, made up of a single layer of endothelial cells joined by tight 
junctions (Figure 2) (Lusis, 2000). 
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Figure 2: Structure of a normal a.rtery . Adapted from Lusis, 2000. 
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The most vulnerable sites for lesion development are the inner walls of curved 
segments and the outer walls of bifurcations of relatively large arteries, where blood flow is 
likely to be disturbed by flow separation and the formation of complex secondary and 
recirculation flows, that is, turbulence (Wada and Karino, 2002). The disturbance in flow 
creates regions oflow shear stress, which makes the endothelium more permeable by altering 
the cells' morphology and causing injury by oxidative damage, such as by superoxide (Galle 
et al., 1999A; Halliwell and Gutteridge, 1999; Wada and Karino, 2002). This part of the 
artery also shows an increase in water filtration velocity, which results in sites of elevated 
LDL concentration (Wada and Karino, 2002) and decreased flow rate, meaning that 
damaging molecules such as LDL or viruses may remain there for longer, and have more of a 
chance to cause injury (Jang et at. 1993; Halliwell and Gutteridge, 1999). 
If low density lipoprotein is able to diffuse through the tight junctions more easily 
than usual, there will be a greater chance of it becoming fixed there through interactions 
between the apoB molecule and the matrix proteoglycans of the subendothelium. A minimal 
level of oxidative modification is then likely to occur, due to its proximity to cells such as 
endothelial cells and smooth muscle cells, that could contribute through their oxidative waste 
(Steinbrecher et al., 1987; Rosenfeld et al., 1990; Lusis, 2000). OxLDL epitopes were found 
within the carotid artery wall a few hours after injection of native LDL into rat (Chisholm and 
Steinberg, 2000). 
There is good evidence that oxLDL is present in the intima prior to the appearance of 
monocytes. A study by Schwenke and Carew showed an increase in oxLDL at lesion-prone 
sites within eight days ofthe start of cholesterol feeding in New Zealand white rabbits, before 
lesion formation began (Rosenfeld, 1996). 
The alternative theory involves injury to the endothelium followed directly by 
monocyte migration into the subendothelial space (Jang et at. 1993; Halliwell and Gutteridge, 
1999). Monocyte adherence is enhanced at sites of increased endothelial cell turnover, where 
haemodynamic injury is greater (Mitchinson et at., 1996). The entry of lipoproteins into the 
intima would then be a secondary event. 
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RECRUITMENT OF MONOCYTES AND LYMPHOCYTES 
The monocytes interact with the artery wall firstly by rolling arrest attachment along 
the endothelial surface in a process mediated by P- and E-selectins, which bind to a 
monocytic carbohydrate domain on L-selectin. This interaction is quite weak and sporadic. 
The selectins are induced by factors such as TNFa, IL-l, histamine and oxLDL (Davies, 
1997; Halliwell and Gutteridge, 1999). 
If the next stage of adhesion molecules is activated, the cell can flatten out and stick 
to the endothelial layer more tightly. Integrin a4~1, also known as VLA-4, found on 
monocytes and T cells, will bind to VCAM-l (vascular cell adhesion molecule) on the 
endothelium. Also LF A-I (leucocyte function associated antigen) on leucocytes interacts 
with ICAM-l and -2 (intercellular adhesion molecule) on endothelial cells. ICAM and 
VCAMbelong to the immunoglobin gene superfamily. They are induced by cytokines such 
as IFNy, chemoldnes, colony stimulation factors and chemotactic factors such as oxLDL 
(Schwartz and Valente, 1995; Davies, 1997). 
The recruitment is selective, since these adhesion molecules have ligands on 
lymphocytes and monocytes, but not granulocytes (Hansson et al., 1995). There are also very 
few B cells in the plaque (Huang et al., 1995). 
Transmigration involves adhesion molecules such as platelet endothelial cell adhesion 
molecule 1 (PECAM-1) on endothelial cells at intercellular junctions, and is directed by 
chemokines and chemotactic factors from under the endothelium, which are transported to 
the surface or released by the endothelium (Halliwell and Gutteridge, 1999). 
Monocytes begin the process of differentiation to macrophages once in the intima, 
due to inflammatory activators such as IFNy, and the presence of less than 2% serum 
(Schmitz and Lackner, 1993). 
INFLAMMATION 
The underlying cause of atherosclerosis is chronic inflammation (Galle et at., 1999 A). 
Its presence is indicated by the activation of the monocytes, macrophages and T cells that 
have entered the intima, along with the antigen presentation, cell-mediated toxicity and 
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cytokine-dependent regulatory loops that appear with it (Figure 3). OxLDL and heat shock 
proteins are the likely antigens. Titres of autoantibodies to hsp60 have been shown to 
correlate with the extent of carotid atherosclerosis (Hansson et al., 1995), and botb oxLDL 
and heat shock proteins are able to acti vate T cells, causing IFNy production (Geng et aI., 
1995). So the inflammation in the lesion results from the cells present, through the factors 
they produce, as well as the oxLDL. 
Inflammation has been demonstrated in atheroscleros is in vivo through the 
appearance of markers such as C-reactive protein , IL-6, thrombosis tissue factor, D-dimer 
and neopterin, which are found to be elevated with acute coronary events (Gurfinkel et 01., 
1999). The anti-inflammatory glucocorticoid dexamethasone suppresses atherosclerosis in 
experimental animals (Sakai et al., 1999). 
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Figure 3: Infl ammation in the early atherosclerotic le sion . Adapted from Lusis, 2000. 
The monocyte::; and macrophages present in the subendothelial space will elevate their 
own numbers by recruiting more monocytes themselves, through the production of 
interleu kins, TNFa and monocyte chemotactic factor. M Herr molecu les will acti vate the new 
cells through T cells, eX;1ccrbating the immune response. The inflammatory response is also 
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increased by macrophages through further injury to the endothelium by free radicals and 
enzymes such as collagenase types I and IV, cathespin, heparin sulphate endoglycosidase and 
elastase which digest the extracellular matrix (lang et al., 1993; Schwartz and Valente, 1995). 
T lymphocytes make up 10-20% of cells in the plaque, and contribute to inflammation 
through IFNy. Its effects, such as smooth muscle cell expression of the FILA class II gene 
HLA-DR, have been found in plaque (Hansson et al., 1989). T cells do not proliferate, so all 
are recruited from the bloodstream (Schmitz and Lackner, 1993). Other pro-atherogenic 
properties include the secretion of macrophage activating factors and the inhibition of 
collagen and a-actin fonnation, which reduces the mechanical strength of the arterial wall 
(Geng et al., 1995). 
The proinflamrnatory properties of oxLDL belong especially to minimally-modified 
LDL, such as is present early on in the plaque development (Lee et al., 1999). It acts as 
antigen, contributing to the inflammatory immune response, and exacerbates it through its 
other properties (Hansson et al., 1995). 
OxLDL increases inflammation by the recruitment ofmonocytes and lymphocytes to 
the subendothelium by chemotaxis, and the stimulation of the surrounding endothelial cells to 
produce monocyte adhesion molecules and growth factors such as MCP-l and M-CSF, which 
increase macrophage proliferation and accumulation (Eligini et al., 1999; Shiffinan et al., 
2000). 
The growth of other cell types is also affected. Lysophosphatidylcholine (LPC) that 
comes into contact with human monocytes and endothelial cells increases the production of 
HB-EGF, a potent mitogen for smooth muscle cells and endothelial cells. LPC and oxLDL 
also cause human monocyte-macrophages to produce vascular endothelial growth factor 
(Chisholm III and Chai, 2000). 
During the development of the plaque, oxLDL induces the production of 
inflammatory cytokines. It stimulates macrophages to release IL-8, which is chemotactic for 
T cells and endothelial cells, mitogenic for endothelial cells and smooth muscle cells and 
increases the adhesion of monocytes to endothelial cells. The highest levels were found in the 
macrophages from the most severe atherosclerotic plaque (Terkeltaub et at., 1994; Wang et 
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at., 1996; Liu et at., 1997B). OxLDL also stimulates the release ofIL-IP from macrophages. 
1bis cytokine encourages proliferation of smooth muscle cells, activates helper T cells, is 
chemotactic for monocytes and increases vascular permeability by upregulating ICAM 
expression on endothelial cells (Davies, 1997). It is found at up to 60-fold its normal 
concentration in human atherosclerotic lesions (Ku et al., 1992). Low concentrations of 
oxLDL also activate T cells by stimulating MHC class II-dependent production ofIFNy 
(Huang et ai., 1995). 
When oxLDL is internalised by the cell, the resulting increase in intracellular 
oxidative stress stimulates the inflammatory response (Frostegard et ai., 1996; Rosenfeld, 
1996). The increase in intracellular oxidative stress is likely to be responsible for many of the 
other changes in gene expression that oxLDL causes, NFKB, found in monocytes, 
macrophages, smooth muscle cells and endothelial cells in atherosclerotic lesions, is 
upregulated by oxidative stress and downregulated by antioxidants. It is a transcription factor 
that controls inflammatory responses (Suzuki et ai., 1994; Kaul and Forman, 1996; Flohe et 
al., 1997; Draczynska-Lusiak et al., 1998; Ginn-Pease and Whisler, 1998, Josse et at., 1998; 
Li et at., 1999), regulating TNFu, IL-1, IL-8, granulocyte and macrophage colony stimulating 
factors G-CWSF, M-CSF and GM-CSF, monocyte chemotactic protein, tissue factor and 
several adhesion molecules, most of those factors found to be regulated by oxLDL (Brand et 
al., 1997). 
OxLDL may cause oxidative stress extracellularly in the plaque by stimulating radical 
production. The protein moiety of oxLDL stimulates NADPH oxidase in U937 and THP-1 
macrophage-like cells and polymorphonuclear leukocytes (Kopprasch et al., 1998; Nguyen-
Khoa et at., 1999), and both oxLDL and oxLp(a) stimulate superoxide synthesis in 
endothelial cells (Galle et ai., 1999B). 
OxLDL can also alter the activities of other enzymes, One example is phospholipase 
A2 (type II), a C~+ -dependent enzyme that hydrolyses phospholipids at the sn-2 position, 
yielding free fatty acids and lysophospholipids. The enzyme is secreted from macrophages 
and found associated with them in the lipid core. It is upregulated by mildly oxidised LDL 
and the cytokines the oxLDL upregulates. It hydrolyses phospholipids in LDL, producing 
lysophosphatidylcholine (LPC) (Hurt-Camejo and Camejo, 1997; Anthonsen et at., 2000). 
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The inflammatory conditions and the activated immune ce1ls contribute to the further 
oxidation ofthe minimally oxidised LDL, which, as it is more extensively oxidised, takes on 
different properties, and continues plaque progression, in particular through foam cell 
fonnation and cell injury and death. 
LDL OXIDATION 
The oxidation ofLDL is central to the current view of atherosclerotic development. It 
is commonly pinpointed as an indicator of atherosclerosis, and how easily it becomes 
oxidised has been linked with a donor's susceptibility to developing the disease. For example, 
a significant correlation was found between susceptibility ofLDL to oxidation by copper and 
severity of coronary atherosclerosis, as assessed by angiography, in young male survivors of 
myocardial infarction (Regnstrom et al., 1992). It is important to note, however, that the 
evidence for its oxidative function in atherosclerosis is often indirect and does not absolutely 
prove a causative role (Stocker, 1994). 
Another factor to be aware of is that tenns in the literature such as 'oxidative 
modification', 'minimally modified' and 'extensively oxidised' are not well defined and their 
definitions vary between laboratories. An attempt at definition is sometimes made through 
the measurement of indices of oxidation, such as TBARS and relative electrophoretic 
mobility. 
A number oflines of evidence support the existence of oxLDL in vivo. Many lipid 
and protein products ofLDL oxidation have been found in atheromas (Chisholm and 
Steinberg, 2000). A large proportion oflipids in the lesion are oxidised (Stocker, 1994) and 
early to late products of oxidation have been found, from cholesteryl hydroperoxides to 
aldehydes. Oxysterols and oxidised fatty acids have been found in lesions and plasma using 
HPLC and GC-MS techniques. They are more abundant in lesions, both fatty streaks and 
advanced plaques, than in nonnal arteries. Levels of oxysterols are high enough to be toxic to 
cells (Daughtery and Roselaar, 1995; Liu et al., 1997A; Garcia-Cruset et al., 2001). 
There is little evidence of oxidation products actually within macrophage cells, as 
might be expected from its later accumulation there during foam cell development. This is 
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usually put down to the difficulty of isolating sufficient cells. However, one study found 
oxysterols at concentrations several-fold higher than in the plaque itself (Jessup and 
Kritharides, 2000). 
The level oflipid oxidation found in human lesions is often proportional to the 
severity of the atherosclerosis (Stocker, 1994; Carpenter et ai., 1995B), although this is not 
always the case (Carpenter et ai., 1995A). 
Lipoprotein fractions oflesions from humans and rabbits have been found to have 
characteristics of oxLDL (Chisholm and Steinberg, 2000) such as increased electrophoretic 
mobility, fragmented apoB and monocytic chemotaxis. In some studies this oxLDL is taken 
up by scavenger receptors, in others it is not (Steinbrecher and Lougheed, 1992; Daughtery 
and Roselaar, 1995) . 
. Lipoprotein fractions oflesions are also able to react with oxLDL-directed antibodies, 
however care in interpretation is required in this approach, as these epitopes are also found on 
apoptotic cells (Chisholm and Steinberg, 2000). In five studies using poly- or monoclonal 
antibodies raised against forms of oxLDL or aldehyde-modified LDL and used against 
lesions of Watanabe heritable hyperlipidemic (WHHL) rabbits, all antibodies stained 
macrophage-rich regions of fatty streaks, only extracellular material in advanced plaque and 
nothing in normal arteries (Esterbauer et ai., 1992). In rabbit lesions with monoclonal 
antibody against the lysine-MDA adduct, quite specific for oxLDL, a positive result was 
found intraceUularly in fatty streaks, and in diffuse and extracellular areas in more advanced 
plaque (Daughtery and Roselaar, 1995). 
An argument against the oxidation ofLDL has been the presence of antioxidants in 
plaque. One study of 11 human atherosclerotic advanced plaque samples found levels of 
ascorbic acid and a-tocopherol comparable or higher than in normal arteries. It is thought no 
oxidation could occur under these conditions. However, oxidation might possibly take place 
by processes unaffected by antioxidants, such as those carried out by enzymes or 
peroxynitrite. The increase in antioxidants might also be a response to oxidative attack in the 
plaque, not found until after the oxidation has occurred (Suarna et al., 1995; Patel et al., 
2000). 
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The presence of oxLDL does not prove it is involved in the disease process. Studies 
with antioxidants are often used to attempt to show a causal relationship, although the 
oxidative stress they are blocking might have originated from a different source. 
A survey of antioxidant studies on lesion dcvelopment in animal models showed that 
16 of23 studies found inhibitory effects slowing lesion development by 30-50%, two reports 
had insignificant positive results, and the remaining five found negative results. The 
antioxidants used included probucol, BHT, N,N' -diphenylphenylenediamine and vitamin E 
(Chisholm and Steinberg, 2000). 
Howcver, a comparison of studies with individual antioxidants shows that results are 
very inconsistent. Both probucol and vitamin E may potentiate atherosclerosis, be beneficial 
against it, or have no effect in different models (Daughtery and Roselaar, 1995; Mitchinson et 
ai., 1996). 
Many antioxidants also have other anti atherogenic properties which may account for 
their inhibition of atherosclerosis. For example, probucol inhibits monocyte adherence and 
decreases their release ofIL-l~. Other analogues ofBHT without these extra effects have had 
no anti atherogenic effects in WHHL rabbits (Daughtery and Roselaar, 1995), Vitamin E 
might inhibit the proliferation of smooth muscle cells (Esterbauer and JUrgens, 1993). 
Trials in humans are limited by only being able to assess atherosclerotic development 
by indirect means such as mortality or morbidity, or angiographic detection of lesions. Most 
prevention trials show no effects of antioxidants on mortality or vascular events (YUi-
Herttuala, 1998). 
Out of four vitamin E supplementation trials done on patients who already had 
coronary artery disease, three had no effect, and one showed a decrease in the number of 
infarcts, but not on total mortality. It is likely that antioxidants are unable to have much of a 
protective effect at this late stage of atherosclerotic development (Li et ai., 1999; Chisholm 
and Steinberg, 2000). 
Several epidemiological studies have looked at antioxidant serum or plasma levels 
and found that popUlations with higher antioxidant levels are at less risk of ischemic heart 
disease mortality, in the case of vitamin E (Ester bauer and JUrgens, 1993), or coronary artery 
disease in the case of selenium (YUi-Herttuala, 1998). Patients with angina or peripheral 
m1ery disease are likely to have lower levels of vitamin C than controls, and humans with 
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peripheral artery disease and coronary artery disease have low plasma levels of superoxide 
dismutase and thiols (Belch, 1994). 
THE MECHANISM OF LDL OXIDATION 
In the laboratory the process ofLDL oxidation in the plaque is emulated using eu2+ 
ions. A ratio ofLDL to Cu2+ of 1: 10-20 over 12-24 hours is required (Esterbauer et al., 1992). 
The Cu2+ binds to the LDL particle on apoB by complexing with histidine or lysine 
and is activated by reduction to Cu +, which might be carried out by cysteine residues of apoB, 
pre-existing hydroperoxides, or material released by a neighbouring cell, such as thiols, 
superoxide anions or hydrogen peroxide (Esterbauer et al., 1988B; Esterbauer and JUrgens, 
1993; Gieseg and Esterbauer, 1994). Oxidation is then most likely to occur by metal-
catalysed decomposition of endogenous peroxides in LDL (Jessup et al., 1990). The cuprous 
ions break down the preexisting lipid hydroperoxides by a Fenton-type reaction to fonn 
alkoxyl radicals, which can attack PUF As and initiate a chain reaction. 
Cu + + LOOH -j> Cu2+ + OH- + LO' 
This scheme is supported by evidence that the reaction with copper is dependent upon 
the initial concentration of lipid hydroperoxides (Noguchi et al., 1993). 
The seeding peroxides may come from dietary fats, or a small amount of oxidation 
occurring in the bloodstream, or, if being tested in vitro, from the process of preparation of 
the LDL (Halliwell and Gutteridge, 1999), In the absence of detectable hydroperoxides, the 
Cu+ might fonn a transition complex with molecular oxygen, [Cu2+-02-'], which can also 
initiate oxidation or release superoxide (Esterbauer and Jiirgens, 1993), 
CELL-MEDIA TED OXIDATION 
It seems likely that the cells within the plaque, and the products they secrete, 
contribute to the oxidation ofLDL within the intima. There are many cells present, and they 
have all been shown to influence this process in vitro. 
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Oxidative modification mediated by cells yields oxLDL with apparently similar 
characteristics to the material obtained in vitro using only copper ions (Jessup et at., 1990). 
This is not surprising, as cell-mediated oxidation also requires metals in the medium in most 
cases, although at much lower concentrations (Kuzuya et at., 1992; Meyer et at., 1995). 
Transition metals and cells are most likely to cause oxidation via catalytic decomposition of 
endogenous peroxides in LDL, analogous to the process in eu2+-mediated oxidation (Jessup 
et at., 1990). LDL prone to oxidation by eu2+ is also more prone to oxidation by cell-
mediated methods (Frostegard et al., 1995). Hence in vitro oxidation represents the in vivo 
situation, as far as is currently known (Garner and Jessup, 1996). 
All cell types in the lesion can oxidise LDL under the right conditions, including 
lymphocytes and activated platelets (Christen et al., 1994; Volf et at., 2000). However, 
neither of these, nor smooth muscle or endothelial cells, are at high concentrations in early 
lesions (Chisholm and Steinberg, 2000), while monocytes and macrophages are much more 
plentiful (Volf et at., 2000). 
A number of specific cell media LDL oxidation mechanisms have been proposed. 
Cells might accelerate oxidation by providing seeding peroxides from their own membranes 
to LDL (Aviram and Rosenblat, 1994; Garner and Jessup, 1996), or maintaining metals in an 
active state by metal reduction (Stocker, 1994). The cells may reduce metals through an 
oxidoreductase enzyme in a process known as transplasma membrane electron transport 
(Garner et al., I 997B; Baoutina et at., 2001B), production of superoxide and hydrogen 
peroxide (Chisholm III et al., 1999), or thiol-recycling (Wood and Graham, 1999). 
If a metal-dependent LDL oxidation in vivo is to be accepted, the source of the 
transition metal ions in vivo must be clarified. Many authors dispute their availability. Others, 
however, say that pro-oxidant iron and copper ions are present in the arterial wall (Smith et 
al., 1992), while two separate groups claimed to find iron deposits in lesions using 
histochemical techniques (Gamer and Jessup, 1996). 
Iron and copper may be available in the acidic and oxidative conditions of an 
inflammatory lesion (Kuzuya et at., 1992; Morgan and Leake, 1993; Winrow et al., 1993; 
Lamb and Leake, 1994; Balagopalakrishna et at., 1999; Halliwell and Gutteridge, 1999), or 
INTRODUCTION 41 
reactions might be catalysed by bound metals (Gamer and Jessup, 1996; Chisholm III et al., 
1999; Herpfer et al., 2002). 
Some possible mechanisms have been proposed that may account for LDL oxidation 
in the intima in the absence of metals. These could also playa part by augmenting any metal-
dependent oxidation that may occur. They are present in the artery due to the activation of 
inflammation (YUi-Herttuala, 1998). 
Reactive oxygen species such as superoxide might be important. However, results of 
studies with SOD, catalase and NADPH oxidase have been inconclusive (Jessup et ai., 1993; 
Wilkins and Leake, 1994; Gamer and Jessup, 1996; Chisholm III et ai., 1999). Superoxide 
and its derivatives may have their importance in cases of potential reactions with NO or 
HOCI(Gamer and Jessup, 1996; Chisholm III et al., 1999; Patel et ai., 2000). 
Indirect evidence of a role for 15-lipoxygenase is provided by a range of cellular and 
in vivo studies, including transfection into cells, overexpression of the enzyme and use of 
inhibitors, suggesting it at least plays a contributory part in oxLDL formation (Chisholm III 
et ai., 1999; Cathcart and Folcik, 2000; Chisholm and Steinberg, 2000). 15-Lipoxygenase 
may act on LDL after uptake, or its products may be transferred to LDL as seeding 
hydroperoxides during their excretion via the CD36 receptor (Cathcart and Folcik, 2000). It 
might also act through the signalling properties of some of its products (Chisholm III et al., 
1999). The enzyme has been found in both human and rabbit lesions (Folcik et al., 1997). 
In vivo evidence of myeloperoxidase' s participation includes the fact that 3-
chlorotyrosine and hypochlorite oxidised proteins have been found in human lesions 
(Kopprasch et al., 1998), and lesions have been found to contain material recognised by 
monoclonal antibodies raised against HOCl-modified LDL (Stocker, 1994). 
THE PROCESS OF LDL OXIDATION AND ITS PRODUCTS 
LDL oxidation has three main phases, each of which are characterised by certain 
processes and oxidation products, Once oxidation is initiated, the lag phase, during which 
lipophilic antioxidants are consumed, begins. (l-Tocopherol is depleted first and p-carotene 
last (Esterbauer et a!., 1992). The lag phase is a sum of the antioxidant-dependent lag and the 
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autoacceleration, which is a function ofthe concentration ofLDL and the occupancy of eu2+ 
binding sites (pinchuk et al., 1998). 
Once the antioxidants are gone, oxidation can proceed unchecked, in the propagation 
phase (autocatalysis), at the fastest possible rate. The acceleration is exponential, to a 
maximum ofthree molecules oflipid hydroperoxide per LDL per minute (Esterbauer et al., 
1992). Fatty acids, found esterified to sterol in phospholipids and triglyceride, are oxidised in 
this phase, primarily to lipid hydroperoxides (Steinberg, 1997). 
Fonned in parallel are the oxysterols, which result from cholesterol oxidation 
(Esterbauer et ai., 1992; Noguchi et ai., 1993; Clare et ai., 1995). The precursors are 7a- and 
7p-hydroperoxycholesterol, found in the early stages of the plaque. By advanced plaque, it 
has decomposed and rearranged to fonn the more abundant 7-oxysterols (Brown et ai., 1997; 
Jessup and Krithrides, 2000). These 7-oxysterols, including 7a- and 7P-hydroxycholesterol 
and 7-ketocholesterol, make up 40% of oxysterols initially fonned during oxidation. Other 
oxysterols include a- and p-cholestan-5,6-epoxy-3p-ol (Liu et ai., 1997A), cholesterol-5a,6a-
epoxide, cholesterol-5p,6p-epoxide and cholestanetriol (Chang et ai., 1997; Garcia-Cruset et 
ai.,2001). 
Other common oxysterols, for example 26-hydroxycholesterol (also known as 27-
hydroxycholesterol), are fonned by enzymatic processes. Its concentration increases with 
lesion severity, consistent with its production by the cytochrome P450 sterol 26-hydroxylase 
enzyme, which is produced by cells in response to cholesterol build-up (Carpenter et ai., 
1995B; Liu et aI., 1997A; Jessup and Kritharides, 2000; Garcia-Cruset et ai., 2001). 
The third phase of oxidation, decomposition, begins once 70-80% of the PDF As are 
oxidised. The phase is characterised by a slow decrease in lipid hydroperoxide concentration, 
due to their labile nature, and an increase in aldehydes, fluorescent chromophores in apoB, 
and negative surface charge and fragmentation of apoB. LDL is not found to be in a high 
uptake fonn (leading to foam cell development) until this phase (Esterbauer et ai., 1992). 
The hydroperoxides from PUF A oxidation are reduced to hydroxides, ketones and 
aldehydes, and undergo carbon-carbon bond cleavage in the presence of transition metals to 
fonn reactive short 3-9 carbon chain aldehydes. Aldehydes can also be fonned by amino acid 
oxidation (Uchida, 2000). 
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Examples of the short chain aldehydes include malondialdehyde (MDA), which 
accounts for an estimated 20% of aldehydes fonned during in vitro LDL oxidation, 4-
hydroxy-2-trans-nonenal (4-HNE), also around 20% (Requena et al., 1997) and hexanal, 
which makes up 40% of the aldehydes (Requena et al., 1997). Other common aldehydes are 
glyoxal and the 2-alkenal acrolein (Uchida, 2000). 
The aldehydes are more stable than free radicals, enabling the hydrophilic ones such 
as MDA to diffuse within or even escape the LDL (Uchida, 2000). They may also fonn 
adducts with apoB or other lipids, especially amino lipids, and stay associated with LDL. 
Lipophilic aldehydes remain with the LDL particle (Esterbauer et al., 1992; Jessup and 
Krithrides, 2000). 
Conjugation of aldehydes to apoB is an important part of the process that apoB 
undergoes during oxidation. The adducts most often cited are found between acrolein, 4-HNE 
or MDA and lysine (Uchida, 2000). 30-40% of the lysine residues are modified in this way 
(Requena et al., 1997). The reaction occurs by Schiff base fonnation (shown below) or by 
the fonnation of Michael adducts with a,p-aldehydes (Esterbauer et al., 1992). Lipid 
peroxidation products such as fatty acid epoxides, hydroxides and hydroperoxides can also 
cause derivatisation of apoB (Steinbrecher et al., 1989). 
R-CHO + protein-NH3+ ---+ R-CH=N-protein + H20 + W 
The amino acids most susceptible to oxidation and derivatisation are lysine 
(mentioned above), cysteine, and the aromatic residues tryptophan, tyrosine and histidine. 4-
HNE fonns adducts with histidine (Uchida, 2000) and cysteine's -SH groups, halving the 
number of free cysteines. Forty percent of tryptophan is oxidised through reactions with 
MDA or 4-HNE (Vanderyse et al., 1992). These reactions neutralize the positive amino 
acids' charges and increase the negative surface charge of the LDL (Pifat et al., 1992). 
There are also other modifications to LDL during oxidation. Reactions with aldehydes 
can cause crosslinking and lead to covalent aggregation (Meyer et al., 1995; Volf et al., 
2000). Alkoxyl radicals cause fragmentation, with apoB first broken into 260kDa and 
232kDa fragments, and then into pieces smaller than 100kDa (Esterbauer et al., 1992). 
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Short-chain core aldehydes derived from phosphatidylcholine are hydrolysed by 
lipoprotein-associated phospholipase A2 to lysophosphatidylcholine (LPC), which increases 
4.3-fold during LDL oxidation (Carpenter et al., 2001). 
EFFECT OF ANTIOXIDANTS ON LDL OXIDATION 
Various antioxidants have been shown to be effective against LDL oxidation 
mediated by cells and eu2+. For example, 1 OOJ-tM vitamin E was able to prevent oxidation by 
endothelial cells as assessed by TBARS and macrophage uptake. BHT and probucol are other 
lipid-soluble antioxidants that were effective. Water-soluble antioxidants tested include 7,8-
dihydroneopterin, 3-HAA, urate, glutathione and ascorbate, which spares other antioxidants, 
possibly reactivating a-tocopherol radicals to a-tocopheroL Calcium antagonists, metal 
chelators and platelet activating factor also have an effect (Esterbauer et al., 1992; Deigner 
and Dresel, 1993; Gieseg and Cato, 2003). 
In vivo, probucol inhibited LDL oxidation in WHHL rabbits and retarded lesion 
development in the aorta. Probucol was not effective in cholesterol-fed rabbits, although BHT 
was (Steinbrecher and Lougheed, 1992). 
FOAM CELL FORMATION 
Inside the subendothelium, monocytes are differentiated to tissue macrophages and 
become activated, contributing to LDL oxidation and inflammation in generaL By the time 
the fatty streak has developed, most have become lipid-filled foam cells, which make up the 
greater part of the lesion at this stage (Figure 4) (Hegyi et al., 1996). 
This transformation occurs by unregulated uptake of highly oxidised LDL. Early 
studies concluded that smooth muscle cells made up the whole foam cell popUlation. 
Macrophages were not considered to be significant until later studies on cells isolated from 
rabbits and monkeys found 80-90% of foam cells had characteristics of macrophages 
(Newman, et at., ·1971; Schaffner et aI., 1980). 
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Figure 4: Foam ce ll formation in the atherosclerotic plaque. Adapted from Lusis, 2000. 
It is probable that oxLDL is mainly taken into the cells by receptor-mediated 
endocytosis via scavenger receptors AI and AIr. which wcr~ the first to be described 
(Nicholson et al., 1995A). They also take up acetyktted LDL. Scavenger receptors are 
upregulated by M -CSF, P DGF and differentiation and down-regulated by Iymphokines, 
T NFa, transforming growth factor~, GM-CSF and LPS (Daughtery and Rose laar, 1995; 
Kozaki et al., 1997) . fsoform r is downregulated by IFNy and consequently, fewer roam cdls 
are found in T cell-rich regions (Gre wal et al., 2001). They are not regulated by increasing 
cellular cholesterol content (Steinbrecher et al., 1987 ). 
Modification of the lysine residues on DL is important for recognition by the 
scavenger receptor (Lougheed et al., 1991). Schi ff bases between the epsilon amino groups of 
lys ine and ;,:ddchydes increase the negative charge of the lipoprotein, which is responsihle for 
interaction with the positively charged collagen domain of the scavenger receptor 
(Steinbrecher et al., 1987; Nicholson et ul. , 1995; Bird et al., 1999). Loss of positive charge 
can also come from a structural change, such as fragmentation (Noguchi et ul., 1993). 
Lipids may also have a role , as oxLDL can compete for uptake with apoPlotic cells, 
which are recognised by phosphatidylserine (Hird et at., 1999). Phospholipid aldehydes (such 
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as MDA and 4-HNE), as free lipids or bound to apoB, are suggested to contribute to receptor 
binding (Jessup and Krithrides, 2000). 
More macrophage receptors that can bind and internalize oxLDL are constantly being 
discovered. CD36 (also known as thrombospondin receptor) and CD32 or FcyRII-B2 
recognise LDL oxidised by copper but not acetylated LDL (Daughtery and Roselaar, 1995; 
Rosenfeld, 1996). MacrosialinlCD68 and LOX-l (Hakamata et at., 1998), SR-PSOX 
(Shimaoka et ai., 2000) and a class B scavenger receptor type I (Nicholson et at., 1995A; 
Jessup and Krithrides, 2000) also take up oxLDL. 
OxLDL can also gain access to the cell without the need for a receptor. A receptor 
merely adds efficiency to oxLDL's delivery (Chisholm III and Chai, 2000). Aldehydes and 
oxysterols, for example, can partition from the lipid phase of the oxLDL into the cel1's 
plasma membrane (Gotoh et ai., 1993; Brown et at., 1997). OxLDL can also be taken up by 
non-specific receptor-mediated endocytosis, especially in an aggregated form (Khoo et al., 
1988; Brown et ai., 1997; Hakamata et ai., 1998). 
After endocytosis, LDL goes through the lysosomal system. The enzymes hydrolyse 
the cholesteryl esters and break down the protein and lipid ofLDL to products that can 
traverse the lysosomal membrane (Maor and Aviram, 1994; Wei et at., 1998). 
Unesterified cholesterol and oxysterols are then transported to the membranes, where, 
if there is more cholesterol than the cell requires, it would normally be exported by reverse 
cholesterol transport (Jessup and Kritharides, 2000). However, this process is impaired in 
foam cells (Yancey and St Clair, 1992), and the excess cholesterol is esterified by acyl-CoA: 
cholesterol acyltransferase (ACAT), the activity of which oxLDL augments. It is then 
deposited in the cytosol as insoluble lipid droplets. The lipid droplets are responsible for the 
name 'foam cell' (van Reyk and Jessup, 1999). Cytoplasmic lipid droplets are mostly 
esterified cholesterol and some triglycerides (Naito et at., 1997; Kritharides et at., 1998). 
Unesterified cholesterol, mainly from heavily oxidised LDL, may accumulate in 
lysosomes, ifit is resistant to lysosomal degradation (Lougheed et al., 1991; Esterbauer et ai., 
1992; Bolton et al., 1997; van Reyk and Jessup, 1999) or has inactivated lysosomal enzymes 
(O'Neil et at., 1997; Wei et ai., 1998; Yuan et ai., 2000), and is not available to ACAT for re-
esterification. This leads to crystallization and precipitation (Maor and Aviram, 1994). Free 
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cholesterol crystals of cholesterol monohydrate have been seen after 48 hours of cell 
incubation with heavily oxLDL (Kellner-Weibel et al., 1998). 
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A progression in foam cell make-up is found in atherosclerosis. Patty streaks contain 
macrophages with cholesterol ester cytoplasmic inclusions, fibrous plaques have lysosomal 
inclusions in macrophages and complicated lesions have smooth muscle foam cells as well 
(Hoff et al., 1991). 
EFFECT OF ANTIOXIDANTS ON FOAM CELL FORMATION 
Antioxidants may also have an effect on this stage of atherosclerotic development. It 
was suggested vitamin E loading ofLDL inhibited cholestcryl ester accumulation in 1774 
macrophages, by preventing cholesteryl ester formation by ACAT (Suzukawa et at., 1994). 
However, the LDL used was not very oxidised, having only been incubated with 5JlM Cu2+ 
for 90 minutes, and would not have been recognised by scavenger receptors. Another study 
found that loading with vitamin E before cholesterol uptake in macrophages did not affect 
foam cell fonnation (Asmis and Jelk, 2000). 
FOAM CELL DEATH 
Once foam cells are formed, the next change observed in the lesion is the formation of 
the acellular lipid core, sometimes called the necrotic core (Figure 5). This is a mass of 
extracellular lipid, mostly cholesterol and cholesterol esters. It will eventually have a cap of 
smooth muscle cells (Mitchinson et al., 1996). This core is thought to come about by 
macrophage foam cell death (Martinet and Kockx, 2001). Evidence given for this is the 
presence of macrophage antigens and ceroid in the core (Mitchinson et at., 1996). Ceroid is 
polymerized lipid and protein (Wei et al., 1998), and comes predominantly from 
macrophages, after the crosslinking of protein of oxLDL and lysosomal proteases (O'Neil et 
at., 1997). 
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Figure 5: Foam cell death and the formation of thc acellular lipid core in atherosclerosis. 
Adapted from Lusis, 2000. 
In spite of the name 'necrotic core', it is now thoughl that most cells in the plaLJlIl' die 
by JPoptosis. Th~ percentage of apoptotic cells measured in plaques of humans and animal 
models has been found to range from less than I % to 60% . This variation is due to lhe 
technique commonly employed, TUN L. It can be non-specific in tissues, labelling non-
nuclear material, non-apoptotic nuclei with acti ve gene transcription, necrotic cells and 
matrix vesicles formed as J result of cell di sintegration. The TU EL assay also may not 
differentiate between cell types, and only marks the execution phase of apoptosis which, in 
cell culture, takes less than six hours. As apoptosis is usually very rapid and quickly cleared 
by surrounding cells, lower estimates are more reasonable (Harada et at., 1997 A; Jovinge et 
at., 1997; Kockx, 1998). 
Only low levels of apoPlosis have been detected in intimal thickened arteries or fatty 
streaks, with the highest levels found in advanced plaque (Kockx, 1998). Cells may undergo 
apoptosis in all parts of the lesion (Kockx et at., 1996), but most apoptotic cells are reported 
to be in the core and fihrous cap, close to oxLDL immunoreactive areas (Hegyi et al., 1996; 
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Jovinge et al., 1997). Most apoptotic markers are also in regions with high densities of 
macrophages, rather than smooth muscle cells (Martinet and Kockx, 2001). 
In spite of this, other cell types, such as endothelial cells, smooth muscle cells and 
lymphocytes, do undergo cell death in the lesion (Martinet and Kockx, 2001). Smooth muscle 
cell death is particularly important, since they form the cap of the lipid core. Apoptotic 
smooth muscle cells have been found in plaque, and also in ballooned rat and mouse carotid 
and rabbit iliac arteries after injury (Bennett and Boyle, 1998). 
The apoptosis is thought to be caused by oxLDL and other factors of inflammation 
such as IFN-y, TNFu, IL-l~ and NO and its derivatives (Mitchinson et al., 1996; Bennett and 
Boyle, 1998; Farber et al., 1999; Martinet and Kockx, 2001). OxLDL causes classic 
apoptosis, characterised by reduction in replication, intemucleosomal DNA degradation, 
blebbing, fragmentation, pyknosis and chromosome condensation (Bjorkerud and Bjorkerud, 
1996). OxLDL induces apoptosis in endothelial cells, lymphocytes, smooth muscle cells, 
macrophages, fibroblasts, lymphoblastoid cells, thymocytes, fibrosarcoma cells, and neurons 
(Fossel et al., 1994; Bjorkerud and Bjorkerud, 1996; Chisholm III and Chai, 2000; Rusinol et 
al.,2000). 
Anv ANCED PLAQUE 
The American Heart Association has classified advanced plaques into three groups, 
depending on composition. Type IV, the atheroma, is predominantly made up oflipid core. 
This is the acellular collection of lipid-rich debris in the deeper part of the plaque, which 
forms as a result of the foam cell and non-foam cell death outlined above. Both intermediate 
and advanced lesions have disintegrating macrophages at the edge of the core and 
macrophage contents within it. Part of this lipid is ceroid, thought to be largely oxLDL 
released from macrophages after their death (Mitchinson et al., 1995). 
There are two varieties of type V. The first is calcific. The predominant mineral form 
is hydroxyapatite, which may be associated with elastin (Stary et al., 1995). The second 
variety has fibrous thickening. Here the lipid core is covered by a fibrous cap and surrounded 
by tissues containing fibres and cells, especially macrophages and smooth muscle cells 
(Mitchinson et ai., 1995). 
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Due to the production of growth factors by surrounding cells, and the elimination of 
the growth inhibitory effect of intact endothelium, around half the smooth muscle cells in the 
intima experience a change in phenotype, becoming able to divide, which leads to a gradual 
increase in the size of the plaque, as well as fibrous cap formation (Jang et at., 1993; 
Steinberg, 1997). 
PLAQUE RUPTURE AND CLINICAL COMPLICATIONS 
If the plaque ruptures, proteins of the blood's coagulation system contact the highly 
thrombogenic material (especially lipids and collagen) of the core (Libby et al., 1998), and a 
blood clot, or thrombus, will fonn. A complicated plaque, containing hematomas or thrombi, 
is the third type of advanced plaque classified by the American Heart Association (Stary et 
at., 1995). A small thrombus may simply contribute to rapid progression of the plaque, 
increasing its complex nature (Jang et al., 1993), Three-quarters of plaques which eventually 
rupture and cause death are found to have ruptured previously (Vinnani et al., 2000). 
Ifthe clot is larger, it may lead to acute ischemic syndromes such as unstable angina, 
myocardial infarction or ischemic sudden death (Jang et al., 1993). Ruptures are the cause of 
death in around 60% of sudden coronary deaths (Virmani et al., 2000). This is a more 
frequent cause of death than obstruction, since the vessel will remodel itself to compensate 
for the lesion (Libby et al., 1998). 
Rupture often occurs at the edge of the lesion, an area rich in inflammatory foam cells 
and T cells, with a decreased number of smooth muscle cells. Macrophages in particular are 
the predominant cells in unstable areas. One way they contribute to instability is by 
producing inflammatory factors. A higher incidence of myocardial infarction and stroke is 
found during infections, during which inflammation is particularly predominant (Lusis, 
2000). 
Inflammatory conditions also increase apoptosis, among both the macrophages and 
the smooth muscle cells. Pronounced cell loss of any cell type by apoptosis increases 
likelihood of rupture (Kockx et at., 1996). Apoptotic macrophages are greatly increased in 
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ruptured plaques compared to stable ones in atherectomy specimens from patients with 
unstable angina (Yao and Tabas, 2001). 
Loss of foam cell macrophages enhances plaque instability by increasing lipid 
accumulation and the release of inflammatory factors as a result of their death. Fewer 
macrophages also means fewer apoptotic cells are able to be cleared, and more secondary 
necrosis occurs, amplifying the release of cellular contents and increasing the acellular lipid 
core (Martinet and Kockx, 2001). 
The advantages of a reduction in macrophage number relate to smooth muscle cells 
and their formation of the new extracellular matrix and fibrous cap. Smooth muscle cells 
provide structural strength to the plaque through their production of proteins such as collagen 
(Bennett and Boyle, 1998). Without macrophages, there will be more smooth muscle cells, 
as the potentially damaging cells are removed (Kaikita et al., 1997), and there will be less 
macrophage synthesis of enzymes which break: down the matrix, such as metalloproteinases, 
collagenases, gelatinases, stromolysin and cathespins, which will also be released upon foam 
cell death (Bennett and Boyle, 1998; Martinet and Kockx, 2001). The presence of 
macrophages in a plaque therefore has both positive and negative effects. 
In summary, then, monocytes and macrophages, their activation in inflammation and 
the oxidative stress which results, as well as oxLDL, are important components in every part 
of atherosclerotic development. 
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RESEARCH PROGRAMME 
The following work will examine one particular stage of the development of 
atherosclerosis: the apoptosis of monocytes and macrophages caused by oxLDL, which leads 
to foam cell death and the growth of the acellular lipid core of the plaque. This is crucial to 
the clinical outcome ofthe plaque. Many factors may contribute to the death of the cell in this 
situation, and here we look in particular at the cell's ability to protect itself from the 
surrounding oxidative stress with its own antioxidant, 7,8-dihydroneopterin. 
The effect of peroxyl radicals generated by AAPH on the cell viability of two 
monocyte-like cell lines, THP-l and U937 cells, is examined in Chapter 3. Two assays, the 
MTT and the trypan blue assay, are used to measure changes of viability directly, and the 
DTNB assay looks at alterations in total cellular reduced thiollevels. 78NP is added to the 
cells in an attempt to protect them from cell viability and reduced thiolloss. 
The same assays are used to examine the effect of oxLDL on the same two cell lines 
in Chapter 4, and 78NP is also included. Details of how 78NP may act as an antioxidant and 
how it may interact with oxLDL and the cells are then clarified. The effect of AAPH, oxLDL 
and 78NP on a PMA-differentiated THP-l macrophage-like cell line is examined. 
The induction of apoptosis by oxLDL in the monocyte-like cell lines is investigated in 
Chapter 5 using assays which examine caspase activation, phosphatidylserine exposure and 
changes in nuclear morphology. The effect of 78NP on these apoptotic characteristics is 
tested, and their relevance to a definition of apoptosis discussed. 
The production of78NP by the three cell types as a result of stimulation with IFNy is 
investigated in Chapter 6. Cells are then incubated with oxLDL and IFNy to test whether this 
level of 78NP is sufficient to protect the cells from cell viability loss. Finally, 78NP 
concentration in vivo is measured in samples of inflammatory material. 
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MATERIALS AND METHODS 
MATERIALS 
CHEMICALS 
All reagents used in this research were of analytical grade or better. All water was 
deionised and ultrafiltered using a Milli-Q filtration system. 
1 ,1,3,3-tetramethoxypropane 
1,4-dithiothreitol (DIT) 
2-thiobarbituric acid (TBA) 
2,2' -azobis (2-methyl-propionamidine) dihydrochloride 
3-aminopropyltriethoxysilane 
5 5' -dithiobis(2-nitrobenzoic acid) 
7,8-dihydroneopterin 
Acetic acid (glacial) 
Acetone 
Acetyl-Asp-Glu-Val-Asp-7-amido-4-methyl-coumarin 
Apotest-FITC A700 kit 
Argon gas 
Ascorbic acid 
BCA protein determination kit 
Bovine serum albumin 
Butylated hydroxytoluene 
CHAPS 
Chelex 20 resin 
Chelex 100 resin 
Chloroform 
Cholesterol reagent 
Copper (II) sulphate 5-hydrate 
Dimethyl sulphoxide (DMSO) 
Dialysis tubing 
Diammonium hydrogen orthophosphate 
Earle's Balanced Salts solution 
Ethanol 
Ethylene diamine tetracetic acid 
Eukitt mounting medium 
Ferrous ammonium sUlphate 
Fetal bovine serum 
Griess reagent (Modified) 
HEPES 
Hoechst 33342 
Hydrochloric acid 
Iodine 
Interferon-,), (specific activity 2x I 07 mg/protein) 
Lipoprotein Electrophoresis kit 
Neopterin 
Methanol 
MIT 
Sigma Chemical Co., St Louis, MO, USA 
Boehringer Maunheim GmbH, Germany 
Sigma Chemical Co. 
Aldrich Chemical Co., WI, USA 
Sigma Chemical Co. 
Sigma Chemical Co. 
Schricks Laboratory, Switzerland 
BDH Lab Supplies, Poole, England 
BDH Lab Supplies 
Sigma Chemical Co. 
Nexins Research, The Netherlands 
BOC Gases, New Zealand 
Sigma Chemical Co. 
Pierce, Illinois, USA 
Gibco BRL, N.Y., USA 
Sigma Chemic~l Co. 
Sigma Chemical Co. 
Bio Rad Laboratories, USA 
Bio Rad Laboratories 
BDH Lab Supplies 
Roche Diagnostics, USA 
BDH Lab Supplies 
Sigma Chemical Co. 
Biolab Scientific, New Zealand 
BDH Lab Supplies 
Sigma Chemical Co. 
Ajax Laboratory Chemicals, Australia 
Boehringer Mannheim GmbH 
Electron Microscopy Sciences, P A, USA 
Sigma Chemical Co. 
Gibco BRL, New Zealand 
Sigma Chemieal Co. 
Sigma Chemical Co. 
Sigma Chemical Co. 
BDH Lab Supplies 
BDH Lab Supplies 
Boehringer Mannheim GmbH 
Beckman Coulter, USA 
Schricks Laboratory 
BDH Lab Supplies 
Sigma Chemical Co. 
Nitrogen gas 
Orthophosphoric acid 85% 
Paraformaldehyde 
Penicillin/Streptomycin 
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(lOOOU/mL penicillin G and lOOO,..glmL streptomycin) 
Phorbol 12-myristate 13-acetate 
Potassium bromide 
Potassium iodide 
RPMI1640 
Sodium chloride 
Sodium dihydrogen orthophosphate 
Sodium dodecyl sulphate 
Sodium hydroxide 
Sodium nitrite 
Sucrose 
Sulphuric acid (18.44M) 
Tergitol, type NP-40 
Trichloroacetic acid 
Trypan blue solution (0.4%) 
Xylenol orange 
SOLUTIONS, BUFFERS AND MEDIA 
A. LDL PREPARATION SOLUTIONS 
EDTA FOR BLOOD COLLECTION 
BOC Gases 
BDH Lab Supplies 
BDH Lab Supplies 
Gibco BRL, N.Y., USA 
Sigma Chemical Co. 
BDH Lab Supplies 
May and Barker Ltd, England 
Sigma Chemical Co. 
BDH Lab Supplies 
BDH Lab Supplies 
Sigma Chemical Co. 
BDH Lab Supplies 
May and Baker Ltd 
Chelsea Sugar Refmery, Auckland 
BDH Lab Supplies 
Sigma Chemical Co. 
Sigma Chemical Co. 
Sigma Chemical Co. 
Sigma Chemical Co. 
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A lOOmglmL EDTA solution was prepared by dissolving EDTA in nanopure 
water and adjusting the pH to 7.4 with 10M NaOH, 
DENSITY GRADIENT SOLUTIONS 
The required amount ofNaCl was dissolved in nanopure water, to give densities of 
l.08g1mL, l.05g/mL and l.OOgimL. A lOmg/mL EDTA solution was prepared as above 
and added to each density gradient solution to give a final concentration of 1,Omg/mL. 
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PHOSPHATE BUFFERED SALINE 
PBS was prepared from stock solutions ofNaCI and NaH2P04 pH 7.4 to give final 
concentrations of 150mM and 10mM respectively. Before use, it was stirred overnight 
with washed with chelex-20, filtered, and bubbled with nitrogen gas for 10 minutes. 
LIPOPROTEIN GEL ELECTROPHORESIS SOLUTIONS 
B-2 barbital buffer at pH 8.6 was made by dissolving the contents of the buffer 
bottle in 1500mL nanopure water. The lipoprotein working stain was made by mixing 
3mL of concentrate with 165mL ethanol and 135mL nanopure water. The fixative was 
made by adding 90mL llanopure water to 450mL reagent alcohol and 30mL glacial acetic 
acid and mixing thoroughly. Destain solution was a mixture of 450mL ethanol and 550mL 
nanopure water. 
All solutions were stored at room temperature. 
B. SOLUTIONS FOR CELL EXPERIMENTS AND CULTURE 
MEDIA FOR CELL CULTURE 
Media was prepared from the powder according to the manufacturer's instructions 
and filtered using a Millex-GP50 filter unit of O.2211m pore size from Millipore 
(Molsheim, SA) and a CP-600 pump from Life Technologies, into sterilised bottles. It 
was stored at 4°C, but warmed to 37°C in a waterbath before use. 
MEDIA FOR CELL EXPERIMENTS 
RPMI with phenol red and L-glutamine was supplemented with 1O,OOOU/mL of 
penicillin/streptomycin and 5% heat inactivated fetal bovine serum. 
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PBS was prepared as above and autoc1aved (15 minutes, 121°C, 15psi). It was 
stored at 4°C and warmed before use. 
RPMI 1640 with L-glutamine but without phenol red and sodium bicarbonate, and 
Earle's Balanced Salts solution without phenol red or sodium bicarbonate were prepared 
as outlined above. 
PHORBOL 12-MYRISTATE 13-ACETATE 
A stock solution of PM A was made by dissolving PMA in DMSO to give a final 
concentration of 0.1 mg/mL. This was stored at -20°C, and diluted to 100ng/mL in RPMI 
1640 media before addition to the cells. 
7,8-DlHYDRONEOPTERIN SOLUTION 
7,8-Dihydroneopterin (2.552mg) was measured out using a Mettler Toledo UMX2 
microbalance (Mettler Toledo GmbH, Greifensee, Switzerland), and dissolved while on 
ice in a foil-covered bottle containing N2-bubbled PBS to a concentration of2.0mM. 
Before addition to cells, the solution was sterilised through a O.2flm fHter. 78NP solution 
was prepared fresh each day. 
C. SOLUTIONS FOR 78NP AND NEOPTERIN HPLC ANALYSES 
A 150mM neopterin standard was made up by dissolving neopterin in 10mM 
phosphoric acid through stirring and sonication in the dark. It was aliquoted out and 
stored at -20°C. 
The mobile phase was prepared on the day of analysis and consisted of a 20mM 
ammonium phosphate solution containing 5% methanol at pH 6, The mobile phase was 
filtered through a 0,45flM filter before use. 
The acidic iodide solution was made by dissolving 2.7g solid iodine and 5,4g 
potassium iodide in 35mL ofnanopure water. 3,71mL of50% TCA was then added, and 
the final volume made up to 5OmL. 
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D. SOLUTIONS FOR PUS PREPARATION 
20mg/mL BHT was made up in methanol and stored at 4°C. 
E. SOLUTIONS FOR HOECHST STAINING 
Two percent 3-aminopropyltriethoxysilane was made by diluting a 98% solution 
in acetone. 
A 4% paraformaldehyde solution was made by adding paraformaldehyde to water, 
heating to 60°C, and adding a few drops of 1M NaOH to help it dissolve. After cooling to 
room temperature, the solution was diluted with PBS. It was stored at -20°C . 
. Hoechst 33342 stain was diluted to ,a working concentration of 101lg/mL on the 
day of use in PBS. Stock stain was stored at -20°C. 
F. SOLUTIONS FOR l\fTT ASSAY 
MIT powder was dissolved in RPM! 1640 without phenol red to 5mg/mL, 
sterilised through a O.2llm filter and stored at -20°C for up to 2 weeks in the dark. 
A O.OIM HCl solution was made up from 11.44M HCI and nanopure water, and 
stirred slowly with 10% SDS. 
G. SOLUTIONS FOR DTNB THIOL ASSAY 
DTNB made up to 3mM in lOmM NaH2P04 buffer, stored at 4°C in tinfoil, and 
used within 2 weeks. 
H. SOLUTIONS FOR CASPASE ACTIVATION ASSAY 
Caspase buffer was prepared by dissolving sucrose, CHAPS and Tergitol NP-40 to 
final concentrations of 10%, 0.1 % and 10-4% respectively in a 100mM HEPES solution. 
The pH was adjusted to 7.25, and the buffer stored in 5mL aliquots at -20°C. 
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1M DTT was made up on the day of analysis in water, and kept it in the dark on 
Ice. 
DEVD-AMC, the caspase substrate, was dissolved in 100% DMSO by adding 
DMSO straight to the bottle the substrate was supplied in and swirling. It was stored in 
small aliquots at -20°C until required and refrozen no more than twice. 
I. SOLUTIONS FOR FOX ASSAY 
A 25mM solution of sulphuric acid was made from a 1M stock solution and 
replaced weekly, due to the leaching of ions from the glass bottle. 
The 5mM xylenol orange solution and 5mM ferrous ammonium SUlphate were 
made up in the 25mM sulphuric acid. 
72% TCA was made by dissolving 72g in nanopure water made up to a final 
volume of 100mL and was stored at 4°C. 
Methanol/chloroform and acetic acid/water mixtures were made up in a 1:1 ratio. 
J. SOLUTIONS FOR NITRITE ANALYSIS 
Griess reagent was dissolved in nitrogen-gassed nanopure water to give a working 
concentration of 4Omg/mL. 
K. SOLUTIONS FOR TBARS-HPLC LIPID ANALYSIS. 
The MDA standard was made by diluting a 6.07M 1,1,3,3-tetramethoxypropane 
solution in a 40:60 ethanol/water mix, then diluting further with water to the required 
concentration. 
The mobile phase was a 100mM sodium dihydrogen orthophosphate solution, 
which was adjusted to pH 6.8 with 10M sodium hydroxide. After filtration, 35% HPLC 
grade methanol was added, and the final mixture degassed by sonication. 
A 42mM 2-thiobarbituric acid solution was prepared fresh on the day of analysis 
in nanopure water by stirring on a hot plate. 
A 2Omg/mL BHT solution was made up in methanol and stored in the fridge. 
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METHODS 
LDL PREPARATION 
A. BLOOD COLLECTION AND PLASMA PREPARATION 
Two hundred mL of blood were drawn from each donor by venipuncture using a 
15G needle and line after an overnight fast The blood was collected directly into 50mL 
Falcon tubes containing O.5mL of 10% EDT A, to give a final concentration of 0.1 % 
EDTA.'The tubes were centrifuged at 4, 100g for 20 minutes at 4°C to separate the plasma 
from the cells . 
. The plasma wasthen transferred to-SS34 rotor centrifuge tubes, and centrifuged at 
11,000g for 30 minutes at 4°C in the fixed rotor. The plasma was collected into a single 
measuring cylinder, to which sucrose was added to give a final concentration of 0.6% 
sucrose before storage at -80°C in 20mL aliquots. Plasma was stored for no longer than 4 
months before use. 
B. EXTRACTION OF LDL FROM PLASMA 
A 20mL tube of frozen plasma was defrosted under cold running water, and then 
centrifuged at 4,100g for 10 minutes at 4°C to pellet precipitated fibrinogen. The 
supernatant was decanted into a beaker, and KBr gradually dissolved in it to a final 
concentration of 41 Omg KBr/mL plasma. The resulting solution was pipetted into 
ultracentrifuge tubes, 3.5mL per tube. 
Using a specially manufactured right-angled needle, NaClIEDTA solutions of 
decreasing densities were layered on top of the plasma. Tubes were then placed in the 
Beckman 41-Ti rotor in the Beckman L8-70M UR ultracentrifuge (Beckman Coulter, CA, 
USA) for 22 hours, at 40,000rpm and 10°C. 
At the end of this time, the tubes were removed from the rotor, and the VLDL 
layer taken off. The orange LDL layer was then sucked out using a right-angled needle 
attached to a syringe. The LDL was degassed with argon gas and filter sterilised into a 
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sterile 5mL serology tube. The purified LDL was stored at 4°C in the dark for a maximum 
of two weeks. 
C, DIALYSIS 
The LDL solution was dialysed to remove residual EDTA for 18 hours against 
three changes of the prepared PBS at 4°C. 
D. CHOLESTEROL DETERMINATION 
LDL concentration was determined as a function of cholesterol level using a kit 
supplied by Boehringer Mannheim. 
One mL of cholesterol reagent was added to 10jlL of LDL and incubated at room 
temperature for 20 minutes, after which the absorbance was measured at 500nm against a 
blank containing only cholesterol reagent. The concentration of the LDL was calculated 
assuming 31.64% of the LDL particle is cholesterol by weight, and that the molecular 
weight ofLDL is 2.5 MDa (Gieseg and Esterbauer, 1994). 
E. LDL OXIDATION 
LDL to be oxidised was filtered with Acrodisc O.2jlm Supor membrane sterile 
filters (Pall Gelman Laboratory, MI, USA) and incubated at 37°C for 24 hours with a [mal 
concentration of 50jlM CUS04. The CUS04 came from a 100mM stock solution, sterilised 
with a 0.2jlm filter before addition to LDL. The LDL was then stirred with chelex-lOO on 
a rotational mixer for two hours at 4°C to remove Cu2+ ions. 
F. LDL CONCENTRATION 
Both oxidised and non-oxidised LDL was concentrated five-fold before incubation 
with cells, using Urifil-l 0 concentrators (Millipore, MA, USA). The LDL was then 
sterilised with an Acrodisc O.2jlm HT Tuffryn membrane sterile filter from Pall Gelman 
Laboratory and the tube stored in the dark at 4°C for up to two weeks. 
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G. LIPOPROTEIN GEL ELECTROPHORESIS 
Electrophoretic mobility was detennined with a Beckman Paragon native gel 
electrophoresis kit and apparatus according to the manufacturer's instructions. 
Three 3J..LL applications of native or oxidised LDL were applied per lane, allowing 
time for absorption between each application. The gel was electrophoresed for 30 minutes 
at 100 volts in B-2 Barbital buffer. The gel was then placed in fixative solution and dried 
overnight The gel was stained for five minutes in lipoprotein working stain and de stained 
by dipping it in the destain solution followed by immersion for five minutes. 
CELL CULTURE 
Cells were grown in culture flasks in 50mL solutions of RPM I 1640 with phenol 
red and L-glutamine, containing 5% HIFBS and 1 O,OOOU/mL penicillin/streptomycin. 
Cells were not allowed to grow to a concentration of over 1 million/mL. They were 
maintained in an incubator (Precision Scientific, Illinois USA) at 37DC, in a humidified 
atmosphere containing 5% C02. Cells were counted using a haemocytometer and a light 
microscope. 
CELL EXPERIMENT PROCEDURES 
All manipulations were perfonned under aseptic conditions in a Class II biological 
safety cabinet (Clyde-Apac BH 2000). All instruments and equipment were either sterile 
plasticware (Nunc products, Nalge Nunc International, Falcon products, Bector Dickinson 
and Co, or Sarstedt, NC, USA) or had been sterilised by autoclave (15 minutes, 121 DC, 
15psi). 
If differentiation ofTHP-l cells was required, cells were counted and the required 
number resuspended in phenol red RPMI 1640 containing HIFBS and PS as well as PMA 
to a concentration of 100ng/mL. Cells were plated out at 1 xl05 cells per well, and 
incubated for a week before use in experiments, The media was changed every three days. 
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For experiments with non-adherent cells, wells of plates were coated with 10llL of 
5% BSA per well, to prevent the cells adhering to the plastic in the absence of serum. 
Cells were counted and the required amount was washed twice with PBS and resuspended 
in warm RPMI 1640 (without phenol red), or Earles' Balanced Salts Solution, to a 
concentration of 25 x 105/mL. The cells were aliquoted out into wells containing RPM! 
1640 or EBSS to give a final concentration of 5 x 105/mL. 
If interferon-/, was to be included, it was added to the well 10 minutes before the 
cells. If 78NP was to be present it was added after the cells 15 minutes before any 
oxidant. This 15 minute incubation took place in the dark. After the oxLDL, AAPH or 
EtOH were added, plates were put into the incubator for the duration of the experiment. 
CELL VIABILITY ANALYSIS BY MTT ASSAY 
The MTT assay is based on the method described in Mosmann's paper of 1983. 
The tetrazolium salt MTT, or 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium 
bromide, is cleaved by reduction to a coloured formazan end product. This requires 
metabolically active cells, The addition of glucose to the media, or the enhancement of 
glucose uptake by cells, will increase MTT reduction (Takahashi, 2002). The absorbance 
of the dissolved formazan was found to be proportional to the number of cells present in 
all cell types tested by Mosmann. 
The MTT is taken up by endocytosis, since it is not penneable to the lipid 
membrane, and is reduced by electron donors from a range of organelles (Takahashi, 
2002). Both enzymes of the mitochondria and the endoplasmic reticulum are likely to be 
responsible, although from inhibitor tests, NADH and NADPH appear to contribute more 
to the reduction than succinate, as was previously believed (Berridge, 1996). Glycolysis is 
therefore a more important process than respiration in determining the level of MTT 
reduction, 
Wellplates were coated with BSA as described in the above section. Cells from the 
experiment were washed twice with warm sterile PBS, then resuspended in 100llL RPMI 
1640, and ali quoted into the wells, which already contained 900flL non-phenol red RPMI 
1640. 100llL MTT reagent was added, and the plates incubated for 3 hours at 37°C. The 
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resulting purple crystals were dissolved by adding O.5mL of SDS-HCI and mixing with a 
pipette tip. Absorbance was measured at 570nm, using water as the blank. 
CELL VIABILITY ANALYSIS BY TRYPAN BLUE EXCLUSION ASSAY 
This technique uses trypan blue, a blue dye able to enter cells once the integrity of 
the cell membrane has been breached and the cells are no longer able to pump the dye out. 
It therefore allows a visual assessment ofthe state ofthe membrane. 
20J,tL of cell sample was taken from a well and mixed with 5J.1L of try pan blue dye 
(to a fmal concentration of 0.08%). The colour was allowed to develop for 20 seconds, 
and then the cell suspension was placed on, a haemocytometer and examined by 
microscopy. Live cells appeared opaque and dead cells blue. The cell viability was 
calculated as a percentage by dividing the total number of viable cells by the total number 
of both dead and viable cells. 
THIOL MEASUREMENT BY DTNB ASSA Y 
This assay is based on the method published by Boyne and Ellman in 1972 using 5 
5' -dithiobis (2-nitrobenzoic acid) (DTNB) or Ellman's reagent. DTNB is an aromatic 
disulphide, which is reduced by thiol-disulphide exchange to form the highly coloured 
thiophenol anion, 3-carboxylato-4-nitrothiophenolate (CNTP) at a stoichiometry of one 
anion per biological thiol originally present (Ando et al., 1973; Jocelyn, 1987). The 
technique as presented here measures total thiols, including those which form part of 
protein, and non-protein thiols, such as glutathione (Hu, 1994). 
Cell incubations with oxidant were carried out in 6-well plates with 3mL of cell 
suspension in each. After the allotted time, cells were removed from wells and centrifuged 
for 5 minutes at 430g at 4°C, then washed twice in cold PBS. The pellet was resuspended 
in 1mL PBS, and the cells lysed by sonication for 2 minutes. 
O.5mL 10% SDS and 151lL DTNB (final concentration 30IlM) were added and the 
solution was mixed and incubated on a rotational mixer for 30 minutes at room 
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temperature. The SDS was used to denature the proteins, in order to ensure the DTNB had 
free access to the thiols (Soszynski et ai., 1997). The resulting colour was measured 
spectrophotometrically at 412nm. The concentration of total cellular thiols could be 
calculated using an extinction coefficient of 1.36 x 104 M-1 cm-I . 
CASPASE ACTIVATION ASSAY 
DEVD-AMC, Ac-Asp-Glu-Val-Asp-(7-amino-4-methylcoumarin), mimics the 
target sequence of caspase-3 and other group II effector caspases, and determines if the 
caspase enzymes are activated (Stridh et ai., 1998) . 
. After incubation with oxLDL or ethanol, cells were pelleted by centrifugation at 
SOOOrpm for S minutes at room temperature. The cell pellets were resuspended in 1mL 
cold PBS, aliquoted into 105 cell portions and centrifuged again. The supernatant was 
taken off, and the pellet frozen at -80°C for a maximum of two weeks. The assay was 
carried out on a Hitachi fluorometer in a custom-made black plastic cuvette, at a constant 
temperature of 37°C. 
The working solution of 1mL buffer, S~L of a 1M DTT solution (final 
concentration SmM) and 1 ~L of caspase substrate (final concentration SO~M) was mixed 
just before the assay and kept warm in the dark. 1 OO~L was added to each pellet and 
mixed, and the increase in fluorescence over time at Aex 370nm (band width Snm) and Aem 
445nm (band width 10nm) was monitored for 3 minutes per sample. The rate at which this 
occurs was described as 'caspase activity'. 
ANNEXIN V-FITC AND PROPIDIUM IODIDE ASSAY 
Annexin V is a Ca2+ -dependent endogenous protein that preferentially binds to 
membrane-associated phosphatidylserine. The level of binding is measured through 
conjugation to fluorescein-isothiocyanate (FITC). Propidium iodide is a dye that enters 
the cells with damaged plasma membranes and incorporates itself into DNA (Blankenberg 
et ai., 1999; Farber et ai., 1999). 
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After treatment with oxLDL or ethanol, and washing with PBS, 105 cells were 
aliquoted into capped plastic tubes and spun at 500g for 2 minutes. The supernatant was 
then aspirated off To the cell pellet, 2J..Lg of PI solution, 200J..LL of binding buffer (diluted 
from lOx) and 2J..LL Annexin-V-FITC (diluted from 1000x) were added, according to the 
manufacturer's instructions (Apotest-FITC A 700 kit, Nexins Research). The tubes were 
left in the dark for 10 minutes, and the fluorescence detected by bivariate flow cytometry 
with a Vantage fluorescence-activated cell sorter from Becton Dickinson. 
HOECHST STAIN 
The fluorochrome Hoechst 33342 binds specifically to A-T base pairs in DNA 
(Schobersberger et al., 1996). 
After incubation for 24 hours with oxLDL or ethanol, cells were washed with 
PBS, and a pellet of 105 cells was resuspended in 60J..LL of 4% paraformaldehyde in PBS 
and left on a rocker at 4°C for 30 minutes. A 20J..LL drop of cell suspension was put on a 
slide treated with 2% 3-aminopropyltriethoxysilane. 
After the cells had dried, the slides were washed twice in PBS and stained with 
one drop of Hoechst at 1 OJ..Lg/mL for 10 minutes in the dark. Slides were then washed five 
times in distilled water, and after drying, a coverslip was applied using Eukitt mounting 
medium. 
Cells were examined using a Zeiss Axioskop 2 MOT epifluorescent microscope 
(Carl Zeiss (NZ) Ltd, Wellington, New Zealand), fitted with an HBO 100W mercury 
vapour lamp and Axiovision 3.1 software. The fluorescent filter used was Chroma 
Technology Corp. Filter set 82000 single band UV exciter for DAPIIHoechsti AMCA 
(Excitation filter D360/40x, Beamsplitter 82100, Emission filter 82101). The images were 
captured using a Zeiss Axiocam HRc CCD camera and processed with Adobe Photoshop 
5.0. 
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GRIESS REAGENT ASSAY 
Griess reagent contains 1 % sulphonamide, 0.1 % naphthylenediamine 
dihydrochloride and 2.5% phosphoric acid (Levine et al., 1996; Rajora et ai., 1996). It is 
used to measure N02- as an endpoint of NO production, after its oxidation in aqueous 
solution (Halliwell and Gutteridge, 1999). 
Cells were incubated with or without 300U/mL interferon-y for up to 48 hours. 
After centrifugation for 5 minutes at 1500rpm, the supernatant was removed. The cells 
were then washed twice in PBS, resuspended in water, and sonicated to ensure lysis. 
Equal volumes of test solution from cells or supernatant and Griess solution were mixed, 
and the absorbance measured at 540nm after 15 minutes. The concentration of nitrite was 
determined using a standard curve constructed with sodium nitrite. 
PROTEIN DETERMINA nON 
Total cell or pus protein concentration was determined using the bincinchonic acid 
(BCA) estimation method with a kit supplied by Pierce, Illinois, USA. 
The working reagent was freshly prepared by mixing reagents A and B in a 1 :50 
ratio: 
Reagent A: sodium carbonate, sodium bicarbonate, BCA detection reagent, 
sodium tartratein, O.IN sodium hydroxide. 
Reagent B: 4% CuS04.5H20 
The assay was carried out by incubation of 5 o ilL samples with 1mL working 
reagent at 60°C for 30 minutes with gentle shaking. Solutions were then cooled in water to 
stop the reaction before reading the absorbance at 562nm against a water blank. The 
protein concentration was calculated from a standard curve constructed using BSA. 
CHAPTER 2 67 
TEST FOR LEVEL OF AGGREGATION IN LDL 
Aggregation levels in LDL can be found by spectrophotometric analysis of 
turbidity at 680nm (Maor et al., 1997; Llorente-Cortes et aI., 2000). 
Both native and oxidised LDL were diluted to 0.5mg/mL and placed into plastic 
cuvettes. The absorbance was then measured on the spectrophotometer. 
FOX ASSAY (FOR PROTEIN) 
. The Ferric-Xylenol orange (FOX) assay modified by Gebicki (Gay et al., 1999) 
was used to measure protein hydroperoxide (ROOR) formation in LDL. 
This assay measures protein hydroperoxide levels by their oxidation of F e2+ ions to 
Fe3+ ions. The Fe3+ ions then react with xylenol orange (XO) to form a complex which 
can be measured spectrophotometrically at 560nm. 
Fe2+ + ROOR -t Fe3+ + OW + RO' 
Fe3+ + XO -t Fe-XO 
One mL ofLDL solution was mixed with 140j..lL of cold 72% TCA by vortexing, 
and chilled on ice for 5 minutes for protein precipitation. The proteins were then pelleted 
by centrifugation at 15,00Orpm and 4°C for 5 minutes. The supernatant was removed, and 
the pellet resuspended in 1 mL of a 1: 1 methanol/chloroform mixture and recentrifuged. 
The supernatant was again removed, and the tube dried upside down for five minutes. The 
pellet was then dissolved in 900j..lL of a cold 1: 1 acetic acid/water solution. 
To the test tubes, and also three control tubes containing acetic acid and water, 
SOj..lL xylenol orange and ferrous ammonium sulphate were added, and the mixtures were 
incubated for 30 minutes in the dark. After centrifugation at 15,00Orpm for 5 minutes to 
remove debris, the absorbance could be read at 560nm using a water blank, and the 
concentration of peroxide calculated using an extinction coefficient of 48,000M-1.cm-l . 
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PTERIN DETERMINATION USING HPLC 
Cell culture media samples were transferred to 1.5mL centrifuge tubes for 
analysis. Celllysates were prepared by washing the cells twice in PBS, then resuspending 
in nanopure water and sonicating for 5 minutes. Adherent cells were sonicated in their 
wells for 10 minutes. 
Twenty J.lL of acidic iodide solution (5.4% hIl0.8% KI) and 25J.lL 50% TCA were 
added to a 250J.lL sample, mixed and incubated in the dark for 60 minutes. If the 78NP 
was to be measured unoxidised, the iodide solution was not added. The oxidation allows 
both 78NP and neopterin to be measured . 
. A spatula of ascorbate was .then added to oxidise the iodine and samples were 
centrifuged at 8800g for 15 minutes. 
Five ilL of 2M ammonium phosphate was added to 100J.lL <?f the supernatant and 
the treated sample was transferred to glass autosampling vials for analysis on a Shimadzu 
(New Zealand, Ltd) SIL-l OA automated high performance liquid chromatography system 
equipped with a SIL-l OA autoinj ector, DGU -14 A pump, RF -1 OAxl fluorescence detector 
and L-ECD-6A electrochemical detector with a glass carbon electrode and silver chloride 
reference cell. lOllL injections were passed through a RP-C18 4.6 x 250mm column 
(Phenomenex) maintained at 35°C inside a Shimadzu CTO-1 OA column oven. The mobile 
phase (20mM NH4H2P04, pH 6.0 and 5% methanol) was pumped through the system at a 
flow rate of ImLimin. 
Neopterin was measured using the fluorescence detector set at an excitation of 
353nm and emission of 438nm. 78NP was detected using the ECD detector with the 
electric potential set to +0.6V. Peak areas were calculated using the Shimadzu software 
package, by comparison with standards, 
TBARS-HPLC LIPID ANALYSIS 
This HPLC technique is used to quantify lipid peroxidation. Malondialdehyde 
(MDA), a breakdown product oflipid peroxides, reacts with 2-thiobarbituric acid (TBA) 
to form a TBA-MDA adduct, a pink colour which can be measured by fluorescence 
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detection. MDA is unstable so is prepared immediately before use by hydrolysis of its 
derivative 1,1,3,3-tetramethoxypropane. The assay used here is a modification of the 
standard HPLC method described by Draper et al. in 1993. 
The amount of free MDA produced in most peroxidizing lipid systems is too low 
to give measurable colour. The level detected is formed by the decomposition of 
hydroperoxides during the acid heating stage. The decomposition can also result in 
peroxyl radicals, which could amplifY peroxidation and subsequent MDA formation, and 
so the chain breaking antioxidant BHT is used to suppress this process during the assay 
(Jentzsch et al., 1996; Halliwell and Gutteridge, 1999). 
SOIlL ofBHT and 2S0llL of phosphoric acid were added to SOOIlL ofO.5mg/mL 
oxLDL or standard and the solution vortexed. After addition of2S0llL ofTBA solution, 
the tubes were mixed by inversion and placed in a heating block at 9SoC for 30 minutes 
with gentle shaking. The tubes were then removed and cooled on ice for S minutes, and 
centrifuged at 21 ,000g for 10 minutes. 20llL per sample could then be injected onto the 
HPLC system described above, using an Econosphere RP C-18, 4.6xSOmm, Sllm column 
(All tech Associates Inc. USA) and fluorescence detection with excitation at S2Snm and 
emission at 5SOnm. Each run included standards of Onmol/mL, 150nmollmL and 
300nmollmL MDA. 
PREPARATION OF PUS SAMPLES 
Pus samples were obtained from patients at the DSA Unit in the Radiography 
department of Christchurch Hospital who gave written consent. Hospital staff transferred 
the pus into plastic screw top tubes, which were kept on ice for a maximum of one hour 
after collection until being frozen at -80°C in the laboratory. 
For analysis, the pus was thawed under cold running water. The samples' 
preparation was carried out under aseptic conditions in a Class II biological safety cabinet. 
Two mL of pus was added to 2mL ofnanopure water and to this mixture, SOIlL each of 
20mglmL BHT and 100mglmL EDT A were added. This solution was homogenized using 
a tissumizer (Tekmar Ltd, USA) for 1 minute. It was then aliquoted out for immediate 
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analysis by HPLC, using the pterin method above. Protein detenninations were also 
carried out for each sample. 
STATISTICAL ANALYSIS 
Statistical analysis was performed using the Statistica software package (Statsoft 
Inc., USA). Comparisons between treatments were perfonned using one-way analysis of 
variance (ANDV A). When significance was observed (p:S;0.05), Tukey's multiple 
comparison test was done to detennine if the means differed from each other by a 
significant margin. Significance levels are indicated in the text, or on the graphs, where 
the following notation is used: * represents p:S;0.05, ** represents p:S;O.01 and *** is 
p:S;O.OOL 
Standard deviations were calculated and are presented on the figures as error bars. 
The means and standard deviations are from experiments conducted in triplicate and 
perfonned at least three times. 
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CELL VIABILITY: MONOCYTES, AAPH AND 78NP 
INTRODUCTION 
This section of work concentrates on the effect of a peroxyl radical flux on two 
monocytic ce111ines, THP-l and U93 7. Peroxyl radicals are a fitting starting point for 
examining oxidative stress in cells, and the influence of 78NP. The radical system is likely to 
be simpler in its reactions than the more heterogeneous oxidised LDL, and peroxyl radicals 
are relevant in vivo, since they are generated as part of the lipid oxidation process (Gotoh et 
ai., 1993). 
AAPH, 2,2' -azobis (2-amidinopropane) hydrochloride is a water-soluble, 
thermolabile compound, which breaks down to give carbon-centred radicals (Halliwell and 
Gutteridge, 1999). The radicals are generated at a known and constant rate, primarily 
determined by temperature, and to a minor extent by solvent and pH. The rate is directly 
proportional to AAPH concentration (Niki, 1990), Decomposition occurs at a first order rate 
constant of~ 6.6 x 10-5min-1 at 37°C. A ImM solution will therefore produce 6.6 x 10-8 
mol of radicalslL/min (Esterbauer and Jiirgens, 1993), The radical production reaches a 
plateau at 50mM (Li et ai., 2001). 
CH3 CH3 
I I 
CrH2W =C-C-N=N-C-C= ~IhCI-
I I I I 
H2NCH3 H3CNH2 
Under suitable conditions, the molecule breaks into two carbon-centred radicals and 
nitrogen. In an instantaneous reaction, some of these radicals will form stable products with 
each other, but most will react with oxygen to give peroxyl radicals (Nild, 1990): 
R-N=N-R -+ 2R + N2 
R+02 -+ROO' 
AAPH has been shown to initiate a lipid peroxyl radical-mediated chain reaction in 
lipid micelles, erythrocyte membranes and red blood cell ghosts (Nild, 1990), and to damage 
DNA in cultured human T cells (Villani et al., 1996). It was also responsible for the 
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fonnation of reactive protein hydroperoxides on BSA (Platt and Gieseg, 2003), U937 cells 
(Gieseg et al., 2000A; Duggan et al., 2002) and low density lipoprotein (Pearson, 2002). 
AAPH causes the appearance of apoptotic features in HL-60 cells, such as DNA 
fragmentation, caspase-3 activation, and possibly lysosomal destabilisation (lshisaka et al., 
2001). It did not cause the appearance of apoptosis in U937 cells, due to a short incubation of 
only six hours, but was able to inhibit the membrane Ca2+-ATPase. AAPH was however said 
to enhance apoptosis in these cells caused by hyperthermia, in which Ca2+ increase and lipid 
peroxidation were the key events reported (Li et al., 2001). The raised temperature would not 
only have stressed the cells, but also increased the radical flux from the AAPH. 
Cell line monocytes are very useful experimental models. Cells can be obtained easily 
in large numbers, do not have a finite survival time, and do not display donor variability. 
Experiments can therefore be meaningfully compared, both within a study, and with work 
already published (Rodriguez et al., 1994). The cell culture is also known to contain only 
monocytes, whereas during blood extractions, lymphocyte contamination can easily occur. 
Cell lines are therefore in some ways better for isolating and testing systems that may occur 
in vivo than blood-derived monocyte-macrophages (Akeson et ai., 1991B). 
U937 is a human histiocytic lymphoma line (Chateau et ai., 1996), which was 
developed in 1976 by Sundstrom and Nilsson from the pleural fluid of a 37 year-old man 
with generalized lymphoma (Sundstrom and Nilsson, 1976; Liu and Wu, 1992). The U 
represents upsilon (Koren, et ai., 1979). It is a monoblast cell, in the early stages of monocyte 
development (Liu and Wu, 1992; Oberg et al., 1993). 
U937 cells have a mean diameter of 12.511. The population doubles in 95 hours. The 
cells have been characterised as monocytes in many tests, including positive staining with a-
naphthyl acetate esterase, the presence oflysozyme in the media, which is only made and 
secreted by monocytes and macrophages, the existence of numerous small granules in the 
cytoplasm, the appearance of complement and Fe receptors on 30% of cells and the 
phagocytosis of test particles by 20% of cells. There was no acid phosphatase or peroxidase 
as in nonnal monocytes, consistent with the histiocytic (malignant) origin ofU937 cells 
(Sundstrom and Nilsson 1976). The cells showed antibody-dependent cell-mediated 
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cytoxicity when activated by supernatants from human mixed cultures (Tsuchiya et at., 
1980). 
THP-1 cells are a human monocytic leukemia cell line (Schwende et at., 1996), 
derived from the blood of a one year-old boy with acute monocytic leukemia. The mean cell 
diameter is 12-14Jl and the cell number doubles in 60-70 hours (Tsuchiya et at., 1980). 
Their characteristics are similar to the U937 line, with a few exceptions. A higher 
percentage of the cells are capable of phagocytosis. The cells have a different HL-A type 
from U937 cells, and did not show antibody-dependent cell-mediated cytoxicity (Tsuchiya et 
at., 1980). THP-1 cells have binding sites for endothelin-l and U937 cells do not (King et at., 
1997). Overall, the cell line is a more differentiated monocytic line than the U937 cells. Its 
ability to phagocytose, secrete INFu and IL-l and synthesise lipoprotein lipase and apoE 
support this (Banka et at~, 1991). Another difference is that U937 cells have around fourfold 
higher CD36 expression than THP-1 cells, both before and after differentiation (Nguyen-
Khoa et at., 1999). 
Identical experiments were conducted with both the U937 and THP-1 monocyte cell 
types. The cells were incubated at 5 x 105 cells/mL with AAPH, the peroxyl radical generator, 
for 12 hours, and the level of cell viability or reduced thiols examined using the MTT and 
trypan blue assays, or the DTNB thiol assay. 
All experiments exploring the effect on cell viability of a particular agent (AAPH, 
oxLDL or ethanol) followed the same pattern. Cells were first tested against a gradient of 
concentrations ofthe cell death mediator, and a concentration which resulted in 
approximately 50% viability loss was chosen for the next stage of the experiments, in which 
the effect of 78NP on this viability change was investigated. 
Results are expressed as a percentage of the control value, to more clearly show the 
change in viability that resulted from the agent itself, or from 78NP, as opposed to the small 
viability loss due to being in a serum-free medium for a prolonged period. This presentation 
also allows for more meaningful comparison of results between assay methods. Experiments 
were repeated a minimum of three times, and a representative result is illustrated here. 
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RESULTS AND DISCUSSION 
The viability loss in THP-1 monocytes with increasing concentrations of AAPH was 
concentration-dependent, levelling off by 50mM (Figure 6). This confirms previous findings 
(Li et al., 2001). Since 10mMrepresented an approximately 50% viability loss, this was the 
concentration used in experiments involving 78NP. This experiment, and those represented 
by Figures 7-9, were conducted in RPM! 1640 without phenol red, and the results measured 
with the MTT assay. 
A proportional decrease in viability with increasing amounts of AAPH was also found 
in U937 cells, confirming the concentration-dependent effect (Figure 7). When the two cell 
types were compared, the amount of viability loss at each concentration was very similar . 
. A difference between the THP -1 cells and U937 cells was found when the effect of 
increasing concentrations of 78NP on the loss of cell viability with 10mM AAPH was 
measured (Figures 8 and 9). THP-1 cells were unaffected by the addition of 78NP, the same 
loss of viability occurring whether it was present or not. But with U937 cells, viability was 
recovered as 78NP concentration increased, reaching significance by 200J.LM. 
As in all experiments using 78NP, a control was included. These cells were incubated 
with 78NP only, at the highest concentration used. No oxidant was included. This showed 
that 78NP alone did not decrease the cell viability, in many cases even increasing it slightly. 
The increase in viability may be due to the 78NP preventing the limited amount of apoptosis 
that occurs in the controls (Gieseg et al., 2001). 
RPM! 1640 was used for these first four experiments for the same reasons that it was 
used with the other cell death mediators to be investigated here: it provides the cells with 
limited nutrition, promoting the survival of control cells and making up a more realistic, 
physiologically relevant surrounding. However, in this instance, the desired result of 
incubation with AAPH was the interaction of the cells with the peroxyl radicals themselves. 
Due to the possibility that constituents of the RPM! 1640 medium, such as amino acids, may 
also interact with the peroxyl radicals and complicate the observed effects, the remainder of 
the experiments in this section was conducted in Earle's Balanced Salt Solution (EBSS), a 
much simpler medium, consisting of glucose and salts. The effect on the cells of the lack of 
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nutrients may be.minimal, since the incubations are only 12 hours long, as opposed to the 48 
hours used in later experiments. 
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Figure 6: Effect of increasing concentrations of AAPH Oil THP-l ceUs in RPM! 1640: MTT assay. 
TIIP-l cells at 5 x 105 ImL were incubated with increasing concentrations of AAPH for 12 hours in RPM! 1640, 
and the effect on cell viability measured using a MIT assay. The data shown is the mean ± SD of triplicates. 
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Figure 7: Effect of increasing concentrations of AAPH 011 U937 ceUs ill RPM! 1640: MfT assay. 
U937 cells at 5 x 105 1mL were incubated with increasing concentrations of AAPH for 12 hours in RPM! 1640, 
and the effect on cell viability measured using a MIT assay. The data shown is the mean ± SD of triplicates. 
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Figure 8: Effect of 78NP on AAPH-mediated decrease in cell viability in TIIP-1 cells in RPMI 1640: 
MTT assay. lHP-l cells at 5 x 105 /mL were incubated with 10mM AAPH and increasing concentrations of 
78NP in RPM! 1640, and the results analysed by MIT assay. A 78NP-only control is included. The data shown 
is the mean ± SD of triplicates. 
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Figure 9: Effect of 78NP on AAPH-mediated decrease in cell viability in U937 cells in RPMI 1640: 
MTT assay. U937 cells at 5 x 105 ImL were incubated with 10mM AAPH and increasing concentrations of 
78NP in RPM! 1640, and the result" analysed by MIT assay. A 78NP-only control is included. The data shown 
is the mean ± SD of triplicates. 
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In spite of the difference in medium, the results of the AAPH concentration gradients 
in the two cell types in EB SS were very similar to those conducted in RPMI 1640 (Figures 10 
-13). The actual values were very close, as were the trends: the loss in cellular viability was 
concentration-dependent, and the two cell types were comparable. The viability levels found 
by each method were broadly similar. 
An effect ofthe medium became apparent once the 78NP was added. In contrast to 
the result in RPMI 1640, a small amount of protection against cell viability loss was provided 
to THP-l cells by the highest concentration of78NP used (p::;0.001), as analysed by the MIT 
assay (Figure 14). However, the difference between cell types was still preserved, as 
protection provided for U937 cells brought the viability levels back up to control levels, and 
significance was reached at the lower concentration of 100llM (Figure 15) . 
. Similar results were found when the trypan blue assay was used. For THP-1 cells, the 
overall increase in cell viability was the same, but began at the lower 78NP concentration of 
50llM (p:'SO.05). The protection provided against AAPH with the U937 cells was also greater 
than that found with the MIT assay, reaching a significance ofp::;O.OOl by 50jlM (Figures 16 
and 17). 
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Figure 10: Effect of AAPH on THP-l cell viability in EBSS: MTT assay. 
TIIP-l cells at 5 x 105 /mL were incubated with increasing concentrations of AAPH for 12 hours in Earle's 
Balanced Salts Solution, and the effect on cell viability measured using a MIT assay. The data shown is the 
mean± SD of triplicates. 
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Figure 11: Effect of AAPH on U937 cell viability in EBSS: MTT assay. 
U937 cells at 5 x 105 1mL were incubated with increasing concentrations of AAPH for 12 hours in Earle's 
Balanced Salts Solution, and the effect on cell viability measured using a MIT assay. The data shown is the 
mean ± SD of triplicates. 
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Figure 12: Effect of AAPH on cell viability ofTHP-l cells in EBSS: trypan blne assay. 
79 
TIJP-l cells at 5 x 105 /mL were incubated with increasing concentrations of AAPH for 12 hours in Earle's 
Balanced Salts Solution, and the effect on cell viability measured using a trypan blue assay, The data shown is 
the mean ± SD of triplicates. 
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Figure 13: Effect of AAPH on cell viability of U937 cells in EBSS: trypan blue assay. 
U937 cells at 5 x l051mL were incubated with increasing concentrations of AAPH for 12 hours in Earle's 
Balanced Salts Solution, and the effect on cell viability measured using a trypan blue assay. The data shown is 
the mean SD of triplicates. 
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Figure 14: Effect of 78NP on AAPH-mediated decrease in cell viability in THP-l cells in EBSS: MTT 
assay. TIlP-I cells at 5 x 105 ImL were incubated with 10mMAAPH and increasing concentrations of78NP in 
Earle's Balanced Salt Solution, and the results analysed by MTT assay. A 78NP-only control is included. The 
data shown is the mean ± SD of triplicates. 
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Figure 15: Effect of 78NP on AAPH-mediated decrease in cell viability in U937 cells in EBSS: MTT 
assay, U937 cells at 5 x 105 ImL were incubated with 10mM AAPH and increasing concentrations of78NP in 
Earle's Balanced Salt Solution, and the results analysed by MTT assay. A 78NP-only control is included. The 
data shown is the mean SD of triplicates. 
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Figure 16: Effect of 78NP on AAPH-mediated decrease in cell viability in THP-l cells in EBSS: 
trypan blue assay. THP-l cells at 5 x 105 /mL were incubated with lOmM AAPH and increasing concentrations 
of78NP in Earle's Balanced Salt Solution, and the results analysed by trypan blue assay. A 78NP-only control 
is included. The data shown is the mean ± SD of triplicates. 
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Figure 17: Effect of 78NP on AAPH-mediated decrease in cell viability in U937 cells in EBSS: trypan 
blue assay. U937 cells at 5 x lOs /mL were incubated with lOmM AAPH and increasing concentrations of78NP 
in Earle's Balanced Salt Solution, and the results analysed by trypan blue assay. A 78NP-only control is 
included. The data shown is the mean ± SD of triplicates. 
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The DTNB assay provides a measure of the cell's total thiol redox potential, which in 
many cases mirrors the viability. It shows the proportion of thiol residues and thiol-
containing constituents of the cell that have been oxidised as a result of cellular damage, so 
serving the double purpose of demonstrating oxidative effects of the so-called oxidative 
agents, as well as the extent of that oxidation. 
The thiolloss was found to be concentration-dependent with AAPH, like the viability 
loss measured by the MIT and trypan blue assays and was similar for each cell type (Figures 
18 and 19). At SmM and SOmM AAPH, the percentage loss was the same as for the viability 
measurements. The values at 10mM AAPH, however, were much higher than their 
counterparts from the viability tests, showing that less thiol oxidation than viability loss 
occurred at this concentration. So that the comparison with these tests could be continued, 
10mM AAPH was used for the experiments with 78NP in spite of this. 
78NP had an effect on AAPH-induced thiolloss (Figures 20 and 21), which continues 
the trend of a difference between cell types. No significant difference between varying 78NP 
concentrations was found for the THP-l cells, but a concentration-dependent effect, 
protective against thiolloss, was found with increasing 78NP concentrations in U937 cells. 
The thiollevels ofthe control were not quite attained. Significance was reached by 200j.tM 
78NP. 
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Figure 18: Effect of increasing concentrations of AAPH on reduced thiollevels in THP-l cells in 
EBSS: DTNB assay. THP-l cells at 5 x 105 ImL were incubated with increasing concentrations of AAPH for 12 
hours in Earle's Balanced Salts Solution, and the effect on reduced thiollevels measured using a DTNB assay. 
The data shown is the mean ± SD of triplicates. 
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Figure 19: Effect ofincreasing concentrations of AAPH on reduced thiollevels in U937 cells in EBSS: 
DTNB assay. U937 cells at 5 x 105 /mL were incubated with increasing concentrations ofAAPH for 12 hours in 
Earle's Balanced Salts Solution, and the effect on reduced thiollevels measured using a DTNB assay. The data 
shown is the mean ± SD of triplicates. 
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Figure 20: Effect of 78NP on oxidation of thiols caused by AAPH in THP-l cells in EBSS: DTNB 
assay. THP-I cells at 5 x 105/mL were incubated with 10mM AAPH and increasing concentrations of 78NP in 
Earle's Balanced Salt Solution, and the results analysed by DlNB assay. A 78NP-only control is included. The 
data shown is the mean ± SD of triplicates. 
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Figure 21: Effect of 78NP on oxidation of thiols caused by AAPH in U937 cells in EBSS: DTNB assay. 
U937 cells at 5 x 105 ImL were incubated with 10mM AAPH and inereasing concentrations of 78NP in Earle's 
Balanced Salt Solution, and the results analysed by DlNB assay. A 78NP-only control is included. The data 
shown is the mean ± SD of triplieates. 
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In considering what effect 78NP might have against oxidative stress in monocytes, it 
would be useful to first understand what happens to AAPH once it is added to the cell 
solution. 
The AAPH will disperse throughout the solution, forming radicals at a certain rate 
(determined by its concentration and the temperature). There are three possibilities for the 
peroxyl radicals: they may next collide with a cell and initiate lipid or protein peroxidation, or 
if the radical combines with a molecule that is part of the medium, oxidation products may be 
formed which could continue oxidation in the medium or go on to damage the celL For 
example, a reaction with an amino acid could yield an amino acid hydroperoxide. Advanced 
glycation end products may come about through oxidation of glucose and its interaction with 
protein (Halliwell and Gutteridge, 1999). If glutathione was affected, thiyl radicals may 
result Thirdly, if two radicals were to come together, the chain would be terminated, and a 
non-reactive product formed. 
All of these possibilities will be found in RPMI 1640 media, but the second to a more 
limited extent in EBSS, which contains only salts and half the amount of glucose found in 
RPM! 1640. Fewer radicals would be likely to come into contact with the cell in RPMI 1640 
medium, although the interaction with other reactive oxygen species would increase. It is 
interesting that no difference was found between the levels of viability loss in each type of 
medium. This implies that the secondary reactive oxygen species cause a similar level of 
damage to the cell as the free radicals. 
Earlier work from this laboratory examining AAPH's effects on U937 cells in EBSS 
found that both lipid and protein peroxidation of the cells occurred, but that protein 
peroxidation levels appeared to have a better correlation with viability loss than did levels of 
lipid peroxidation (Duggan et at., 2002). AAPH might then be expected to damage proteins 
in the cells tested here. 
A positive result with the assays used itself provides information about the damage 
AAPH and its products are inflicting on the cell. The MTT assay examines the activity of 
certain enzymes important in cellular metabolic processes, such that a lowering of this 
activity shows a decrease in the cells' metabolism and hence available energy (Mosmann, 
1983). The trypan blue assay demonstrates that cell membrane integrity has been lost, and has 
been used to define the end ofapoptosis (Reid et al., 1993C; Van den Dobbelsteen et al., 
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1996; Hampton and Orrenius, 1997; Yuan et al., 2000), and described as detecting necrosis 
(Escargueil-Blanc et at., 1994; Meilhac et at., 1999; Nonaka et at., 1999; Galan et at., 2001). 
The MIT assay point is thought to be earlier than that ofthe trypan blue assay, but still 
towards the end ofthe apoptotic process, since energy is required to undergo apoptosis 
(Cannody and Cotter, 2001). 
However, the excellent correlation between the degree of cell viability loss with a 
certain AAPH concentration across the different assays suggests the stages of cell death being 
measured are very close in time. Since the trypan blue assay certainly examines a later stage, 
the MIT assay might be expected to do so also. 
A parallel between the levels of viability loss measured by the MTT assay and a 
membrane integrity assay was also found in human monocyte-macrophages incubated with 
1.0mg/mL oxLDL, where the lactate dehydrogenase assay was used. It was suggested that no 
change in MIT metabolism would be found until enough damage had been done to the 
mitochondria to stop them functioning, and that this was a later event (Hardwick et at., 1996). 
In human endothelial cells with 1.Omg/mL oxLDL, trypan blue changes occurred around the 
same time as changes measured by the MIT assay (Escargueil-Blanc et at., 1997). Therefore 
these assays cannot be used to prove that AAPH causes any of the characteristics of 
apoptosis, although necrosis or secondary necrosis is probably reached. 
AAPH may cause damage to the cell either directly via radicals, or indirectly via 
peroxides or aldehydes formed in the medium, and this damage is intensive enough to result 
in primary or secondary necrosis. The damage may be focussed on protein, rather than lipid. 
We can also see that the process is oxidative, since a reponse to the DTNB assay is found, 
although we cannot tell whether the oxidation is directly due to the AAPH, or whether it is a 
response to other types of damage AAPH initiates. The thiolloss may be a separate event, not 
required for viability loss with AAPH, as the percentage of reduced thiolloss is less than the 
viability loss with some concentrations. 
78NP might be expected to act as a scavenging, chain-breaking antioxidant in the 
presence of AAPH, as it can scavenge peroxyl radicals with a rate constant of 107 M-1 S-l, 
which is close in efficiency to a-tocopherol (Oettl et at., 1997). It was suggested to act in this 
way in experiments where it was found to lengthen the lag phase ofLDL oxidation with 
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AAPH or Cu2+. The fact that the antioxidant activity was directly proportional to 78NP 
concentration supported this contention. However, the same study also led to the suggestion 
that it was unlikely 78NP was directly scavenging peroxyl radicals in solution, as it had the 
same efficiency with Cu2+ oxidation (Gieseg et al., 1995). 
Both cell types in these experiments are exposed to the same radical fluxes or 
mixture of oxidants fonned in the medium. In RPMI 1640, 78NP is unable to protect the 
THP-1 cells from these products at all, implying that scavenging is not the process by which 
it is protecting either cell type in this medium. In EBSS, where the oxidants are more likely to 
be peroxyl radicals, which can be scavenged, 78NP has a limited protective effect in THP-1 
cells and a fairly complete one in U937 cells. So 78NP does seem to be able to act as a 
scavenging antioxidant to a limited extent, but its main effect in the U937 cells may occur by 
another mechanism. Another possibility is that 78NP or AAPH may associate with the cells 
in a way which limits 78NP's access to the peroxyl radicals. 
The protective effect found for thiols in the U937 cells suggests this is another means 
by which 78NP can protect cells. 78NP could prevent reduced thiol oxidation in several 
different ways. It could stop them becoming oxidised in the first place, by acting as an 
antioxidant itself or decreasing the cell's signal to oxidise the thiols. It might also enhance 
their synthesis, so those oxidised could be replaced, or stop the efflux ofthiols from the cell, 
if this is occurring. The regeneration of reduced thiols from oxidised versions is the only 
scenario which has been tested. Aaron Platt found in his Master's work that 78NP could not 
regenerate oxidised thiols on BSA (Platt, 2002). The effect of 78NP on thiols is not as great 
as the effect on overall cell viability in EBSS, and so thiolloss may be the only important 
factor, since viability can be back up to control levels without the complete recovery of all 
oxidised thiols. 
The previously published work examining lipid and protein peroxidation in U937 
cells with AAPH found that 78NP could inhibit the protein hydroperoxide fonnation 
completely at 200IlM, but could not affect TBARS and lipid hydroperoxide fonnation 
(Duggan et al., 2002). If78NP is able to interact with protein, it may be in a suitable position 
to protect protein thiol residues. However, since it could not protect the viability or thiols of 
CHAPTER 3 88 
both cell types to the same extent, and both contain protein, protection against protein 
peroxidation by 78NP does not always occur. 
As mentioned earlier in this chapter, the THP-1 cell type is more differentiated than 
the U937 cells. This, or another factor, may affect the interaction of 78NP and AAPH with 
the cells, which has not been well studied. 78NP and the peroxyl radicals may interact with 
the cell membrane, or AAPH and 78NP may be taken into the cell. The THP-l cells' ability 
to phagocytose in a non-specific manner, or the differing membrane composition (shown by 
the variation in receptor levels) might be important. The 78J\1P may simply be better placed in 
U937 cells to protect thiols and cell viability. Alternatively, the substances it affects, inside 
the cell or on the membrane, may initiate signalling cascades having varying effects in each 
cell type. This is examined in Section 2 of Chapter 4. 
The difference between the two cell types may not be entirely due to differences in 
responses to 78NP itself. Different reactions to the oxidative stress inducers may also playa 
role, if78NP is only able to be effective in one ofthe cases. 78NP is obviously able to have a 
positive effect on THP-l cells, since not only can it protect them in very rare cases, but the 
incubations of cells and 78NP only, included as a control in all experiments, show that the 
78NP can enhance the viability of these cells as well as it can those ofthe U937 type. 
The disparity in differentiation of the cell types may result in each having different 
active metabolic pathways and responses to oxidative stresses. THP-I cells constitutively 
release ceruloplasmin, whereas U937 cells do not, unless under stimulation from IFNI'. It is 
the U937 cells' only ferrioxidase protein, oxidising ferrous ions so that they can bind to 
transferrin and be removed from the celL This may imply a higher level of iron ions within 
unstimulated U937 cells, and perhaps, therefore, a higher level of oxidative stress, through 
the Fenton reaction (Mazumder et at., 1997). Although this does not seem to affect the level 
of cell viability loss, it may create a situation in which 78NP is more effective as an 
antioxidant. 
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SUMMARY 
AAPH appears to cause TI-IP-l and U937 cells to respond in a similar manner. 
Cytotoxicity levels were not dependent on the media used or the viability assay they were 
measured by. Reduced thiollevels were lowered by the AAPH treatments, but not by as 
much as the viability levels. 
78NP was always able to protect U937 cells from AAPH, in many cases bringing 
viability levels back up to the level of the untreated cells. It only increased viability in THP-l 
cells in EBSS, and the increase was much smaller than that in U937 cells. 78NP could also 
decrease the loss of reduced thiols, but only in U937 cells, and did not have as great an effect 
as it did on the viability. 
Therefore, although 78NP is an effective peroxyl radical scavenger, this study 
suggests that radical scavenging is unlikely to be its primary mechanism of protection in 
TI-IP-l cells, and possibly also in U937 cells. Scavenger levels are shown by the small 
amount of protection provided to TI-IP-l cells. In U937 cells, reduction ofthiolloss also 
contributes, but since thiollevels do not return to control levels, other protective mechanisms 
may also playa role. 
CHAPTER 4 90 
OXIDISED LDL AND 78NP: EFFECTS ON CELL VIABILITY 
INTRODUCTION 
This section of work examines the effect of oxLDL on the cell viability ofthe two 
monocyte cell lines used in the previous chapter, as well as the phorbol 12-myristate 13-
acetate (PMA)-differentiated THP-l macrophage-like cell line. The protective capacity of 
78NP is also tested in the more complex macrophage-like system, which may be more 
relevant to the in vivo situation of plaque development. 
It has been shown previously that when THP-l monocytic cells are incubated with 
phorbol esters such as PMA for periods of around seven days, they develop into cells which 
look, and behave, like macrophages (Akeson et at., 1991A). The changes that occur during 
differentiation are said to make them a good model for the macrophages that are involved in 
atherosclerotic plaque formation (Akeson et at., 1991A; Ferret et at., 2000). 
During PMA-induced differentiation, the THP-l cells stop proliferating, accumulate 
in the GO/G1 phase and adhere to the plate, becoming granular and irregular in shape (Akeson 
et at., 1991A). Membrane antigens typical of macro phages, including CDllb and CDI4, are 
expressed (Schwende, 1996). The cells' ability to phagocytose opsonized zymosan or latex 
beads is also enhanced (Mouithys-Mickalad et ai., 2001) and receptor expression is modified. 
The LDL receptor is down-regulated (Auwerx et ai., 1989; Rodriguez et at., 1994) and the 
oxLDL-binding scavenger receptor classes A I and II and CD68/macrosialin receptor are 
upregulated (Akeson, et ai. 1991A; Geng and Hansson, 1992; Wang, 1999). 
Differentiated U937 cells were not used for the work on macrophage-like cells 
outlined here, as differentiation of this cell type by chemical stimulus has been found to be 
unreliable. Some studies report phagocytosis and others do not (Koren et ai., 1979) and even 
scavenger receptor stimulation does not always occur (Via, 1989). With retinoic acid and 
1,25-dihydroxy vitamin D3 as differentiation agents, there is no cell cycle arrest (Ferret et at., 
2000). 
Interactions between monocytes and macrophages and LDL or oxLDL are important 
at every stage of atherosclerotic development. During the later stages of development, oxLDL 
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exerts a pro-inflammatory or cytotoxic effect on cells in the plaque, which alters the plaque 
stability, leading to rupture. OxLDL also has a range of other effects on cells, which may 
complicate this situation. Those involving cytokines are likely to be less relevant here, as no 
other cell type is present 
Lightly oxidised or low concentrations of oxLDL, as well as native LDL, can have 
mitogenic effects on most cells (see Table 1). The proliferative responses can be seen in part 
as responses to sublethal injury, evoked to elicit repair by neighbouring cells via release of 
growth factors such as GM-CSF and M-CSF. This may not always be advantageous, as cells 
are more susceptible to toxicity during growth, especially the DNA synthesis (S phase) part 
ofthe cell cycle (Martens et at., 1998; Martens et ai., 1999; Sakai et ai., 1999; Chisholm III 
and Chai, 2000). 
Lightly oxidised LDL also has many pro-inflammatory properties, important in the 
early phases of atherosclerotic development, as outlined in Chapter 1, such as the recruitment 
of cells to the intima, the induction of growth factors, cytokines and some enzymes, such as 
phospholipase A2 (type II). 
More extensively oxidised LDL appears to have two major effects on atherosclerotic 
development: foam cell formation and stress on cells leading to cell death in foam cells and 
other surrounding cells. Since this study encompasses oxLDL's effects on cell viability, this 
type ofoxLDL was used. 
Lipid hydroperoxides and aldehydes can have toxic effects on cells (Table 1). It has 
been suggested that lipid hydroperoxides may be more toxic to cells than aldehydes (Siowet 
ai., 1999). However, when fractions of oxLDL have been compared for cytotoxicity, the 
neutral lipid fraction, primarily the oxysterols, is found to account for most, or all, of the 
toxic effect (Hughes et at., 1994; Clare et at., 1995; Rusinol et at., 2000; Therond et at., 
2000; Yuan et at., 2000; Garcia-Cruset et ai., 2001). 
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Table 1: Effects ofLDL on cell viability 
... __ ._-
Effect Mechanism Cell types studied References 
Lightly oxLDL, low Mitogenic Human arterial smooth Huang et al., 
concentrations of muscle cells, bovine 1995; Bjorkerud 
oxLDL and native vascular smooth muscle and Bjorkerud, 
LDL cells, lung fibroblasts, 1996; Yla-
U937 monocytes, THP- Herttuala S., 
I monocytes and 1998; Martens et 
macrophages, human al., 1999; Sakai 
monocyte/rnacrophages, et al., 1999 
mouse peritoneal 
macrophages, T cells 
Extensively oxLDL Cytotoxicity Alkoxyl and lipid Human fibroblasts, I Coffey et al., 1995 
components peroxyl radical human vascular smooth Siow et al., 1999 
1.Lipid formation 
i 
muscle cells . 
; hydroperoxides 
~c; 
Cytotoxicity Covalent adducts with Uchida, 2000 2.Aldehydes Human monocyte-
proteins, DNA- and macrophages, 
phospholipids formed hepatocytes, aortic 
Accumulation in smooth muscle cells, 
membranes (5-10mM) human erythrocytes, 
Chromosomal human neutrophils, 
aberrations, point neurons 
mutations, enzyme 
inhibition, alteration of 
glutathione and protein 
sulfhydryls, inhibition 
of Ca2+ sequestration 
. Signalling ROS production, NFtcB 
activation prevented 
i 
3.Oxysterols Cytotoxicity Replacement of Human endothelial cells, Hughes et al., 
cholesterol in human monocyte- 1994; Clare et al., 
membranes macrophages, peripheral 1995; Ning etal., 
Alteration of membrane blood mononuclear cells, 1996; Rusinol et 
structure, function and porcine aortic smooth al., 2000; Therond 
fluidity muscle cells, Chinese et aI., 2000; Yuan 
Inhibition of calmodulin hamster ovary cells. et al., 2000; 
HMG-CoA reductal'le Garcia-Cruset et 
al., 2001 
Binding to microsomal MCF-7 human breast 
anti-oestrogen binding . cells 
site i 
OxLDL's effects on gene expression have been explored in THP-l cells by two 'gene 
surveys'. In one study, THP-l cells were exposed to a very low concentration of highly 
I 
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oxidised LDL for up to 4 days and the RNA of 10% of the genes was examined. Overall, 121 
genes had increased activity and 68 were downregulated. There were no effects until after 24 
hours, and most genes were affected to the highest level at day 4. Three of the products of the 
upregulated genes are found in foam cell-rich plaque: adipophilin, heparin-binding epidermal 
growth factor-like growth factor (HB-EGF) and thrombomodulin. The roles ofthe other 
genes are unknown. The genes that were downregulated were involved in promoting the anti-
microbial potential of the cell, such as carbonic anhydrase, RNase A2 or CD64, or part of cell 
cycle progression or the synthesis of building blocks for cell division, for example 
thymidilate synthetase and lamin Bl (Shiffman et al., 2000). This suggests that oxLDL does 
affect the gene expression of cells in the plaque, and that in its highly oxidised state, oxLDL 
may be anti-inflammatory, since genes involved in pro-inflammatory activities were 
downregulated. 
This theory was continned by another study perfonned over only 24 hours in THP-l 
monocytes also incubated with a low dose of extensively oxidised LDL. The expression of 
human ferritin light chain increased, meaning the cell had more iron-binding capacity. Also 
upregulated was the anti-inflammatory perioxisomal proliferator-activated receptor-y 
(PP ARy), a member of the nuclear honnone receptor family and a key transcriptional 
regulator of foam cell fonnation and gene expression in inflammation and differentiation. 25-
Hydroxycholesterol, 7-ketocholesterol, 9-HODE and 13-HODE played important roles in the 
upregulation; the last two are known to be ligands for PPARy (Cader et al., 1997; Jang et al., 
1999). Table 2 outlines the effects of extensively oxidised LDL on cell signalling pathways. 
An increase in intracellular oxidative stress is likely to be involved in many of the 
changes in gene expression that oxLDL causes. NFKB, found in atherosclerotic lesions, is a 
transcription factor that controls inflammatory responses and is influenced by the cellular 
redox status (Draczynska-Lusiak et al., 1998; Li et al., 1999). Superoxide may be involved in 
the intracellular oxidative stress, as it has been measured in endothelial cells and U937 
monocytes during oxLDL-induced apoptosis. However, preventing its production did not 
always delay cell death, which suggests it is not essential in signalling (Galle et al., 1999B; 
Lizard et al., 2000). 
The oxLDL might also alter the cells' defenses against oxidative stress. Tert-butyl 
hydroperoxide decreased antioxidant enzyme activity over 24 hours in U937 monocytes, 
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including superoxide dismutase and glutathione peroxidase. OxLDL has also been shown to 
induce cytosolic antioxidants Cu/Zn superoxide dismutase and GSH peroxidase and 
mitochondrial antioxidant Mn superoxide dismutase in hypercholesterolemic rabbits and 
human peripheral blood monocyte/macrophages (Kinscherf et at., 1997). 
Other effects of oxLDL on viability that have been studied are specifically related to 
the apoptotic process, which is examined in Chapter 5. 
Table 2: Effects of extensively oxLDL on cell signalling 
• Cell types studied Effects if studied References 
PPARy Monocytes and Upregulation of CD36, Tontonoz et al., 1998; 
macrophages cholesterol efflux Tontonoz and Nagy, 
Downregulation of iNOS 1999; Jessup and 
ROS generation, cellular Kritharides, 2000; 
oxygen consumption, Chawla et al., 2001; 
, metalloproteinase Dominaitiene et al., 
prodnction, ge1atinase B, 2001; Fischer etal" 
scavenger R class A, 2002; Argmann et al., 
inflammatory cytokines 2003 
including TNFa, 1L-6, 
IL-W 
. Through receptors LXRa 
• andRXR 
Inhibits NFKB activation Chung et al., 2000 
by binding to subunits 
JARs (tyrosiue kinases) MRC5 fibroblasts Mazh~re et al., 2001 I 
and Stats (transcription 
, factors) 
I Serine and threonine · MRC5 fibroblasts, mouse p38 is necessary for . Chisholm and Chai, 
• kinases including PKC, peritoneal macrophages, PPARr activation 12000; Maziere et al., 
, ERK, p38 smooth muscle cells 2001; Zhao et aI., 2002 I Ca2+ Polymorphonuclear PKC-dependent, part of • Chisholm and Chai, 
leukocytes, mouse superoxide production • 2000; van Tits et al., 
peritoneal macrophages, 2000 
· smooth muscle cells 
NFKB Monocytes, macrophages Controls pro- Brand et al., 1997; 
Via increased smooth muscle cells, inflammatory responses, Kinscherf et al., 1997; 
intracellular oxidative endothelial cells, THP-I including TNFa, IL-l, Draczynska-Lusiak et al., 
stress such as superoxide cells, peripheral blood IL-8, O-CWSF, M-CSF, 1998; Galle et al., 1999; 
Short-term exposure to mononuclear cells ! OM-CSF, monocyte Li et al., 1999; Lizard et 
oxLDL upregulates, chemotactic protein, al., 2000 
long-term exposure tissue factor, adhesion 
I downregulates ! molecules 
A surprisingly small amount of work has been done on oxLDL-induced cell viability 
loss (usually examined as apoptosis) and effects of antioxidants. Phenolic compounds 
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protected endothelial, PC12 and neuronal cells from oxLDL-induced apoptosis (Draczynska-
Lusiak et al., 1998; Vieira et al., 1998; Schroeter et al., 2000; Kotamraju et al., 2001). 
Enzymatic antioxidants SOD and catalase inhibited apoptosis in endothelial cells 
(Galle et al., 1999), and SOD attenuated it in mesangial cells (Shanna et al., 1996). 
In smooth muscle cells, 'Y- and a-tocopherol were effective, although a-tocopherol 
was more so (de Nigris et al., 2000). 'Y-Tocopherol inhibited oxLDL-induced apoptosis in 
human coronary artery endothelial cells (Li et al., 1999). a-Tocopherol has also been found to 
be protective against oxLDL in human coronary artery endothelial cells, a human epidermoid 
carcinoma cell line, mouse mesangial cells and vascular smooth muscle cells. The protection 
was only partial for the vascular smooth muscle cells and a-tocopherol acetate had a similar 
effect (Guyton et al., 1995; Li et al' J 1999; Tashiro et al., 1999; Li et al., 2000; Masella et al., 
2000). Vitamin E prevented apoptosis in U937 cells incubated with 7-ketocholesterol (Lizard 
et al., 2000). 
Pretreatment with vitamin C reduced apoptosis in human vascular smooth muscle 
cells by 1.5mglmL oxLDL (Siow et al., 1999), and partially inhibited apoptosis in human 
monocyte-derived macrophages, whereas dehydroascorbic acid gave complete inhibition 
(Asmis and Wintergeist, 1998). Vitamin C was not effective against 7-ketocholesterol in 
U937 cells (Lizard et al., 2000). 
Results with butylated hydroxytoluene (BHT) also vary. It had no effect against 
oxLDL in rabbit aortic smooth muscle cells (Liu et al., 1998), gave partial inhibition in 
vascular smooth muscle cells (Guyton et al., 1995) and gave complete inhibition in human 
umbilical vein endothelial cells (Harada-Shiba et al' J 1998). BHT blocked oxLDL-induced 
apoptosis of mouse peritoneal macrophages (Niu et at., 1996) and Ml myeloid leukemic cells 
transfected with p53 (Lotem et al., 1996). Probucol was partially protective with vascular 
smooth muscle cells (Guyton et aI., 1995) and mouse mesangial cells (Tashiro et al., 1999). 
Antioxidants effective against thiol oxidation could also prevent oxLDL apoptosis. 
N-acetylcysteine was successful in Ml myeloid leukemic cells transfected with p53 and 
incubated with oxLDL (Lotem et al., 1996), mouse mesangial cells with oxLDL (Tashiro et 
al., 1999) and U937 cells with 7-ketocholesterol, as was GSH (Lizard et al., 2000). N-
acetylcysteine and vitamins E and C together prevented apoptosis in endothelial cells with 
oxLDL, by stopping caspase activation (Dimmeler et al., 1997). 
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Cycloheximide did not protect human monocyte-macrophages against oxLDL-
induced apoptosis, suggesting protein synthesis was not important. It could protect against 
apoptosis in macrophages with gliotoxin and thymocytes with dexamethasone (Hardwick et 
al., 1996). NO donors and metalloporphyrins were potent inhibitors of oxLDL-mediated 
apoptosis in endothelial cells (Kotamraju et al., 2001). 
Many results, then, point towards a protective effect of antioxidants against oxLDL-
induced cell viability loss, strengthening the possibility that 78NP, acting as an antioxidant, 
may be able to protect the cells in the same way. 
The same three assays described in Chapter 3 were used to examine first the effect of 
different concentrations of oxLDL on the two monocytic cell lines, followed by the effect of 
78NP on this cell viability change at one oxLDL concentration. A series of experiments were 
then undertaken to clarifY the protective activity of 78NP, and to look at what may be 
happening to the 78NP itself as it is incubated with the cells. The influence of AAPH, oxLDL 
and 78NP on cell viability in THP-l macrophage-like cells was then studied. 
RESULTS AND DISCUSSION 
A. MONOCYTES, oxLDL AND 78NP 
1. PROPERTIES OF OXLDL 
The oxLDL prepared by the procedure set out in Chapter 2 has been characterised 
relative to native, non-oxidised LDL. This is undertaken with two aims: to prove that the 
LDL is in fact oxidised, as it has characteristics typical of oxidation, and to allow its 
comparison with oxLDL used by other groups. The three most common sets of properties 
from the literature, TBARS, aggregation and relative electrophoretic mobility (REM) were 
used, as well as other methods commonly employed in our laboratory which provide useful 
information. 
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Table 3: Characteristics of oxLDL 
Figure 22: Lipoprotein gel ofLDL. Lane 1 and 5 are non-oxidised LDL, lane 2 and 6 are LDL after 
incubation with 5f.lM Cu2+ for 24 hours, lane 3 and 7 are LDL after incubation with 20JlM Cu2+ for 24 hours, 
and lane 4 and 8 are LDL after incubation with 50J1.M Cu2+ for 24 hours. 
The TBARS HPLC lipid analysis provides an estimate of oxidative products such as 
lipid peroxides and aldehydes in the LDL. OxLDL was analysed at 0.5mglrnL, and it was 
found that there were approximately 9-fold more TBARS in the oxLDL than in native LDL 
(Table 3). TBARS were likely to have decayed from their peak level as oxidation progressed, 
since this oxLDL is extensively oxidised. 
An example of reduction ofTBARS over time was given by LDL oxidised at 
1.Omg/rnL with 1 00 11M eu2+ for 24 hours (a situation similar to the oxidation method 
employed here), which had TBARS increasing by 26-fold at four hours, but only II-fold at 
the end of the oxidation time (Darley-Usmar, et al., 1991). Less extensively oxidised LDL, 
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incubated with only 5/lM Cu2+ for 20 hours, had an increase in TBARS levels of27-fold 
following oxidation (Steinbrecher et al., 1987). 
A modified version of the FOX assay was used to measure protein hydroperoxides in 
LDL at 0.3mglmL (Table 3). The low values, only 3-fold more than native LDL, reflect a 
decay of the peroxides over time, in a similar fashion to the TBARS levels. 
The relative electrophoretic mobility of oxLDL and native LDL was compared using 
lipoprotein gel electrophoresis. OxLDL's mobility was 3-fold greater than that of native LDL 
(Table 3, Figure 22). LDL oxidised at I.OmglmL with 100flM Cu2+ for 24 hours also had a 
REM that tripled by the end ofthe oxidation period (Darley-Usmar, et al., 1991). LDL 
oxidised by THP -1 monocytes in Hams FlO medium for 24 hours showed a 3.5-fold increase 
in mobility (Gieseg and Cato, 2003). 
The gel shown in Figure 22 demonstrates the effect of a range of eu2+ concentrations 
on LDL charge during the 24 hour incubation period. Lanes 1 and 5 represent non-oxidised 
LDL, lanes 2 and 6 represent LDL incubated with 5/lM Cu2+, lanes 3 and 7 with 20/lM Cu2+ 
and lanes 4 and 8 with 50flM Cu2+. A detectable change in REM only occurred with the 
highest Cu2+ concentration, supporting the choice of this concentration to ensure oxidation. 
The increase in REM is indicative of extensive oxidation, as a certain level of lipid oxidation 
is thought to be required before a major change in REM can occur (Fong et al., 1987). 
The final characterisation involved the quantification of aggregation in the LDL by a 
spectrophotometric measurement at 680nm. At 0.5mglmL, the oxLDL was approximately 
five-fold more aggregated than the native LDL, even though it was filtered before analysis 
(as it was before addition to the cells), which would have removed very large aggregates 
(Table 1). LDL is known to aggregate during oxidation, especially in the later stages (Maor et 
al.,1997). 
There are significant differences between the oxLDL preparations of different 
laboratories. The concentration of the LDL when oxidised, the oxidant and its concentration, 
the length of the oxidation, the temperature of oxidation and transition metal or metal 
chelator concentration will affect the finished product (Lougheed and Steinbrecher, 1996; 
Ziouzenkova et al., 1998). Native LDL is very heterogeneous, with different ratios of 
components such as PDF As and antioxidants from each group of donors, which will also 
affect the properties of the oxLDL (Esterbauer et al., 1988). 
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Oxidation ofLDL by Cu2+ to an 'extensively oxidised' state is a good option for 
experimental use. The above analyses reinforce that this is the form resulting from the 
procedures used here. Extensively oxidised LDL shares many traits with LDL isolated from 
human atherosclerotic lesions, aortas with fibrous plaques and complicated lesions at 
autopsy. Both display similar increases in electrophoretic mobility and fluorescence at 360nm 
ex and 430nm em, and similar banding patterns on SDS-P AGE gels showing fragmentation 
of apoB. Both show an increase in TBARS levels and are recognised by antibodies to 
epitopes for proteins modified by MDA or 4-HNE. Both are also degraded equally by mouse 
peritoneal macrophages, although degradation of the atherosclerotic examples varied more 
between samples. The atherosclerotic samples also tended to self-aggregate more, leading to 
increased uptake, probably by phagocytosis (Hoff and O'Neil, 1991). 
Oxidation with copper ions is an attractive oxidation method as it is simple and 
reproducible (Pinchuk et al., 1998). This method was also chosen as it is the most common 
method of oxidation in the literature, increasing the ease of comparison with other studies. 
Another advantage is that the copper ions are easy to completely remove at the end of the 
oxidation period. 
2. EFFECT OF OXLDL ON CELL VIABILITY IN MONOCYTES 
THP-l or U937 cells were incubated with various concentrations of oxLDL or non-
oxidised LDL (as a control). The initial goal was to determine the length of incubation 
required to achieve around 50% cell viability loss, so that the effect of 78NP could be tested. 
After 24 hours of incubation with O.5mglmL, 1.5mglmL and 3.0mglmL oxLDL, there 
was very little viability loss in THP-1 cells, although that which occurred was concentration-
dependent (Figure 23). The 1.5mglmL non-oxidised LDL sample gave an increase in cell 
viability, as it was likely to provide serum-like nutrients for the cells which are missing from 
the medium, and also encourages growth (Frostegiird et al., 1990). Only the MTT assay was 
used, as this was simply a test to determine incubation length. 
The concentrations of oxLDL used in this study are similar to the levels of LDL found 
in vivo. The normolipidernic concentration ofLDL in serum is 3.OmglmL, 60% of the total 
serum cholesterol (Esterbauer et al., 1992). In the artery wall LDL concentration is higher 
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than that of other lipoproteins, and the range is still within that found in plasma (Steinbrecher 
and Lougheed, 1992). 
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Figure 23: Effect of increasing concentrations of oxLDL on THP-l cells after 24 hours: MTT assay. 
TIIP-l cells at 5x 1 05 cells/mL in RPM! 1640 were incubated with varying concentrations of oxLDL for 24 
hours, and the results analysed by MIT assay. A 1.5mg/mL non-oxidised LDL control was also included. The 
results are expressed as the mean ± SD of triplicates. 
After 48 hours of incubation, 1 'smgfmL oxLDL reduced cell viability to close to 60% 
(Figure 24). This is the concentration of oxLDL chosen for experiments on 78NP protection. 
Again, the non-oxidised LDL caused no viability loss, although there was also no significant 
increase in viability by this timepoint The loss in viability caused by the oxLDL was 
concentration-dependent in a linear fashion, and the losses measured by each assay were very 
similar. 
As with the AAPH experiments, varying concentrations of 78NP had no significant 
effect on the oxLDL-mediated cell viability loss in THP-1 monocytes (Figure 25). Control 
cells incubated with 200f.1,M 78NP without oxLDL did not lose viability. 
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Figure 24: Effect of increasing concentrations of oxLDL on THP-l cells over 48 hours: MTT and 
Trypan blue assays. TIIP-l cells (5 x 105cells/mL) were incubated with varying concentrations of oxLDL for 
48 hours in RPMI 1640, and the results analysed by MIT or trypan blue assay, A non-oxidised LDL control at 
1.5mg/mL was included. The results are expressed as the mean ± SD of triplicates. 
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Figure 25: Effect of increasing concentrations of 78NP on 1.Smg/mL oxLDL and THP-l cells: (A) 
MTT, (B) Trypan blue. THP-l cells (5 x 105 cells/mL) were incubated with 1.5mglmL oxLDL for 48 hours in 
RPM! 1640, with increasing 78NP concentrations, and the results analysed by MIT or trypan blue assay. A 
control with 200~ 78NP and no oxLDL was included. The results are expressed as the mean ± SD of 
triplicates. 
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The effect of oxLDL on the U937 cell type was investigated under the same 
experimental conditions. A 48 hour incubation with the three different oxLDL concentrations 
caused concentration-dependent and linear viability loss (Figure 26), similar to that observed 
with the THP-1 cells. The MTT and trypan blue assays yielded very similar results, and the 
values were also very close to those obtained for the THP-1 cells, as in the experiments with 
AAPH. Again, 1.5mglmL non-oxidised LDL increased the cells' viability. 
Increasing concentrations of 78NP caused an increase in cell viability in U937 cells 
incubated with oxLDL, which was significant at the lowest 78NP concentration tested of 
1 OJ.tM (p~ 0.01) (Figure 27). 78NP alone at 200).!M increased viability slightly. 
150 
125 
-e 
-c 100 8 
';f!. 
-
25 
MIT 
fZ:Z?J Trypan Blue 
0.5 1.5 3 non-oxlDl 
[OxlDl] (mg/ml) 
Figure 26: Effect of increasing concentrations of oxLDL on U937 cells over 48 honrs: MTT and 
Trypan blue assays. U937 cells (5 x 105 cells/mL) were incubated with varying concentrations of oxLDL for 
48 hours in RPM! 1640, and the results analysed by MTT and trypan blue assay. A non-oxidised LDL control at 
1.5mg/mL was incJuded. The results are expressed as the mean ± SD of triplicates. 
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Figure 27: Effect of increasing concentrations of 78NP on 1.Smg/mL oxLDL and U937 cells: (A) 
MTT, (B) Trypan blue. U937 cells (5 x 105cells/mL) were incubated with 1.5mg/mL oxLDL for 48 hours in 
RPM! 1640, with increasing 78NP concentrations, and the results analysed by MIT or trypan blue assay. A 
control with 200~ 78NP and no oxLDL was included. The results are expressed as the mean ± SD of 
triplicates. 
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Incubation of oxLDL with lliP-l cells resulted in a gradual loss of total reduced 
thiols, following the pattern and percentage of reduction found for viability quite closely 
(Figure 28). By contrast, the oxidation ofthiols in U937 cells, as shown in Figure 29, was 
markedly different. The loss at O.SmglrnL oxLDL was similar to the result found with THP-l 
cells, but with higher concentrations the thiollevels dropped away completely. At 1.SmglrnL 
oxLDL, there appeared to be no reduced thiols left in U937 cells. In both cell types 
1.SmglrnL non-oxidised LDL increased the level of reduced thiols slightly. 
The sudden loss of reduced thiols in U937 cells was examined more closely. A greater 
range of oxLDL concentrations was incubated with U937 cells in Figure 30. The rapid 
decrease could be seen to occur between O.SmglmL and 1.2mglrnL oxLDL, with 0.8mglrnL 
acting as an intermediate point. After a critical concentration, the reduced thiols were rapidly 
oxidised or lost from the cell, and could not be regenerated through re-reduction or 
resynthesis. 
The thiolloss in U937 cells over time was examined using the three original oxLDL 
concentrations of O.5mglrnL, 1.SmglrnL and 3.0mglrnL (Figure 31). OxLDL at O.SmglmL 
actually caused an increase in reduced thiols before the level came back down, in this case to 
a little above the level of the untreated cells. With 1.SmglrnL oxLDL the initial decrease was 
gradual, until between 6 and 12 hours the levels dropped suddenly. Using 3.OmglrnL oxLDL 
the same effect was observed, but the large decrease in thiollevels occurred earlier, between 
2 and 6 hours. These results support the idea of a turning-point, after which cellular thiol 
maintenance cannot be sustained. 
The fact that these sudden thiol changes were not observed with THP-1 cells was 
further demonstrated in Figure 32. The alterations in reduced thiollevel at 24 hours, 
represented here, were much the same as those at 48 hours, making it unlikely that major 
thiolloss had happened earlier and been partially restored. 
The loss of reduced total thiols in THP-1 cells was unaffected by any 78NP 
concentration, whereas U937 cell thiollosses could be partially regained, although the 
difference was not statistically significant unti1100jlM 78NP (Figures 33 and 34). This 
mirrors the effect of 78NP on U937 cell viability (Figure 27). 
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Figure 28: Effect of increasing concentrations of oxLDL on thiol content of THP-l cells over 48 
hours: DTNB assay. THP-l cells (5 x 105cells/mL) were incubated with varying concentrations of oxLDL for 
48 hours in RPM! 1640, and the results analysed by DTNB assay. A non-oxidised LDL control at 1.5mg/mL 
was included. The results are expressed as the mean ± SD of triplicates. 
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Figure 29: Effect of increasing concentrations of oxLDL on tbiol content ofU937 cells over 48 hours: 
DTNB assay. U937 cells (5 x 105cells/mL) were incubated with varying concentrations of oxLDL for 48 hours 
in RPM! 1640, and the results analysed by DTNB assay. A non-oxidised LDL control at l.5mg/mL was 
included. The results are expressed as the mean ± SD of triplicates. 
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Figure 30: Effect of a "ider range of concentrations of oxLDL on reduced tbiolloss in U937 cells over 
48 hours: DTNB assay. U937 cells (5 x 1Q5cells/mL) were incubated with varying concentrations of oxLDL for 
48 hours in RPMI 1640, and the thiolloss analysed by DTNB assay. The results are expressed as the mean ± 
SD of triplicates. 
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Figure 31: Effect of three oxLDL concentrations on U937 cell tbiolloss over time: DTNB assay. 
U937 cells (5 x lQ'cells/mL) were incubated with three concentrations of oxLDL for up to 48 hours in RPMI 
1640, and the thiolloss analysed by DTNB assay. The results are expressed as the mean± SD oftriplicates. 
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Figure 32: Effect of increasing concentrations of oxLDL on reduced thiolloss in THP-l cells over 24 
hours: DTNB assay. TIIP-l cells (5 x 105cellsJmL) were incubated with varying concentrations of oxLDL for 
24 hours in RPM! 1640, and the loss ofthiols analysed by DTNB assay. The results are expressed as the mean ± 
SD of triplicates. 
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Figure 33: Effect of increasing concentrations of 78NP on reduced thiolloss in oxLDL-treated THP-l 
cells: DTNB assay. nIP-I cells (5 x 105cel1s/mL) were incubated with 1.5mg/mL oxLDL for 48 hours in 
RPMI 1640, with increasing 78NP concentrations, and the results analysed by DTNB assay. A control with 
200JlM 78NP and no oxLDL was included. The results are expressed as the mean ± SD of triplicates. 
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Figure 34: Effect of increasing concentrations of 78NP on reduced thiolloss in oxLDL-treated U937 
cells: DTNB assay. U937 cells (5 x 105cells/mL) were incubated with 1.5mg/mL oxLDL for 48 hours in RPMI 
1640, with increasing 78NP concentrations, and the results analysed by D1NB assay. A control with 200JIM 
78NP and no oxLDL was included. The results are expressed as the mean ± SD of triplicates. 
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In order to understand how 78NP is acting to protect U937 cells, the mechanism of 
damage employed by oxLDL must be considered. This is investigated in more depth in 
Chapter 5, but nonetheless some information can be uncovered from the results found so far. 
It would be beneficial to understand how the oxLDL interacts with the cells, and 
whether it is actually taken up by them, as occurs in foam cell formation. Most researchers 
agree that THP-1 and U937 cell monocytes express LDL receptors, but not scavenger 
receptors (Takata et al., 1989; Aleeson et al., 1991A; Palkama, 1991; Miki et al., 1996; 
Wang, 1999; Tanimoto et al., 2001). Scavenger receptor expression is induced during 
differentiation of monocyte cells to macrophages with PMA (Banka et al., 1991; De Kimpe et 
al., 1998; Shimaoka et al., 2000) or other phorbol esters such as TP A (Adachi et al., 1993; 
Suematsu et al., 1995). 
One study found that effects of oxLDL on U937 monocytes and human peripheral 
blood monocytes, including chemokille receptor and p38MAPK upregulation, could be 
attenuated by scavenger receptor inhibitors, implying the existence of these receptors (Lei et 
al., 2002), but this was not demonstrated or investigated further. 
However, monocytes such as the cell lines used in this study might still take up the 
oxLDL using other receptors or mechanisms. CD36 was found to internalize oxLDL in U937 
monocytes, but only to a limited extent, since the receptor was not replaced at the membrane 
(Pietsch et al., 1996). U937 cell expression ofCD36 is thought to be around four-fold higher 
than in THP -1 cells (Nguyen-Khoa et al., 1999). A third novel form of scavenger receptor A, 
resulting from alternative splicing, was found in THP-1 monocytes and human monocyte-
derived macrophages, but this blocked acLDL uptake (Gough et al., 1998). An HDL receptor 
has been found in THP-1 monocytes (Webb et al., 1997). Histamine and forskolin increase 
the expression of LOX-1 (Tanimoto et al., 2001). A study using a biosensor surface with 
acLDL attached found at least two acLDL binding sites in U937 monocyte cells, although 
acLDL uptake as a result of binding was not shown by this work (Rice, et al., 2002). 
THP-1 monocytes are all able to phagocytose 0.8f!m diameter latex particles, whereas 
only 20% ofU937 cells do (Sundstrom and Nilsson, 1976; Tsuchiya et al., 1980). THP-1 
monocytes may ingest oxLDL by this non-specific route, although this has not been tested. 
Aggregated LDL may be often phagocytosed, as its uptake can be inhibited by cytochalasin B 
which inhibits phagocytosis (Khoo et al., 1988). 
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Differentiation ofmonocytes by oxLDL during incubation could induce scavenger 
receptor expression. This has been found in U937 cells with O.lmglmL ofoxLDL. Markers 
of differentiation such as MHCII and surface antigen Leu3 expression were enhanced, and 
adherence to endothelial cells was stimulated (Frostegard et al., 1990; Lei et al., 2002). 
Scavenger receptors were induced in THP-1 monocytes by oxLDL immune complexes, 
through binding to Fc receptors (Kiener et al., 1995). The levels of oxLDL used in the work 
shown here is likely to be too great to cause differentiation before injury. No signs of 
differentiation such as an increase in size or adherence to the plate were ever observed. 
Even if oxLDL were unable to be taken up by monocytes, it could still affect them in 
an oxidative manner by transferring some of its components into the cell membrane 
(Frostegard et al., 1990). Aldehydes, for example, can partition from the lipid phase of the 
oxLD L into the cell's plasma membrane (Gotoh et al., 1993). 
One study with THP-l monocytes and oxLDL found that the rate of cholesterol 
synthesis dropped and the rate of cholesterol esterification increased, and more cholesterol 
esters were stored than in human monocyte-derived macrophages. This did not happen in the 
presence of acLDL or native LDL (Banka et al., 1991). This type of result suggests that THP-
1 monocytes may well metabolise oxLDL, even though the receptor or alternative mechanism 
of uptake has not yet been identified. 
Whatever the mechanism of interaction may be, oxLDL is certainly able to damage 
cells, decreasing their viability. The MTT assay shows oxLDL is able to alter the THP-l and 
U937 cells' enzyme activities, metabolism and energy levels and the trypan blue assay shows 
an effect on cell membrane integrity, indicating that necrosis or secondary necrosis has 
occurred, The loss of viability was dependent on the oxLDL concentration and linear over 
time. 
Viability loss is remarkably similar in the MTT and trypan blue assays, supporting the 
conclusions made in the previous chapter about the two assays measuring stages in the 
pathway towards cell death which are close in time. Both THP-1 and U937 cells lost viability 
at the same rate and had similar responses to each concentration. No disparities were found 
here to account for the distinct effect of78NP on each cell type. 
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The fact that 78NP has no viability-improving effect in THP-l cells with oxLDL 
strengthens the evidence that the oxLDL used is extensively oxidised. Lightly oxidised LDL 
contains many lipid hydroperoxides, which are thought to damage the cell through the 
creation ofperoxyl and alkoxyl radicals (Coffey et al., 1995). 78NP provides some protection 
to the THP-1 cells against peroxyl radicals, as shown in the previous chapter. The oxLDL 
used here will consist mainly of oxysterols and products of protein oxidation. The oxidation 
of apoB 1 00 will result in conjugation to aldehydes and crosslinking causing aggregation 
(Esterbauer et al., 1992; Meyer et al., 1995). The result also suggests that the generation of 
free radicals as part of the cell signalling set in motion by oxLDL may not be vital to the 
other effects of oxLDL, since 78NP can also scavenge superoxide (Shen, 1994). 
Alternatively, these radicals may not be accessible to exogenously added 78NP. 
The scavenging properties of 78NP may therefore not be so vital during incubation 
with oxLDL. The other capabilities hinted at in the AAPH studies, such as redox modulation 
involving thiols, may be even more important. 
The first difference found in the response ofTHP-l and U937 cells to an injury-
provoking stimulus was the oxLDL-induced oxidation of thiol constituents. The THP-1 thiol 
loss was gradual and concentration-dependent, following the gradient ofloss of viability 
obtained with the MIT and trypan blue assays. U937 cells lost their reduced thiols gradually 
for a short time, and then very suddenly were depleted of almost all the rest. They appeared 
to reach a critical point (dependent on the period of incubation for each oxLDL 
concentration) after which it was impossible to maintain reduced thiols. This could represent 
an inability to re-reduce the thiols, perhaps as the cellular environment became too oxidative. 
It could mean that new thiols were unable to be synthesized, or perhaps an efflux of 
glutathione occurred, greatly reducing the number of thiol residues in the cell. 
The lowering of reduced thiols may relate to loss of activity of important enzymes or 
transcription factors, as well as glutathione. The p50 subunit ofNFKB is thiol-sensitive, since 
some ROS may oxidise key cysteine 62, which is required for DNA binding. This oxidation 
may be part of its downregulation after a longer exposure to oxLDL (Brand et at., 1997). 
A loss in reduced thiollevels following oxidative stress has been reported in U937 
cells treated with tert-butylhydroperoxide (tBOOH). tBOOH oxidises glutathione, causing an 
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increase in GSSG intra- and extracellularly after two hours of incubation (Nardini et al., 
1998). GSH was extruded before membrane leakage in U937 cells with puromycin (Ghibelli 
et ai., 1998). In U937 cells with 7 -ketocholesterol, down-regulation of antioxidants including 
glutathione and a decline in transcription levels of catalase, superoxide dismutase and 
thioredoxin were found (Lizard et al., 1998). 
The thiol changes show that, in spite of the very similar overall viability losses, 
oxLDL does act on each cell type differently. The oxLDL had a minor oxidative effect in 
THP-1 cells, lowering reduced thiols in parallel with viability, as did AAPH in both cell 
types. Thiolloss might not be the defining event in viability loss in THP-1 cells with oxLDL 
or AAPH. Native LDL increased thiollevels, as part of its improvement ofthe cell's overall 
viability, and 78NP alone had a similar effect. This suggests that reduced thiols do contribute 
to viability in THP-l cells in some way. 
Also noteworthy is the increase in reduced thiols found with the lower oxLDL 
concentration. This has been reported before in a range of cell types. Both THP-l monocytes 
and macrophage-like cells incubated with O.SmglrnL extremely oxidised LDL experienced an 
initial small decrease in glutathione levels, and an elevation by 24 hours. It was found that if 
cells were pretreated with a non-toxic oxLDL dose, the increase in glutathione would protect 
the cells against a subsequent toxic dose of2.0mglrnL (Gotoh et al., 1993). In THP-1 cells 
incubated with O.SmglrnL oxLDL for 24 hours, glutathione levels dipped in the first three 
hours, then increased, to a greater level with more oxidised LDL. No loss of viability was 
found (Darley-Usmar, et ai., 1991). 
Low concentrations oflightly oxidised LDL at first decreased GSH in human vascular 
endothelial cells, but the levels were doubled by 24 hours, in a dose dependent fashion 
between O.12SmglrnL and O.5mglmL oxLDL. The effect was not found with native or 
acetylated LDL. OxLDL stimulated the transcription of yGeS via increases in AP-l DNA 
binding activity mediated by reactive oxygen species (Cho et al., 1999). 
In U937 cells, oxLDL's oxidative effects were much greater than its overall effect on 
viability. Reduced thiols were completely abolished, suggesting that the oxLDL may be well 
placed to oxidise them in this cell type, or may set in motion a chain of events that causes this 
oxidation, which it does not in THP-l cells. Since the complete loss of thiols did not occur 
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with AAPH in U937 cells, it not an obligatory part oftheir response to oxidative stress; rather 
it is something more particular for the oxLDL. 
Different fractions of oxLDL have varying effects on glutathione loss in human 
endothelial cells. The depletion of reduced thiols did not necessarily correlate with the 
cytotoxic effects. 7-Ketocholesterol fractions caused a greater percentage of viability loss 
than glutathione loss, whereas aldehydes depleted 100% of the glutathione and caused less 
viability loss. Oxysterols cannot be conjugated by GSH, which may playa part in the 
difference (Therond et al., 2000). 
Possibly the difference in thiols in the cell types may relate to a difference in 
signalling pathways set in motion by oxLDL. IfU937 cells do not express transcriptional 
regulator PPARy in response to oxLDL, as suggested (Inoue et aI., 2001), and THP-1 cells 
do, a longer incubation with oxLDL would not have the anti-inflammatory effects in U937 
cells that would be found in THP-1 cells. ROS generation might not be reduced, which would 
impact directly on reduced thiollevels. 
The difference between the effects of AAPH and oxLDL on thiols in U937 cells may 
reflect different degrees of influence over intracellular oxidative balance. U937 cells were 
found in one study to have a lower level of glutathione expression than THP-l cells. They 
also had much less thioredoxin and thioredoxin reductase, almost no thioredoxin at all. They 
had slightly higher levels ofMnSOD (Ferret et aI., 2000). U937 cells' antioxidant defenses 
may be weaker overall, or less oriented towards the type of oxidative stress produced by 
oxLDL. If the U937 cells have higher levels of superoxide dismutase, they may be better able 
to cope with a radical flux than stress caused by non-radical reactive oxygen species. 
The more spectacular drop in thiols in U937 cells may well account for at least some 
of 78NP's protective ability in this cell type, and lack of it in THP-1 cells, as was the case 
with AAPH. U937 cells may be more sensitive to an oxidative environment, as suggested by 
the loss of their thiols. Loss of thiols would then certainly exacerbate the oxidative effect of 
the oxLDL. The increased oxidative stress may mean that 78NP can therefore playa role in 
reviving the cell, by helping to create a more reducing environment. It may lower or slow 
oxidation of the thiols. 
Increase in reduced thiols has been reported to improve U937 cell viability in a range 
of circumstances. Addition of GSH or its precursor N-acetylcysteine halved loss of viability 
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with 7-ketocholesteroL GSH and N-acetylcysteine could also impair etoposide but not 
cycloheximide viability loss (Lizard et al., 1998). Thiolloss was suppressed by N-
acetylcysteine and enhanced by BSO in U937 cells with the 2-oxoaldehydes methylglyoxal 
and 3-deoxyglucosone and this was reflected in viability (Okado et al., 1996). U937 cells lost 
50% of their reduced glutathione with tBOOH by 2 hours, and the addition of caffeic acid 
halved this loss (Nardini et al., 1998). 
Low micromolar concentrations of neopterin were found to activate NFKB, and both 
78NP and neopterin enhanced cGMP effects and transiently increased intracellular Ca2+ 
levels (Barak M. and Gruener N., 1991; Woell et al., 1993; Schobersberger et al., 1996; MUff 
et al., 1999). Since longer incubations with oxLDL downregulate NFKB, and oxLDL also 
alters ca2+ levels, the protection by 78NP may involve the reduction of these oxLDL effects. 
However, since 78l\TP can only affect cell viability loss with oxLDL in U937 cells, whichever 
pathways 78NP alters to improve viability must only be important for the effect of oxLDL in 
the U937 cell type. Other pathways may take on a greater significance in the absence of 
PP ARy in these cells. 
If there is a difference in cell uptake, the 78NP may be in a position where it can 
undertake this protective role with the thiols. For example, with Jurkat cells and anti-Fas 
antibody, it was found that an external antioxidant could lessen the impact of glutathione loss, 
and hence delay, although not prevent, apoptosis (Van den Dobbelsteen et al., 1996). 
This may be not the only way in which 78NP acts to inhibit oxLDL-mediated cell 
death. The next set of experiments aims to clarifY its possible roles and the ways it carries 
them out. 
B. CHARACTERISING THE PROTECTIVE EFFECT OF 78NP 
1. THE STABILITY OF 78NP OVER THE DME OF INCUBATION 
To determine the stability of 78NP during an experiment, 200~M 78NP was 
incubated with THP-l monocytes or RPMI 1640 for up to 72 hours, in a mimic of an 
experimental situation. The concentrations of three compounds, 78NP, neopterin and 7,8-
dihydroxanthopterin (78XP), were examined by HPLC. 
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The major oxidation product was found to be 78XP (Figure 35). The sample 
chromatogram shows 78NP after incubation with cells for 12 hours. In the BCD 
chromatogram, peak 5 represents 78NP and peak 7 is 78XP. As time went on, peak 5 shrunk, 
and peak 7 grew from an imperceptible size to become very large. On the fluorescence 
chromatogram, peak 7 is 78NP/neopterin, and 78XP does not show up. The 78NP/neopterin 
peak diminished over time. 
The results from the BCD detector showed that the 78NP concentration slowly 
decreased over the 72 hours, until it had all been converted to 78XP, which steadily increased 
(Figure 36). The 78NP incubated with the cells degraded at a slower rate, with a concurrently 
slower pace of 78XP formation, suggesting the cells were stabilising the 78NP. Effluxed 
thiols, reductants or antioxidants may have been responsible for this, and the cells' own 
production of a small amount of 78NP may also have contributed. 
Since the fluorometric peaks of neopterin and 78NP are separated by only 0.2 
minutes, they cannot be distinguished by this analysis. Examining the size of the peak, it can 
be seen that some neopterin must have been present, since otherwise much more than the 
original200J1M 78NP was detected (Figure 37). Since from the standards we know that 
neopterin is around threefold more fluorescent than 78NP, that amount can be calculated. The 
levels are small, but present from the start. 
An interesting difference between the samples with and without cells was also found 
here. When cells were included, the concentration of neopterin rose slightly over time, 
suggesting the cells may be producing a small quantity, or else another metabolite they 
release may encourage some oxidation of 78NP towards neopterin. The cells may also 
stabilise the neopterin, since without the cells, the neopterin component appeared to break 
down, decreasing in concentration over time. 
This data showed that cells, at least without the presence of an oxidant, appear to 
stabilise 78NP rather than increase its oxidation. 78NP did not appear to be being taken up by 
the cells in great amounts, as close to the fu1l200j.tM of 78NP or 78XP was always detected 
without lysis of the cells. 
*** 
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Chromatogram *** Filename: SB2806C1 ch='-l DA'I'A=SBZ806Cl. D4.5 97/06/29 00: 19: 5 
mv,-______________________ -, Vial # 4 
Sample cells + 78NP 
400 
o 5 10 
min 
Inj. Volume 10 
Detector Other 
Operator 
Hethod Name 
*** Peak Report 
PKNO TIME 
1 3.134 
2 :3 .263 
3 3.958 
4 4.148 
55.459· 
6 6.527 
7 9.364 
Sarah 
NP2C ECD.lviET 
AREA 
84486 
90250 
365981 
4532961 
6132137 
54243 
6337736 
17597794 
HEIGHT 
10672 
10584 
42431 
199328 
259051 
3120 
239679 
764865 
*** Chromatogram *** Filename:SB2806c2 Ch=2 DATA=SB2806C2.D45 97106/29 00:19:5 
Detector : RF-10AXL 
*** Peak Report *** 
PKNO TIME AREA HEIGH'l' 
1 3.142 1920 152 
2 3.375 3569 303 
3 3.629 5714 536 
4 3.875 3627 415 
5 4.047 12519 911 
6 4.658 1896 214 
7 5.425 15566498 1003530 
500 8 5.896 212390 15323 
9 6.242 127862 7391 
10 8.478 39078 1543 
! 11 10.531 36349 2338 
12 11.196 41048 2236 
--~----------------------------------
16072470 1034892 
~B.L6 l 1O. L\ 
'2:4 v I 12 o 
5 
o 5 10 
min 
Figure 35: Sample chromatogram from HPLC analysis of the stability of 78NP over 72 hours. This 
chromatogram is from a sample of 78NP incubated with celis, and analysed at 12 hours using the pterin method 
with both the ECD and fluorescence detectors. The top chromatogram shows the ECD results. Peak 5 represents 
78NP and peak 7 78XP. The lower chromatogram is the fluorescence detector trace, the single peak shows 
78NP and neopterin. 
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Figure 36: The stahility oflOO"M 78NP over 72 hours with and without cells. 
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200llM 78NP was incubated in RPMl1640 with or without THP-l cells (5 x 1Q5cells/mL) at 37°C for 72 hours. 
The concentration of 78NP and 78XP was measured at each timepoint using the pterin HPLC method without 
oxidation with acidic iodide solution, using the ECD detector. 78XP concentration was calculated using a 
fluorometric ratio of3: 1 with 78NP, determined earlier by HPLC with a new 78XP standard. 78XP is too 
unstable to use as a standard after storage. The results are expressed as the mean ± SD of triplicates. 
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Figure 37: Changes in neopterin concentration during incubation of a 200pM 78NP solution with and 
without cells over 72 hours. 200f.lM 78NP was incubated in RPMI 1640 with or without TfIP-l cells 
(5 x 105 cells/mL) at 37°C for 72 hours. The concentration of neopterin was measured at each timepoint using the 
pterin HPLC method without oxidation with acidic iodide solution, using the fluorescence detector. The results 
are expressed as the mean SD of triplicates. 
2. THE INTERACTION OF 78NP WITH CELLS 
In order to examine whether 78NP interacts with cells, 50JlM 78NP was added to 
cells, as in previous viability experiments. After washing, cells were lysed, and levels of 
remaining 78NP measured. 
The control cells showed low levels of 78NP, indicating that they were producing a 
small amount of the pterin (Figure 38). Both cell types appeared to associate with 78NP, but 
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the patterns in which this occurred over time were different. Just under 400nM of 78NP was 
associated with THP-1 cells almost immediately after being added to the wells, and this 
quantity did not increase over the next ten minutes, which is the time at which oxidants are 
added in viability experiments. After two hours the concentration of 78NP interacted with 
was greater. In U937 cells, only approximately 250nM 78NP was associated with the cells 
immediately after addition to the wells, but this amount had more than doubled by 10 
minutes, the time of oxidant addition. The levels of 78NP interacting with the cells fell again 
over two hours. 
78NP is therefore able to interact with cells, in a strong enough way to remain 
associated with the cells during two sets of centrifugation and PBS washes. The difference 
between the cell types provides yet another avenue of possibilities to explain the ability of 
78NP to protect U937 cells but not THP-1 cells from AAPH and oxLDL. Perhaps the added 
78NP interaction at the time of the onset of oxidative stress gives the U937 cells an important 
advantage in those earlier moments. 
This experiment does not differentiate between the possibilities of 78NP being taken 
into the cell or simply contacting the membrane. A fractionation experiment could give some 
interesting insights into the nature of the interaction. 
To see whether this association alone could be responsible for the protection of the 
cells from oxLDL, U937 cells were incubated with 20011M 78NP for 20 minutes (Figure 39) 
or two hours (Figure 40), then washed to remove the 78NP not interacting with the cells 
before addition of 1.5mglmL oxLDL, as in other viability experiments. 
This type of situation reduced cell viability loss in a study in which U937 cells were 
preincubated with adult T cell leukemia-derived factor (ADF). ADF is a radical scavenger 
that is a human homologue of thioredoxin. It still protects cells from TNFa-apoptosis even 
after it is washed off, reducing the cells' sensitivity to TNFa, perhaps by scavenging radicals, 
or interacting with molecules on the surface, especially thiol-sensitive proteins such as 
thioredoxin reductase (Matsuda M. et al., 1991). 
In this study, in spite of a small amount of78NP being present, as illustrated in the 
previous experiment, no measurable protection of cell viability was provided (Figures 39 and 
40). So while the U937 cells' capacity to bind more 78NP early on may give the cells a 
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headstart against oxidative stress over the THP-1 cells, this could not be the only factor that 
determines the difference between the two cell lines. 
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Figure 38: Association between 78NP and THP-l or U937 cells. 
TIIP-l cells or U937 cells inRPMI 1640 (5 x 105cells/mL) were incubated with 501lM 78NP for up to 2 hours, 
before the cells were washed twice in PBS and the remaining 78NP measured using the pterin HPLC method. 
The results are expressed as the mean ± SD of triplicates. 
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Figure 39: Incubation ofU937 cells with 200p.M 78NP for 20 minutes and washing before oxLDL 
addition. U937 cells (5 x 1Q5cells/mL) were incubated with 200llM 78NP for 20 minutes then washed twice in 
PBS and resuspended in RPM! 1640 before 1.5mg/mL oxLDL was added. Controls included cells with oxLDL 
only, cells with 200llM 78NP only and cells which had 78NP added 10 minutes before the oxidant, which was 
allowed to remain for the duration of the incubation with the oxLDL. The results were analysed by MIT assay 
and are expressed as the mean ± SD of triplicates. 
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Figure 40: Incubation of U937 cells with 200p.M 78NP for 2 hours and washing before oxLD L 
addition. U937 cells (5 x 1Q5cells/mL) were incubated with 200llM 78NP for 2 hours then washed twice in PBS 
and resuspended in RPM! 1640 before l.5mg/mL oxLDL was added. Controls included cells with oxLDL only, 
cells with 200llM 78NP only and cells which had 78NP added 10 minutes before the oxidant, which was 
allowed to remain for the duration of the incubation with the oxLDL. The results were analysed by MIT assay 
and are expressed as the mean ± SD of triplicates. 
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3. THE EFFECT OF 78NP ON oxLDL 
It is possible that 78NP's cell viability protecting effect with U937 cells was partially 
due to an ability to 'detoxify' the oxLDL, perhaps even before it reaches the cells. The 
oxidative components of the oxLDL may be able to be reduced by the 78NP. Ascorbate and 
dehydroascorbic acid have been reported to reduce apoptosis mediated by oxLDL in human 
monocyte-derived macrophages. Ascorbate lowered TBARS and lipid peroxide levels on 
oxLDL, while dehydroascorbic acid further oxidised or fonned adducts with oxidised thio! 
groups (Asmis and Wintergerst, 1998). 
To test whether 78NP can reduce oxLDL's toxicity, 1.5mg of oxLDL in RPMI 1640 
was preincubated for 24 hours at 37°C with 78NP at 370j.tM and 926~. These 
concentrations were used so that when the oxLDL and 78NP solution was later added to a 
well containing THP-l or U937 cells, the 78NP concentration would be diluted to the 20j.tM 
and 50j.tM concentrations used in earlier cell viability experiments. 
As before, 20j.tM or 50llM of 78NP, added to the cells just 10 minutes before the 
oxLDL, was unable to reduce the loss of cell viability in THP-1 cells due to the oxLDL 
(Figure 41). The large amount of protection given by the samples that had the 78NP and 
oxLDL preincubated together was therefore a result of a process that took place during the 
preincubation period, when the oxLDL was exposed to a much higher concentration of 78NP. 
This possibility is supported by the outcome with the U937 cells, in which 20llM and 
50j.tM of 78NP were able to slightly stop the viability loss mediated by oxLDL, but the 
preincubated samples had much more success, due to the contact of the oxLDL with the 
much greater amounts of 78NP before addition to the cells (Figure 42). 
Controls were also perfonned. OxLDL preincubated at 37°C by itself did not degrade 
by 24 hours, although it did by 42 hours, giving less than half the viability loss. 78NP 
preincubated alone, and then added to cells 10 minutes before oxLDL, as in other 
experiments, was still able to reduce U937 cell viability loss, even after 42 hours 
preincubation. Lower 78NP concentrations preincubated with oxLDL, which once added to 
the well correspond to 78NP concentrations too low to protect U937 cells, were unable to 
degrade the oxLDL. 
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In conclusion, 78NP is able to directly reduce the toxicity of oxLDL, but the 
concentrations required to do this are much greater than those used in the cell viability 
experiments. This mechanism is therefore unlikely to be a major contributor to the observed 
effect of 78NP. Ifthe 78NP was degrading oxLDL in the experiments already presented, 
THP-l cells should also have been protected from oxLDL-mediated damage. 
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Figure 41: The effect of preincubation of oxLDL with 78NP in THP-l cells. 
The ability of 78NP to degrade oxLDL was tested by incubating 1.5mg of oxLDL with 78NP at 37°C for 24 
hours before adding it to the TIIP-I cells (5 x 105cells/mL). Concentrations of78NP were selected so that, once 
added to the cells, they would be diluted to concentrations already tested for effect on cell viability. Here an 
original concentration of370~ became 20llM (20A) and 9261lMbecame 50llM (50A). The oxLDL was at 
l.5mg/mL. A 200~ 78NP only control was included, and the analysis performed by MIT assay. The results 
are expressed as the mean ± SD of triplicates. 
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Figure 42: The effect of preincubation of oxLDL with 78NP iu U937 ceIls. 
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The ability of78NP to degrade oxLDL was tested by incubating oxLDL with 78NP at 37°C for 24 hours before 
adding it to the U937 cells (5 x 105 cells/mL), The experiment was carried out as explained in the previous figure 
legend. The results are expressed as the mean SD of triplicates. 
4. THE EFFECT ON THP-l AND U937 CELLS OF OTHER OXIDANTS AND ANTIOXIDANTS 
It is possible that the difference between the two cell types in their reaction to 78NP is 
not due specifically to 78NP, or even to oxLDL or AAPH, but rather a general reaction of 
each cell type to oxidants and antioxidants. U937 cells may be able to be protected from 
oxidants by any antioxidant, whereas THP-l cells may simply not respond to antioxidants. 
These scenarios were both investigated using other oxidants and antioxidants. Two 
concentrations of ascorbate (25!lM and 200~ were used in Figures 43 and 44 in an attempt 
to protect the cells against 1.5mglmL oxLDL. A greater concentration could not be used as it 
alone caused a loss of cell viability. 
Ascorbate was ineffective in both cell types, indicating that the U937 cells are not 
responsive to simply any antioxidant. Having still not found an efficient antioxidant for THP-
1 cells, we cannot be sure that it is possible to protect THP-l cells from damage by oxLDL 
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with antioxidants. Ascorbate alone at 200).iM did not cause a significant change in cell 
viability. 
Ascorbate has been effective in other cell types with oxLDL. It partially inhibited 
oxLDL-induced apoptosis in human monocyte-derived macrophages (Asmis and Wintergerst, 
1998), and could prevent apoptotic changes caused by 1.5mg/mL oxLDL in human vascular 
smooth muscle cells, as well as prevent increases in MIT readings and plasma membrane 
permeability (Siow et al., 1999). Ascorbate did not delay apoptosis in U937 cells incubated 
with 7 -keto cholesterol (Lizard et al., 2000). 
An extensive literature search has turned up no examples ofTHP-1 cells being 
protected from oxLDL-mediated cytotoxicity by antioxidants. In fact, very few studies have 
been done looking at antioxidant effect on cytotoxicity with THP-1 cells. Only two found a 
positive outcome of antioxidants with these cells: N-acetylcysteine could reverse apoptotic 
effects of diesel exhaust particles in THP-1 macrophages (Hiura et al., 1999), and lipophilic 
antioxidants such as probucol, vitamin E and BHT could inhibit cell damage by low levels of 
Cu2+ in THP-1 monocytes. A lipophilic chelating agent was required to allow transport of the 
copper into the cells (Crutchley and Que, 1995). 
Ethanol (EtOH) was used as another cellular toxin to test 78NP's capabilities. It is a 
similar cell death mediator to oxLDL, in that it has a range of effects on cells, some of which 
involve oxidative stress. EtOH may cause oxidative stress by affecting antioxidant protection 
systems. It decreased SOD activity in rat brain homogenates and cultures of rat, mouse, 
hamster and chick neuronal cells. It was shown to increase lipid peroxidation in the livers of 
rats and baboons, and decrease GSH levels in the liver, brain and kidney cells of those 
animals (Halliwell and Gutteridge, 1999). 
In cell culture, the formation of radicals has been found to be important to ethanol's 
effects. EtOH enhanced levels of iNOS rnRNA in rat alveolar macrophages through the 
formation of the hydroxyethyl radical (Greenberg et al., 1999). The production of superoxide 
by PMA-stimulated and unstimulated blood monocyte-derived macrophages, Kupffer cells, 
sinusoidal endothelial cells and isolated colonocytes was significantly increased by 
incubation with EtOH (Wickramasinghe, 1989; Grisham et al., 1991; Hasegawa et al., 2002). 
EtOH stimulation produced hydrogen peroxide in SVEC4-10 cells (Qian et al., 2003) and 
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catalase and vitamin E prevented EtOH-induced Ca2+ rises in vascular smooth muscle cells 
(Li et al., 2003). 
Ethanol has been found to cause increased apoptosis in human and rat monocytes 
isolated after an alcohol drinking binge (Singhal et al., 1999), in HL-60 cells after incubation 
with low concentrations of ethanol for four days (Arror and Baker, 1997) and in THP-1 cells, 
with the concentrations of ethanol and lengths of incubation used here (Brown et al., 1996). 
Two concentrations of ethanol, 3% and 6%, incubated with THP-1 cells for 3 hours, 
caused little loss in cell viability, and a 6 hour incubation period was used for the remainder 
of the experiments (Figure 45). The reduction in cell viability was similar for both 3% and 
6%. Three % ethanol was chosen to test the effect of increasing concentrations of78NP in 
THP-1 cells, since 78NP may have a better chance at protecting against a lower ethanol 
concentration. However, the 78NP was ineffective at all concentrations against the ethanol 
(Figure 46). 
In U937 cells, there was a much larger difference between 3% and 6% at 6 hours 
(Figure 45). The response to 78NP was tested at both concentrations, and had no effect at 
either (Figure 47 and 48). 
So here is yet another case in which THP-1 cells do not respond to 78NP, and a first 
instance ofU937 cells not being affected by it, demonstrating that the type of oxidant used 
does actually affect 78NP's protective capacity in U937 cells. 
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Figure 43: The effect of ascorbate on oxLDL-mediated cell viability loss in THP-l cells. 
TIIP-1 cells (5 x 1Q5cells/mL) in RPMI 1640 were incubated with 1.5mg/mL oxLDL and increasing 
concentrations of ascorbate for 48 hours. A 200llM ascorbate only control was included. Analysis was 
performed with the MTr assay. The results are expressed as the mean ± SD of triplicates. 
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Figure 44: The effect of ascorbate on oxLDL-mediated cell viability loss in U937 cells. 
U937 cells (5 x 1Q5cells/mL) in RPMI 1640 were incubated with 1.5mglmL oxLDL and increasing 
concentrations of ascorbate for 48 hours. A 200llM ascorbate only control was included. Analysis was 
performed with the MTr assay. The results are expressed as the mean ± SD of triplicates. 
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Figure 45: Loss of viability in THP~l cells and U937 cells in 6 hours with ethanol. 
129 
1HP-l or U937 cells (5 x 105cells/mL) in RPM! 1640 were incubated for 6 hours with two concentrations of 
ethanol. The results were analysed by MTT assay, and expressed as the mean ± SD of triplicates. 
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Figure 46: Effect of 78NP on ethanol-induced loss of cell viability in TEIP-l cells in6 hours. 
1HP -1 cells (5 x 105 cellslmL) in RPM! 1640 were incubated for 6 hours with 3 % ethanol and increasing 
concentrations of 78NP. A 78NP-only control was included. The results were analysed by MIT assay, 
and expressed as the mean ± SD of triplicates. 
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Figure 47: Effect of 78NP on loss of cell viability induced by 3% ethanol in U937 cells in 6 
hours. U937 cells (5 x 105cells/mL) in RPMl1640 were incubated for 6 hours with 3% ethanol and 
increasing concentrations of 78NP. A 78NP-only control was included. The results were analysed by 
MIT assay, and expressed as the mean SD of triplicates. 
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Figure 48: Effect of 78NP on loss of cell viability induced by 6% ethanol in U937 cells in 6 
hours. U937 cells (5 x 105 cellslmL) in RPMl 1640 were incubated for 6 hours with 6% ethanol and 
increasing concentrations of78NP. A 78NP-only control was included. The results were analysed by 
MIT assay, and expressed as the mean ± SD of triplicates. 
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5. THE EFFECT OF TIME OF 78NP ADDITION ON ITS PROTECTIVE CAPACITY 
Previous research from our laboratory has reported that in order for 78NP to have a 
protective effect on cells, it must be added to the cells between five and ten minutes earlier 
than the oxidant (Gieseg et aI., 1995; Duggan et al., 2002). It was proposed that some sort of 
equilibrium with the cells must be established for the 78NP to have its effect. Incubation with 
cells was found to be required in order to obtain reproducible, concentration-dependent 
results, which was suggested to show an association with the membrane, which may be the 
point of protection (Duggan etai., 2002). 
The necessity of this preincubation was tested by adding 200llM 78NP to wells 
containing U937 cells in RPMl1640, two hours or ten minutes before 1.5mglmL oxLDL, or 
at the same time as the oxLDL. There was no significant difference between the resulting 
protective effects for each time of 78NP addition (Figure 49). 
The idea of adding 78NP at different times was taken further by adding 78NP to cells 
incubated with 1.5mglmL oxLDL in RPMI 1640 at five timepoints during the 48 hour 
incubation. 78NP was first added to U937 cells ten minutes before the oxLDL was added, as 
in the usual experimental situation, It was also added 2,6, 12 and 24 hours after the oxLDL. 
The 24 hour timepoint was therefore halfway through the total 48 hour incubation (Figure 
50). 
Late addition of antioxidants has been successful before. In U937 cells incubated with 
cadmium, antioxidants added after treatment, as well as prior to it, could restore the cells to 
full viability (Galan et ai., 2001). 
The protective effect provided by 78NP added two hours after oxLDL was not 
significantly different to when it was added ten minutes before oxLDL addition (Figure 50). 
Even when 7KNP was added six hours into the incubation with oxLDL, it still appeared to 
have a small protective capacity, although it was no longer significant. Once twelve hours 
was reached, the damage already done or set in motion by the oxLDL was unable to be 
compensated for by the 78NP, and so from this time on, 78NP had no effect. The part or parts 
of viability loss on which the 78NP has an effect have therefore completely past by twelve 
hours. They must occur relatively early, as they have taken place for many cells by six hours. 
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A similar situation has been found in myeloid cells incubated with a range of 
apoptotic initiators, including cycloheximide, y-irradiation and p53. Apoptotic cells were not 
seen until at least eight hours after the start of the incubation, and protection could be 
provided by protease inhibitors, BHA, IL-6 or IFNy added at any time up to this eight hour 
point. The protective effect would still be the same in the case of IFNy and IL-6, and reduced 
but still significant in the case ofBHA and the protease inhibitors (Lotem and Sachs, 1996). 
To help explain this time effect of 78NP, the length of incubation ofU937 cells with 
1.5mg/mL oxLDL required to obtain a drop in cell viability was examined. A gradual, linear 
loss of viability over time was found when cells were incubated with oxLDL for between two 
and 48 hours, and viability was analysed at the end of each timepoint (Figure 51). 
If, however, cells were incubated with the oxLDL for between two and 48 hours, and 
at the end of the designated time, washed twice in PBS to remove the remaining oxLDL, and 
resuspended in fresh RPMI 1640 for incubation for the remainder ofthe 48 hour period, the 
results were different (Figure 52). A small decrease in cell viability was apparent by two 
hours of incubation with oxLDL. The viability dropped slightly more by six hours. From 
twelve hours on, the effect was complete. The process the oxLDL had initiated did not 
require any further input from the oxLDL after this time. 
This incubation (or re-incubation) for the whole 48 hours was necessary in order to 
see the full effects of the oxLDL. Whatever process the oxLDL began, it seemed to require 
time before its effects were fully visible, at least for the assays used here. 
This has implications for the interaction of oxLDL with the cells. If oxLDL is taken 
up by the cells, the full amount required for maximum effect on viability is not acquired until 
twelve hours. Alternatively, the oxLDL may need to spend all this time interacting with the 
membrane from outside the cell, to slowly set the pathways of cell death in motion. 
Another example of cell death after removal of the stimulant was found when U937 
cells, Jurkat T cells and pre-B leukemia JM1 cells were incubated with cladribine. Apoptosis 
still occurred after the drug was removed, since commitment to death had already happened. 
It is probably linked to mitochondrial membrane potential loss (Marzo et al., 2001). With 
U937 cells incubated with puromycin, inhibitors of cell viability loss were not effective if 
GSH was already extruded. This represented a committed step in the process of cell death 
(Ghibelli et al., 1998). This may be the case for U937 cells incubated with oxLDL. 
CHAPTER 4 133 
In a similar investigation involving the loss of reduced thio1s caused by 1.5mglmL 
oxLDL over the 48 hour incubation period (Figure 53), no extra incubation time was required 
for an effect of oxLDL to be seen. The oxidative effect on thiols was therefore much more 
immediate. No loss of reduced thiols had occurred at the zero timepoint. By two hours, the 
reduction was smalL By six hours, a little more loss had occurred. From 12 hours onwards no 
more significant changes took place, and the maximum amount of thio110ss had occurred. 
The results shown in the three Figures 50, 52 and 53 fit together well, presenting a 
picture of the changes occurring in U937 cells over a 48 hour incubation with oxLDL, and 
how 78NP can affect this. Both cell viability and thio110ss occur gradually at first, reaching 
their maximum by 12 hours of incubation. 78NP is only able to be effective if added before 
this 12 hour timepoint. By 12 hours, the outcome ofthe incubation of oxLDL with the cells 
has either been achieved, or been irreversibly set in motion. Certainly the loss of reduced 
thio1 components has taken place, and this may perhaps be a first step in the loss of cell 
viability which is able to be detected by the M1T and trypan blue assays later. 
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Figure 49: Effect of addition of 78NPat times before oxLDL addition. U937 cells (5 x 105cells/mL) 
were incubated in RPM! 1640 with 1.5mglmL oxLDL and 200llM 78NP for 48 hours. The 78NP was added to 
the cells at three different times: 2 hours or 10 minutes before the oxLDL, or at the same time as the oxLDL. A 
2001lM 78NP only control was included. The results were analysed by MTf assay, and expressed as the mean ± 
SD of triplicates. 
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Figure 50: Effect of addition of 78NP at times after oxLDL addition. U937 cells (5 x 105cells/mL) were 
incubated in RPM! 1640 with l.5mglmL oxLDL and 200llM 78NP for 48 hours. The 78NP was added to the 
cells at five different times: 10 minutes before the oxLDL, or 2,6, 12 or 24 hours after the oxLDL. The results 
were analysed by MIT assay, and expressed as the mean ± SD of triplicates. 
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Figure 51: Effect ofthelength of incubation ~th oxLDL on cell viability. 
U937 cells (5 x 105cells/mL) were incubated in RPM! 1640 with l.5mg/mL oxLDL for up to 48 hours. After 2, 
6, 12 or 24 or 48 hours, the cells were removed from the wells and washed twice with PBS. The results were 
then analysed by MIT assay, and expressed as the mean ± SD of triplicates. 
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Figure 52: Effect oflength ofillcubation with oxLDL on cell viability after 48 hours. 
U937 cells (5 x lOscells/mL) were incubated in RPM! 1640 with l.Smg/mL muDL for up to 48 hours. After 2, 
6, 12 or 24 hours, the cells were removed from the wells and washed twice with PBS. They were resuspended in 
RPM! 1640 and incubated for the remainder of the 48 hours. The results were then analysed by MTI' assay, and 
expressed as the mean ±: SD of triplicates. 
CHAPTER 4 136 
125 
-
- T "6 100 
-... 
.. 
c 
0 .......-
u 
~ 75 0 
...,.-
-
-II) 
"6 
-- 50 .c .. -
n; 
'0 
I- 25 
- --r-
-r 
0 I I I I 
o 2 6 12 24 48 
Length of incubation with oxLDL (hours) 
Figure 53: Effect of length of incubation with oxLDL on loss of reduced thiols. 
U937 cells (5 x 105ceUS/mL) were incubated inRPMI 1640 with 15mg/mL oxLDL for up to 48 hours. After 2, 
6, 12, 24 or 48 hours, the samples were analysed by DINB assay. The results were expressed as the mean SD 
of triplicates. 
C. CELL VIABILITY OF TBP-l MACROPHAGE-LIKE CELLS 
The changes that occur during differentiation are said to make PMA-differentiated 
THP-l macrophage-like cells a good model for the macrophages that are involved in 
atherosclerotic plaque formation (Akeson et aI., 1991A; Ferret et aI., 2000). The effects of 
AAPB, oxLDL and 78NP on cell viability were tested in this more complex cell system, 
which may be more relevant to the in vivo situation of plaque development. 
Cell viability loss by a gradient of AAPH concentrations with THP-I macrophage-
like cells in RPMI 1640 media was concentration-dependent but slight, reaching only 30% 
viability loss with 50mM of AAPH (Figure 54). The use ofEBSS media (Figure 55) resulted 
in a greater cell viability loss, which appeared to plateau at around 50% of control cell 
viability, the 10mM and 50mM samples having no significant difference between them. 
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Increasing 78NP concentrations had no significant effect upon 10mM AAPH -induced 
viability loss in EBSS (Figure 56). A 200J.tM 78NP-only control did not cause a change in 
viability. 
Three concentrations of oxLDL were tested with the THP-1 macrophage-like cells for 
their effect on cell viability in RPMI 1640. Four different incubation lengths were examined. 
Very little viability loss occurred by 24 hours, and there was no significant difference 
between the various concentrations, as shown in Figure 57. By 48 hours (Figure 58), 40% 
viability loss had occurred, but again the loss was not concentration-dependent. At 72 hours, 
there was an even smaller reduction in viability, as if the cells might be recovering, and again 
no significant difference between concentrations, as seen in Figure 59. At 96 hours (Figure 
60), the 0.5mglmL oxLDL sample appeared to have fully recovered, having a viability of 
nearly 100% of the control, while the other two concentrations were still at around 70% of 
the control, as at the previous timepoint. 
Increasing concentrations of78NP had no apparent effect on the viability loss due to 
L5mglmL oxLDL at 48 hours (Figure 61), as was seen with the THP-1 monocytes (Figure 
25). 
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Figure 54: Effect of AAPH on cell viability of THP-l macrophage-like cells in RPMI 1640. 
138 
TIIP -1 macrophage-like cells (1 x 105 cells/mL) were incubated with increasing concentrations of AAPH in 
RPMI 1640 for 12 hours. Analysis was performed by MIT assay. Re!.'Ults are expressed as the mean ± SD of 
triplicates. 
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Figure 55: Effect of AAPH on cell viability of THP-l macrophage-like cells in EBSS. 
TIIP-1 macrophage-like cells (1 x 105cells/mL) were incubated with increasing concentrations of AAPH in 
EBSS for 12 hours. Analysis was performed by MIT assay. Results are expressed as the mean ± SD of 
triplicates. 
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Figure 56: Effect of 78NP on AAPH-mediated loss of cell viability of THP-l macrophage-like cells in 
EBSS. nIP-l macrophage-like cells (1 x 1Q5cells/mL) were incubated with increasing concentrations of78NP 
and 10mM AAPH in EBSS for 12 hours. A 200llM 78NP-only control was included. Analysis was performed 
by MIT assay. Results are expressed as the mean ± SD of triplicates. 
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Figure 57: Effect of oxLDL on cell viabllity of THP-1 macrophage~like cells in RPMI 1640 over 24 
hours. THP-1 macrophage-like cells (1 x lOscells/mL) were incubated with increasing concentrations of oxLDL 
in RPMI 1640 for 24 hours. Analysis was perfonned by MIT assay. Results are expressed as the mean ± SD of 
triplicates. 
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Figure 58: Effect of oxLDL on cell viabllity of THP-l macropbage-like cells in RPMI 1640 over 48 
bours. THP-l macrophage-like cells (l x lOsceUs/mL) were incubated with increasing concentrations of oxLDL 
in RPMI 1640 for 48 hours. Analysis was perfonned by MTI' assay. Results are expressed as the mean± SD of 
triplicates. 
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Figure 59: Effect of oxLDL on cell viability of THP-1 macrophage-like cells in RPMI 1640 over 72 
hours. THP-l macrophage-like cells (1 x 105cells/mL) were incubated with increasing concentrations of oxLDL 
in RPM! 1640 for 72 hours. Analysis was performed by MIT assay. Results are expressed as the mean SD of 
triplicates. 
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Figure 60: Effect of oxLDL on cell viability ofTHP-1 macrophage-like cells in RPMI 1640 over 96 
hours. THP-I macrophage-like cells (1 x 105cells/mL) were incubated with increasing concentrations of oxLDL 
in RPM! 1640 for 96 hours. Analysis was performed by MIT assay. Results are expressed as the mean ± SD of 
triplicates. 
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Figure 61: Effect of 78NP on oxLDL-mediated loss of cell viability of THP-l macrophage-like cells in 
RP:MI 1640. 1HP-l macrophage-like cells (1 x 105cells/mL) were incubated with increasing concentrations of 
78NP and l.Smg/mL oxLDL in RPMI 1640 for 48 hours. A 2001lM 78NP-only control was included. Analysis 
was perfonned by MIT assay. Results are expressed as the mean ± SD of triplicates. 
Two points ofinterest arise from these results. Firstly, it appears the differentiated 
TIIP-1 cells are hardy and difficult to damage, even with very high AAPH or oxLDL 
concentrations. They even seem to recover from the insult ifleft long enough. It should be 
remembered that there are only a fifth of the number of cells that have been present in 
previous experiments, even though the concentration of the oxidants remains the same. 
The cells' metabolism has been altered by differentiation. For example, lipid 
metabolism genes become active. Previous research found incubation with acLDL increases 
cholesterol esterification, although less esterification occurs in TIIP-1 macrophages than in 
other cell types. The hydrolysis of the resulting cholesterol esters is also slow (Kritharides et 
al., 1998). A similar degree of oxLDL accumulation was found in both TIIP-1 monocytes 
and PMA-stimulated THP-1 cells, but the PMA enhanced the amount of degradation of the 
oxLDL (Lougheed et al., 1991). 
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The secondary products of macrophages are also produced. This includes the 
secretion of nitric oxide, IL-l~, TNFa, M-CSF, CSF-l, tissue factor VIla, lipoprotein lipase 
and apoE, and the transcriptional activation of c-fos and c-jun, collagenase, phospholipase A2 
and human metallothionein IIA (Auwerx et at., 1989; Via et at., 1989; Akeson et at., 1991B; 
Liu and Wu, 1992; Schwende et at., 1996; Kritharides et at., 1998; Mouithys-Mickalad et al., 
2001). The cells are also able to generate an oxidative burst, activating NADPH oxidase. 
Superoxide production increases tenfold with stimulation (Schwende, 1996). OxLDL is one 
possible stimulant (Nguyen-Khoa et al., 1999). 
The proportions of antioxidants change with the cells' new oxidative enviromnent. 
TIIP-l monocytes were reported to have a threefold lower glutathione level than THP-l 
macrophages that had been incubated with PMA for 48 hours (Gotoh et at., 1993). Another 
study found THP-l macrophage-like cells expressed 30% more CU/ZnSOD, 40% more 
MnSOD, 70% more thioredoxin and 120% more thioredoxin reductase, but had no increase 
in catalase or glutathione (Ferret et al., 2000). 
Because of these changes, it is not surprising that THP-l macrophage-like cells have 
an altered response to AAPH and oxLDL, becoming more robust and long-lived. THP-l 
macrophage-like cells have been previously shown to have increased tolerance to ionizing 
radiation (Munn et al., 1995), and did not experience the same level of hydrogen peroxide 
induced apoptosis as the THP-l monocytes (Ferret et al., 2000). 
THP-l cells differentiated with PMA were found to be very resistant to 5.0mg/mL 
oxLDL in a study examining phosphatidylserine exposure and propidium iodide uptake after 
24 hours, with less than 10% of cells undergoing apoptosis (Vicca et at., 2000). The same cell 
type underwent limited cell death with 1.0mg/mL oxLDL or 20)lg/mL 7-ketocholesterol over 
24 hours and this was halved in cells with greater expression of the class A scavenger 
receptor (Liao et al., 2000). 
This effect has also been found in other cell types. Cells of the rat pheochromocytoma 
cell line PC12 were less sensitive to pterin or 5-azacytidine-induced apoptosis after 
differentiation, and PHA-differentiated peripheral blood mononuclear cells underwent 
delayed cell death with oxLDL. It is important to note that contrary results have also been 
reported, with some authors finding neurons more sensitive after differentiation, depending 
on cell type and agent (Alcouffe et al., 1999; Enzinger et at., 2002). 
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Other responses to oxLDL have also been reportedly altered due to cell 
differentiation. PP ARy, which regulates genes during differentiation, and human ferritin light 
chain expression were found to be decreased in THP-1 cells incubated with PMA, in spite of 
an increase in transcription (Jang et ai., 1999). Other studies, which only examined rnRNA 
levels, have described upregulation of nuclear receptors including LXRa, RXRy and PP ARy 
by oxLDL in THP-1 cells stimulated by PMA (Ricote et al., 1998; Mikita et al., 2001). 
Extensively oxidised LDL reduced TNFa levels in THP-l macrophages, also contrary to 
findings in undifferentiated cells. A drop in mRNA was found, but part of the decrease might 
have been due to oxidative modification of the TNFa so that it did not show up with the 
ELISA method used (Girona et al., 1997). 
A reduced reaction to oxLDL toxicity can perhaps be anticipated, since oxLDL 
stimulates protein kinase C in monocytes, but PMA treatment downregulates it (Deigner and 
Claus, 1996; Schwende, 1996). A possible reduced upregulation of PP ARy and a lowering of 
TNFa in differentiated cells may also alter the expected effects of oxLDL on the cell (Girona 
et ai., 1997; Jang et ai., 1999). 
The differentiation process involves the development of much better defenses, and an 
altered response to oxidative stress, including the activation of lipid metabolism. In the case 
of oxLDL, it was suggested that the increased scavenger receptor expression ensures more 
degradation of the oxLDL, reducing its toxicity (Lougheed et ai., 1991; Liao et ai., 2000). 
The lipid changes and scavenger receptors are also affected by cell density. The density used 
in this set of experiments is low, and would result in cholesterol accumulation, esterification 
and scavenger receptor expression that are relatively high, which would lower the cells' 
viability loss from oxLDL (Rodriguez et ai., 1994). 
The increase in endogenous antioxidants during differentiation would have a role 
against oxidative effects of oxLDL and peroxyl radicals from AAPH. The possible increases 
in glutathione and thioredoxin would be important, since both oxLDL and AAPH were 
shown to lower reduced thiollevels (Gotoh et ai., 1993; Ferret et ai., 2000). Thioredoxin, 
being present on the cell surface (Nishiyama et al., 1999), may be effective against AAPH or 
any extracellular oxidative effects of oxLDL. 
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The macrophage-like cells might also generate their own oxidants, through the 
oxidative burst, for example, as a result of stimulation by oxLDL (Nguyen-Khoa et al., 
1999). This might modify the oxLDL particle before uptake, altering its toxicity. The toxicity 
of the oxLDL might also be reduced by the cells' adherence to the bottom ofthe well-plate, 
which could restrict access to the cells for the oxidants. 
In the same way, this would restrict access to the cells for exogenous 78NP, which 
may partly account for the lack of effect of the 78NP in protecting the cells from the 
oxidative damage that does occur. There are other possible reasons for the 78NP's lack of 
effect on cell viability. If the oxLDL is being processed in a different way from monocytic 
cells, for example in a different part of the cell, 78NP may not be in the right place in the cell 
to combat this damage. Also, the THP-l macrophage-like cells may still possess the 
characteristics of the THP-I monocytes which caused 78NP to be ineffective. The results 
with this macrophage cell type do not provide any evidence that 78NP is able to protect cells 
from oxLDL-mediated cell death in the atherosclerotic plaque. 
SUMMARY 
OxLDL caused concentration-dependent viability loss to a similar degree in both 
THP-l and U93 7 monocytes. While THP-l cells showed an equivalent loss of reduced thiols, 
U937 cell thiolloss was marked by a sudden and complete depletion after a critical timepoint. 
78NP protected U937 cells from the decrease in viability and reduced thiols, but 
neither of these effects were apparent with the THP-l cells. This is likely to reflect a 
difference in cellular metabolism of oxLDL, and its influence on total reduced thiols. 
Several insights were provided into how 78NP may act to protect U937 cells from 
oxidants, while at the same time not protecting THP-l cells, and how it may interact with the 
cells. 78NP oxidised over 72 hours to 78XP. The inclusion of cells in the solution stabilised 
the 78NP, slowing this process. 78NP was able to interact with both cell types, although to a 
different degree \vith each over time. The actual amount of78NP which became associated 
with the cells was not enough to protect them itself, so it is difficult to know if this interaction 
is an important one in terms of the survival of the cells. 
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78NP was able in some way to degrade or 'detoxify' oxLDL during an incubation of 
24 hours, but the concentrations required for this were much larger than those used in 
experiments, so this is unlikely to be a significant mechanism in the protection of cells from 
oxLDL. 
Tests using both cell types with oxLDL and ascorbate, or ethanol and 78NP showed 
that U93 7 cells cannot be protected from cell viability loss by every antioxidant, and that 
78NP cannot protect U937 cells against all stresses. THP-1 cells have not yet been shown to 
be protected against oxLDL by an antioxidant. 
The effect of the addition time of the 78NP depends on the timing of cellular 
responses caused by the oxidant. The time of78NP addition to an oxLDL assay system did 
not affect the result for the first two hours of the incubation. It still had some effect if added 
six hours later, but from twelve hours, no protective capacity was evident. Twelve hours was 
also the time at whichthe oxLDL had first caused the maximum amount ofthiolloss, and the 
process resulting in the maximum amount of cell viability loss had been irreversibly begun. 
Commitment to cell death must have occurred by this point. 
PMA-differentiated THP-l macrophage-like cells were very resistant to cell viability 
loss with AAPH and oxLDL, even at high concentrations and over long periods oftime. This 
may be due to the changes in cell metabolism that have occurred as a result of the 
differentiation process. 78NP was not effective against cell viability loss caused by either 
AAPH or oxLDL. This may also be a result of the changes of differentiation, or the 
continuing possession of the properties which did not allow THP-l monocytes to be protected 
by 78NP from AAPH and oxLDL. 
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MONOCYTES, OXLDL AND APOPTOSIS 
INTRODUCTION 
These studies characterise the induction of apoptosis by oxLDL in U937 and THP-1 
monocyte cells. The effect of 781\lP on the development of apoptotic features is examined. 
Apoptosis in the plaque is thought to be caused by oxLDL and other factors of 
inflammation such as TNFa (Farber et al., 1999). Apoptosis may inhibit intimal thickening, 
limit cell accumulation, counteract mitosis and cause very little inflammation, and would 
therefore be anti-atherogenic. However, the death of smooth muscle cells, increased release 
of matrix-digesting enzymes and accumulation oflipids and Ca2+ may promote rupture and 
calcification (Geng et al., 1997). 
OxLDL is reported to cause apoptosis in most studies examining its effects on cell 
viability. This encompasses a wide range of cell types, including macrophage and monocyte 
cell types such as P388Dj cells (Reid et al., 1993A), J774 cells (Yuan et al., 2000), J774.A1 
monocytes and macrophages (Yang et al., 1996), mouse peritoneal macrophages (Niu et al., 
1996), mouse macrophages (Liu et al., 1997 A), THP-1 monocytes (Vicca et al., 2000), 
human blood peripheral mononuclear cells (Kinscherf et al., 1998) and human monocyte-
derived macrophages (Asmis and Wintergerst, 1998). Endothelial cells are also represented 
(Dimmeler et al., 1997; Kinoshita et al., 1999; Rusinol et al., 2000), including human 
endothelial cells (Escargueil-Blanc et al., 1997), human coronary artery endothelial cells (Li 
et al., 1998) and HUVECs (Galle et al., 1999). Smooth muscle cell types looked at include 
human vascular smooth muscle cells (Siow et al., 1999), rabbit aortic smooth muscle cells 
(Nishio et al., 1996) and human arterial smooth muscle cells (Bjorkerud and Bjorkerud, 
1996). Other cell types studied include cultured lymphoblastoid cells (Escargueil et al., 
1992), Jurkat T cells (Alcouffe et al., 1999), mesangial cells (Sharma et al., 1996), rat dorsal 
root ganglion cells (papassotiropoulos et al., 1996), neuronal cultures (Keller et al., 1999), 
lung fibroblasts (Bjorkerud and Bjorkerud, 1996), Chinese hamster ovary cells and 
thymocytes (Rusinol et al., 2000). 
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Both heavily and lightly oxLDL are reported to cause apoptosis (Escargueil et al., 
1992; Reid et al., 1993A), however most authors do not characterise their oxLDL further than 
stating that it is oxidised. The majority of studies use eu2+ -oxidised LDL, although one paper 
compares eu2+ - and HOC1-oxidised LDL, determining that the former had higher TBARS 
and carbonyls and the latter more protein carbonyls and advanced oxidation protein products. 
With THP-1 monocytes, the eu2+-oxidised LDL was reported to induce a stronger apoptotic 
response (Vicca et al., 2000). 
Concentrations of oxLDL purported to cause apoptosis vary, ranging from O.lmglmL 
to 1.0 mglmL in various human endothelial cells (Escargueil-Blanc et al., 1997; Li et al., 
1998; Galle et al., 1999) and O.2mglmL with mouse macrophages (Niu et al., 1996; Liu et aI., 
1997) to 1.25mglmL and 5.OmglmL with THP-1 monocytes (Vicca et al., 2000). 
Timeframes for the experiments looking at oxLDL effects are relatively long, running 
from 24 to 48 hours, independent of cell type or oxLDL concentration (Escargueil et al., 
1992; Niu et al., 1996; Yuan et al., 2000). Studies that only considered changes up to 24 
hours were performed on Jurkat T cells (Alcouffe et al., 1999), rat dorsal root ganglion cells 
(Papassotiropoulos et al., 1996) and THP-l monocytes (Vicca et al., 2000). 
The studies here examine oxLDL-induced apoptosis in two monocyte cell lines, one 
of which, U937 cells, has not previously been examined for apoptotic characteristics in the 
presence of oxLDL. The cells are incubated with concentrations of extensively oxLDL 
known to cause viability loss over 48 hours, a period of time likely to be sufficient for the 
apoptotic process to be completed and secondary necrosis to begin, as indicated by trypan 
blue staining. 
OxLDL appears to cause the full spectrum of well-recognised apoptotic markers. 
Most studies look at only a limited set of features, usually between one and five, mostly two 
or three. While this may be adequate to identify the cells' condition as apoptotic (depending 
on which assays are used), it causes difficulties in relating one set of experimental conditions 
to another. 
The most popular way of assessing the presence of apoptosis is oligonuc1eosomal 
laddering on gels, showing DNA fragmentation, This was observed with oxLDL in P388DI 
cells (Reid et al., 1993A), mouse macrophages (Liu et ai" 1997), THP-l monocytes 
CHAPTERS 149 
(Bjorkerud and Bjorkerud, 1996), cultured lymphoblastoid cells (Escargueil et al., 1992), 
endothelial cells (Dimmeler et ai., 1997; Escargueil-Blanc et aI., 1997; Lizard et ai., 1999), 
smooth muscle cells (Bjorkerud and Bjorkerud, 1996; Nishio et ai., 1996; Lizard et ai., 1999; 
Siow et aI., 1999), lung fibroblasts (Bjorkerud and Bjorkerud, 1996) and Chinese hamster 
ovary cells (Rusinol et al., 2000). 
Other typical nuclear features were also found after incubation with oxLDL. TUNEL, 
which labels single strand breaks in the DNA strand (Nishio et al., 1996), an earlier phase of 
DNA fragmentation, gave positive results in J774 cells (Yuan et ai., 2000), rat dorsal root 
ganglion cells (Papassotiropoulos et ai., 1996), smooth muscle cells, endothelial cells (Nishio 
et ai., 1996; Lizard et al., 1999) and Chinese hamster ovary cells (Rusinol et ai., 2000). 
Chromosome margination, or pyknosis, was found in J774 cells (Yuan et ai., 2000), 
human arterial smooth muscle cells, lung fibroblasts and THP-l monocytes (Bjorkerud and 
Bjorkerud, 1996), and chromosome Condensation was shown in human arterial smooth 
muscle cells, lung fibroblasts and THP-l monocytes (Bjorkerud and Bjorkerud, 1996). 
The other most commonly examined apoptotic feature is caspase activation. Caspase 
enzymes were activated as a result of oxLDL in J774 cells (Yuan et al., 2000) and endothelial 
cells (Dimmeler et ai., 1997). Caspase inhibitors reduced apoptosis and so indirectly proved a 
role for caspases in the apoptosis ofTHP-l monocytes (Vicca et ai., 2000), bovine 
endothelial cells (Farber et ai., 1999), endothelial cells, smooth muscle cells (Lizard et at., 
1999) and neuronal cultures (Keller et ai., 1999) incubated with oxLDL. 
Many other apoptotic characteristics have been shown to be caused by oxLDL. 
However, most were not tested for in more than one or two cases. P ARP activation was 
identified in cultured lymphoblastoid cells (Escargueil et al., 1992), and Fas protein 
expression was increased by oxLDL in human coronary artery endothelial cells (Li et al., 
1998), whereas Fas pathway activation was not required for oxLDL-mediated apoptosis in 
macrophages (Yao and Tabas, 2001). Ceramide increased in human monocytes, bovine 
endothelial cells and human endothelial cells (Kinscherf et al., 1998; Kinoshita et al., 1999; 
Lizard et ai., 2000), Cytochrome c was released in human monocytes, bovine endothelial 
cells and human endothelial cells (Lizard et al., 2000). Membrane blebbing occurred in 
human arterial smooth muscle cells, lung fibroblasts and THP-l monocytes (Bjorkerud and 
Bjorkerud, 1996). Bcl-2 or Bel-XL decreased in human coronary artery endothelial cells (Li et 
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at., 1998), human monocytes, bovine and human endothelial cells (Lizard et at., 2000) and 
human vascular smooth muscle cells (Siow et at., 1999). A Ca2+ rise was seen in cultured 
lymphoblastoid cells (Escargueil et at., 1992) and inferred in neuronal cultures through use of 
a Ca2+ chelator (Keller et at., 1999), and in Chinese hamster ovary cells through discovery of 
an apoptosis-resistant mutant unable to take up Ca2+ (Rusinol et at., 2000). 
Various components of oxLDL have been examined separately for their effects on 
apoptosis. 7~-hydroxycholesterol and 25-hydroxycholesterol caused apoptosis in U937 cells 
and HL60 cells (Yuan et al., 2000), as did 7 -keto cholesterol (Lizard et ai" 1998), which also 
induced apoptosis in bovine endothelial cells and human endothelial cells (Lizard et at., 
2000). 7 -Ketocholesterol and 7~-hydroxycholesterol induced apoptosis in smooth muscle 
cells and endothelial cells (Nishio et al., 1996; Lizard et al., 1999). 2-0xoaldehydes caused 
apoptosis in U937 cells and RAW 264.7 cells (Okado et at., 1996). Mouse peritoneal 
macrophages and rabbit aortic smooth muscle cells were found not to undergo apoptosis with 
lysophosphatidylcholine (Nishio et al., 1996; Niu et at., 1996). Tert-butylhydroperoxide 
caused DNA single strand breaks in U937 cells (Brambilla et at., 1998). 
Aggregated LDL inhibited apoptosis in THP-l cells and human peripheral blood 
monocytes stimulated by PMA (Kubo et at., 1997). AgLDL induced the human homologue 
ofE2 ubiquitin-conjugating enzyme, which may suppress apoptosis by poly-ubiquitination 
and degradation of proteins that induce apoptosis, including p53 (Kikuchi et al., 2000). This 
form ofLDL has also been shown to decrease levels of caspases-l and -3 (Martinet and 
Kockx, 2001). 
In some cases, oxLDL causes necrosis. This maybe in a specific cell type, or due to a 
high concentration of oxLDL. Neuronal cultures and mesangial cells showed necrotic 
features with high concentrations of oxLDL (Sharma et at., 1996; Keller et al., 1999). 
OxLDL caused mainly necrosis in EBV-transformed B cells and lymphoblastoid cells, 
possibly because of increases in Bcl- XL and Bcl-2 expression (Escargueil-Blanc et al., 1997; 
Alcouffe et at., 1999). The same effect was found ifBcl-2 was at high levels in HL60 cells 
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and lymphocytes (Meilhac et a!., 1999). Necrosis was also found in fibroblasts (Lizard et ai., 
1999). 
Often, necrosis is reported to follow apoptosis, if an incubation is carried out for long 
enough. A loss in membrane integrity will be found, indicated by trypan blue staining or the 
lactate dehydrogenase assay (Papassotiropoulos et ai., 1996; Escargueil-Blanc et ai., 1997). 
In this case, the necrosis is described as secondary, or post-apoptotic, necrosis. Secondary 
necrosis often occurs in vitro at the conclusion of the apoptotic process, due to the absence of 
other cells to engulf the apoptotic cells and clear the debris (Papassotiropoulos et a!., 1996). 
This was found in 1774 cells and P388Dl cells after 48 hours (Reid et ai., 1993A; Yuan et ai., 
2000), rat dorsal root ganglion cells and THP-l monocytes at 24 hours (Papassotiropoulos et 
ai., 1996; Vicca et ai., 2000), and in human endothelial cells at around 12 hours, the same 
time as changes were measured by the MTI assay (Escargueil-Blanc et ai., 1997). 
Antioxidants have been able to reduce apoptosis caused by oxLDL Superoxide 
scavengers decreased oxLDL-apoptosis in neuronal cultures (Keller et al., 1999) and human 
coronary artery endothelial cells (Li et al., 1998) and SOD and catalase inhibited the 
apoptosis ofHUVECs (Galle et ai., 1999). 
GSH, N-acetylcysteine and vitamin E could stop apoptosis in U937 cells with 
ketocholesterol, reducing production of superoxide. Vitamin C and melatonin did not delay 
apoptosis, although superoxide production was prevented (Lizard et ai., 2000). 
Three assays are used here to try to define the type of apoptosis that may be occurring 
in THP-l and U937 monocyte cells. A fluorescent caspase assay examines the activity of 
caspase-3, the Annexin V/PI assay looks at the externalization of phosphat idyl serine in the 
cell membrane and the cells' internalization of propidium iodide dye, and the Hoechst stain 
allows details of nuclear morphology to be visible. Together, the three features provide a 
broad view of apoptotic deVelopment over time and different parts of the process. Their 
relevance and the importance of testing for these particular characteristics are discussed later. 
The possibility of 78NP influencing these features of the apoptotic process is also 
investigated. 
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RESULTS AND DISCUSSION 
A. ACTIVATION OF CASP ASE ENZYMES 
Caspases are possibly the best biochemical marker of apoptosis, since there is 
such limited evidence that they appear in necrosis (Leist and Nicotera, 1997). Their 
presence alone is often considered proof of apoptosis. This reliance may be 
problematic, as, for example, an immunoassay may simply pick up the inactive 
zymogen, showing the cell is capable of apoptosis, but not that apoptosis is occurring 
(Bennett and Boyle, 1998). There are also some instances of apoptosis in which caspase 
activation does not appear. 
Caspase-3 is an executioner caspase, carrying out the protein-cleavage 
processes of apoptosis, rather than merely forming part of the signalling cascade. Its 
presence would therefore be a reliable indicator of the occurrence of caspase-mediated 
apoptosis in the cells at the time of freezing. Much of the DEVD-AMC activity is due 
to caspase-3, although other effector caspases may potentially have a role (Stridh et al., 
1998; Hampton et al., 2002B). 3% Ethanol was used as a positive control in these 
experiments, as it had already been shown to induce caspase activity in THP-1 cells 
(Brown et al., 1996). 
A timecourse looking at oxLDL-induced caspase activity was performed on each cell 
type over 48 hours, using four different oxLDL concentrations. 
Once oxLDL was added to THP-l cells, the caspase activity began to increase 
steadily (Figure 62). The increase started earlier the higher the concentration of oxLDL. The 
extent of the rise was less for the higher concentrations: it peaked and decreased again, and in 
the case of 3.OmglmL oxLDL, was back down to control levels by 48 hours. In keeping with 
this pattern, the 1.SmglmL oxLDL sample was the next to begin increasing, which it did 
marginally at 6 hours, taking off at 12 hours, then peaking and beginning to fall again by 24 
hours. The O.SmglmL oxLDL sample began its rise at 12 hours, and was still increasing by 
the end of the timecourse, as was the O.2mglmL oxLDL sample, which showed increasing 
caspase activity from 24 hours. 
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If caspase activity is used as a definition of apoptosis, all the concentrations of oxLDL 
used here induce apoptosis in THP-l cells, albeit at different rates and to varying extents. The 
drop in caspases seen to occur with the higher concentrations of oxLDL, which will probably 
also occur with the lower concentrations, in time, may be due to the onset of secondary 
necrosis. This view is supported by the data gathered from the studies of phosphatidylserine 
exposure and nuclear morphology in the following sections of this chapter. 
The increase in caspases appears to be an early sign of cell death, found before 
any changes were detected by the two cell viability assays used in other chapters. This 
reiterates the fact that the trypan blue and MIT assays measure the later stages of cell 
death. 
The addition of increasing concentrations of 78NP to THP-l cells incubated with 
1.5mglmL oxLDL did not significantly affect the level of caspase activation (Figure 63), 
much as it could not influence the level of cell viability in this cell type (Figure 25). 
Previous studies reported that 78NP and neopterin caused apoptosis. However, 
200llM 78NP and 200llM neopterin did not cause an increase in caspase activity alone. Pterin 
levels said to have this effect are usually in the millimolar range (Enzinger et at., 2001), but 
200llM 78NP and 200llM neopterin were described as enhancing IFJ\1y and TNFa-mediated 
apoptosis (Schobersberger et ai., 1996). 
U937 cell control samples' caspase activity rose slightly over time, and cells 
incubated with 0.2mglmL oxLDL were not significantly different (Figure 64). The remaining 
oxLDL concentrations caused a drop in caspase activity which began earlier and happened at 
a faster rate the higher the concentration of oxLDL. This drop represented an almost total 
obliteration of any caspase activity found. 
The level of caspase activity found over 48 hours with oxLDL was markedly lower in 
U937 cells than in THP-l cells. The highest value for the THP-l cell timecourse was 
58.07±l.05 pmol AMC/minJl06cells, but for U937 cells it was only 2.67±O.19 pmol 
AMC/minl106cells. This highest level for the U937 cells was lower than that found for the 
THP-l cells' control and was therefore practically non-existent. So while the trends for this 
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cell type are examined, it is worthwhile bearing in mind that the scale on which they occur is 
very smalL 
Continuing the trend of having an effect with U937 cells, but not with THP-1 cells, 
78NP was able to alter the effect of the oxLDL on caspase activity. The four graphs in Figure 
65 each represent one oxLDL concentration, and show the effect of 200J..LM 78NP on it over 
time. The concentrations are expressed separately for reasons of clarity. To make it easier to 
see both how the oxLDL has changed the caspase activity and how 78NP has influenced this, 
the information on the graphs is expressed relative to the control. 
With O.2mglmL oxLDL, no real deviation from the control caspase levels was found, 
and the addition of78NP did not alter this. With O.5mglmL oxLDL, the drop observed at 12 
hours was countered by the 78NP, which caused a large rise above the control, resolving 
itself to control levels as the oxLDL-only sample leveled out. So once the oxLDL began to 
cause a decrease in the caspase activity, the 78NP compensated for tins. At 24 hours, it was 
over-compensating, but only to the level of the control in the THP-1 cells, not an activation 
great enough to contribute to the development of apoptosis. 
With 1.5mglmL oxLDL, the drop in caspase activity came earlier, and 78NP was able 
to reduce the decrease until 24 hours, after which no further significant difference between 
the two was found. With 3.0mglmL oxLDL, the trend was much the same as with 1.5mglmL. 
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Figure 62: A timecourse study of the effect of increasing oxLDL concentrations on caspase activity in 
THP-l cells. Tl-IP-1 cells (5 x 105cells/mL) were incubated with varying oxLDL concentrations for up to 48 hours 
in RPMI 1640. At certain times, cells were removed , washed and prepared for analysis by caspase assay. The 
resu lts are expressed as the mean ± SD of triplicates. 
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Figure 63: The effect of increasing concentrations of 78NP on oxLDL-induced caspase activity in 
THP-l cells. TIIP-1 cells (5 x 105cells/mL) were incubated with 1.5mg/mL oxLDL for 48 hours in RPM! 1640. 
The cells were then washed and prepared for analysis by caspase assay. Two controls, with 200!!M 78NP or 
200!!M neopterin (NP), without oxLDL are included. The results are expressed as the mean ± SD of triplicates. 
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Figure 64: A timecourse study of the effect of increasing oxLDL concentrations on caspase activity in 
U937 cells. l '937 cc: lI s (5 x IO\:01Is/mL) wc:re incubated wi th vary ing oxLDL concentrations for up to 48 hours in 
RPMf 1640. At certain times. c:ells were removed. washed and prepared for ana lysis by caspase assay. The results 
are express0d as the mean ± SD of tripli catc:s. 
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Figure 65: The effect of 78NP on oxLDL-induced caspase activity in U937 cells. 
U937 cells (5 x 105ceIls/mL) were incubated with increasing concentrations of oxLDL with or without 200~ 
78NP for up to 48 hours in RPM! 1640. The cells were then washed and prepared for analysis by caspase assay. 
The results are expressed as the mean ± SD of ttiplicates. This Figure is continued on the next page. 
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Figure 65: The effect of 78NP on oxLDL-induced caspase activity in U937 cells. 
U937 cells (5 x 105cells/mL) were incubated with increasing concentrations of oxLDL with or without 200JlM 
78NP for up to 48 hours in RPMI 1640. The cells were then washed and prepared for analysis by caspase assay. 
The results are expressed as the mean ± SD of triplicates. 
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The activation of caspases as part of oxLDL-mediated cell death is another difference 
between THP-1 and U937 cells in response to oxLDL. 
The lack of caspase activity in U937 cells may be a feature specific to oxLDL, as 
there are several reports in the literature of caspase activation in U937 cells. Some were 
tested using fluorescent substrates as was carried out here, and in others, caspase activity was 
inferred from the ability of caspase inhibitors to stop apoptosis. Caspase-dependent apoptosis 
was found in U937 cells incubated with cadmium, heat, X-rays (Galan et ai., 2001), FasL, 
TNFa., and UV irradiation (Varela et ai., 2001; Exner et at., 2002). U937 cells incubated with 
the plant lectin ricin were found to have caspase-3 and -6 activity (Sadakata et al., 2000), if 
incubated with camptothecin (topoisomerase I inhibitor) caspases-1 and -3 were active (Yu et 
al., 2000), with etoposide (topoisomerase II inhibitor) there was caspase-8 and -3 activity 
(Lizard et at., 1998) and with arsenic trioxide, caspase-3 activation was achieved (Jing et al., 
1999; Park, et al., 2001). 
U937 cells may only use caspases in apoptosis in some situations. In U937 cells 
irradiated with X-rays, 5 and 20 Gy induced different forms of apoptosis. The high dose 
caused death before division and the low dose caused death only in postmitotic cells. Caspase 
inhibitors were only effective for the higher dose in the premitotic cells (Shinomiya et ai., 
2000). 
In an interesting case, U937 cells activated caspases-8 and -3 in response to 
cladribrine. In spite of this, a general caspase inhibitor had only a very small effect on 
morphology development, mitochondrial potential loss and phosphatidylserine exposure. The 
caspases may not play an early role in apoptosis in this situation, instead being activated by 
cytochrome c release and enhancing apoptosis (Marzo et ai., 2001). The low levels of active 
caspases found in U937 cells with oxLDL here may similarly represent a different system for 
the carrying out of apoptosis, or may show that the U937 cells are not undergoing apoptosis. 
In U937 cells treated with 7-ketocholesterol, a component of oxLDL, procaspase-8 
cleavage was found, but there was only a slight cleavage of procaspase-3 (Lizard et al., 
1998). Caspase-3 was thought to have only a minor role in this apoptosis. The alternative was 
considered to be a rapid progression to secondary necrosis, so that caspase-3 was difficult to 
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detect. Here, caspase-3 activity and variations in its levels were in fact detected, making this 
an unlikely reason for its apparent absence. 
There are no examples in the literature comparing the different apoptotic pathways of 
U937 and THP-1 cells which might help to account for the differing use of caspases. 
Recalling the extra sensitivity of the reduced thiol components ofU937 cells to 
oxLDL (Figure 29), it was considered that this might be linked to the lack of caspase activity 
found under the same conditions. Caspase enzymes have an essential catalytic site cysteine 
residue. It is sensitive to the redox state of the cell, and responds to alterations in the 
glutathione ratio (Boggs et at., 1998; Vissers et al., 1999). The cysteine residue's oxidation 
by oxLDL would therefore render caspase enzymes inactive. In U937 cells incubated with 
ketocholesterol, levels of caspase-3 declined through nitrosylation of its p 17 subunit (Lizard 
et at., 1998). One of the reasons a higher oxidative stress level induces necrosis is that the cell 
cannot maintain a reducing environment and repair oxidised caspases (Hampton and 
Orrenius, 1997). The 78NP effect found here on caspases could preserve the reduced thiol 
residues in the enzyme. 
Figure 66 summarises the effect of 1.5mglmL oxLDL on viability, thiollevels and 
caspase activity in U937 cells, and enables comparison of the timing and magnitude of 
change of these three parameters. Cell viability initially rose, then fell gradually. The 
decrease in caspase activity and reduced thiols mirrored each other more closely. They fell 
slowly up to 6 hours, then dipped sharply to 12 hours, remaining relatively static thereafter. 
This provides support for the idea of a relationship between thiol and caspase activity loss in 
U937 cells. 
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Figure 66: Comparison ofloss of cell viability, rednced thiols and caspase activity in U937 ceUs "ith 
1.5mglmL oxLDL over 48 hours. U937 cells (5 x 105cells/mL) were incubated with 1.5mg/mL oxLDL for up 
to 48 hours in RPMI 1640. Cells were removed at various timepoints and analysed by MIT assay, DTNB assay 
or caspase assay. The results are expressed as the mean ± SD of triplicates. 
Examples of this type of situation have been found previously. Hydrogen peroxide 
impaired caspase activity, both in intact cells and celllysates. If added to lurkat T cells 30-90 
minutes after Fas, the hydrogen peroxide directly inactivated the caspases, also delaying 
blebbing and fragmentation. The effect was temporary, and after the hydrogen peroxide was 
consumed, apoptosis proceeded (Hampton and Orrenius, 1997). The same was seen in 
macrophages after apoptosis initiation by NO or serum withdrawal. Caspases-8 and -3 were 
inhibited, and this was prevented and reversed by dithiothreitol (Borutaite and Brown, 2001). 
When lurkat T celllysates were incubated with DEVD-AMC, and hydrogen peroxide 
was added, immediate inhibition of caspases was seen (IC50 7JlM). After removal of the 
hydrogen peroxide, DTI could regenerate the caspase activity, but only very slowly. If 
hydrogen peroxide was added before the substrate, the IC50 was 310JlM. It was suggested the 
substrate might induce conformational changes in the enzyme, making it more reactive to the 
hydrogen peroxide (Hampton et al., 2002B). 
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Protein peroxides added to Jurkat celllysates after apoptotic induction with anti-Fas 
antibody also reduced caspase activity. The activity could be partially restored with DTT, 
showing that again the effect was thiol-dependent. Tryptophan-derived peroxides were the 
most effective, requiring only physiological concentrations, however whole proteins had no 
effect. The inhibition was at a thirtieth of the concentration of hydrogen peroxide required. 
The presence of substrate impaired reactivity, the opposite effect found from that with 
hydrogen peroxide, showing the peroxides were targeting the active site (Hampton et al., 
2002A). 
Other substances can inactivate caspases through reaction with thiols. NO can inhibit 
caspases through nitrosylation of the active site thiol by a cGMP-independent mechanism 
(Boggs et al., 1998). Selenium repressed caspase-3 activity in human embryonic kidney cell 
lysatesirradiated with UVB, as well as purified recombinant caspase-3 activity. DIT could 
reverse the effect, indicating it was through oxidation of the cysteine residue (Park et al., 
2000). Zn2+, which reacts with thiols, also inhibited caspases (Stennicke and Salvesen, 1997). 
Thiol-alkylating agents such as iodoacetamide or N-ethylmaleimide could block caspase 
activation in U937 cells incubated with the plant lectin ricin (Sadakata et al., 2000) and 
actinomycin D (Mohr et al., 1997). 
In a mimic of the hydrogen and protein peroxide studies, the experiment represented 
in Figure 67 was designed to test whether oxLDL could have a disabling effect on caspase 
enzymes. The earlier experiments outlined above on caspases and reduced thiols in U937 
cells suggested this might be the case. 
The study was conducted with celllysates over a very short time. A more pronounced 
effect on caspases might be expected over a greater timeframe. U937 and THP -1 cells were 
incubated with 6% or 3% ethanol respectively for 6 hours to activate caspase enzymes. The 
cells were then washed with PBS and assayed for caspase activity. After 150 seconds, O.5mg 
of oxLDL was added to the cuvette and the rate of substrate cleavage every hundred seconds 
between 400 and 1000 seconds recorded. The volume added amounted to 241l1. An addition 
of 8111 (0.167mg) was also tested for comparison, but no effect was found. The same volume 
of PBS was added for control samples. The results are expressed as % change in substrate 
cleavage rate during this time, found by comparing the rates for hundred second intervals 
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between 400-500 and 900-1000 seconds. No disproportionate immediate drop occurred after 
oxLDL addition, making this comparison valid. 
The rate of fluorescent substrate cleavage remained quite constant in THP-l cells with 
ethanol only. A lowering of approximately another 10% was found when oxLDL was added, 
contrary to the caspase activity heightening effect oxLDL has when added to whole THP-I 
cells. However, since this concentration amounts to 5.0mglmL (0.5 mg added to 100JlL), this 
would not be so surprising over time. It is interesting that it had such an immediate effect. 
The 8JlL addition, a concentration close to the 1.5mg/mL oxLDL concentration which caused 
caspase activation over 48 hours, did not affect activation over this very short amount of 
time. Ifincubated with cell lysate for longer before analysis, it might have had an effect. 
The difference in caspase activity with and without oxLDL was amplified in U937 
cells. The overall caspase levels were still much smaller than in the THP-I cells, as was 
found earlier. In U937 cells incubated only with ethanol, levels were found to increase around 
25% over the 600 seconds, perhaps as more procaspase-3 was cleaved. Since the enzyme 
levels are lower, substrate availability is not a problem. Once oxLDL was also added, the 
levels dropped dramatically. The difference between the increase without oxLDL and the 
decrease with it is around 65%, a loss of over half the caspase activity. 
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Figure 67: Effect oncaspase activity ofthe addition of oxLDL. U937 cells and TIIP-l cells at 5 x 
105cells/mL were incubated with EtOH (6% and 3% respectively) for 6 hours in RPMI 1640 to activate caspase 
enzymes. The cells were washed, lysed and assayed for the caspase activity. After 150 seconds, O.5mg oxLDL 
was added. Rate of substrate cleavage was recorded between 400 and 1000 seconds. TIle results are expressed as 
the mean ± SD of triplicates. 
OxLDL appeared to oxidise the thiol of caspase enzymes in U937 cells to a greater 
extent than in THP-1 cells. The data does not differentiate between a direct and indirect 
effect. U937 cells may have a different form of intracellular oxidative stress, or be more 
sensitive to oxidative stress, or respond differently to oxLDL, creating an intracellular 
oxidative stress, which THP-1 cells do not experience (see discussion in Chapter 4). The 
appearance of a difference in oxLDL effect on caspases in celllysates suggests that the 
varying effects of oxLDL on THP-1 and U937 thiol oxidation (Figures 28 and 29) was not 
due to a difference in access to the cell. Rather, the distinction related to intracellular 
components. 
An increase in oxidative processes is found in human monocytes, bovine endothelial 
cells and human endothelial cells with oxLDL (Lizard et ai., 2000). This might include 
production of hydrogen peroxide, superoxide and hydroxyl radicals, as shown in endothelial 
cells incubated with oxLDL (Dimmeler et ai., 1997). 
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The tendency for the reactive site thiol to become oxidised will be increased by 
the loss of the cell's total reduced thiols, as occurred in U937 cells with oxLDL, but not 
in THP-1 cells. This would act as an indirect form of oxidative stress, passively 
allowing oxidation, without the need generate more radicals (Ghibelli et at., 1998). It is 
less damaging than generating non-specific oxidants (Vanden Dobbelsteen et at., 
1996). With a lower glutathione level a cell has a decreased ability to resist oxidation or 
scavenge reactive oxygen species (Buttke and Sandstrom, 1995). GSH depletion with 
L-buthionine-[S,R]-sulfoximine has been shown to potentiate oxLDL cytotoxicity 
(Bustamente et at., 1995; Galan et at., 2001). 
A lowering of thiols is necessary in many cases for apoptosis to take place. Apoptosis 
may still be caspase-dependent, or if the thiols are completely depleted, the cells might then, 
as U937 cells do here, have a mechanism other than caspases for carrying out apoptosis. In 
U937 cells incubated with 7 -ketocholesterol, GSH loss happened early on. Adding more GSH 
or N-acetylcysteine impaired apoptosis. This could also prevent etoposide-induced apoptosis, 
but not cycloheximide apoptosis. GSH was found. to strongly inhibit early signs of apoptosis 
such as caspase-8 and cytochrome c release, but only delay DNA fragmentation and not 
affect caspase-3, the later signs (Lizard et at., 1998). The fact that GSH was not effective in 
all situations suggests that although U937 cells may often lose their reduced thiols as part of 
apoptosis, the loss is also apoptotic mediator-specific. 
The loss of glutathione may itself playa central role in apoptosis. For example, it may 
control mitochondrial transmembrane potential, since the permeability transition pore is a 
multi-ion thiol sensitive channel. This will have the effect of regulating the release of 
mitochondrial molecules such as AIF and cytochrome c. It can also regulate neutral Mg2+_ 
dependent sphingomyeIinase, which makes ceramide (Lizard et at., 1998; Liu et at., 2001). In 
U937 cells incubated with 7-ketocholesterol, loss of endogenous GSH favoured apoptotic 
features such as decreased mitochondrial membrane potential and cytochrome c release, 
supporting the idea of a thiol-sensitive channel on mitochondria (Lizard et at., 1998). 
In some situations, if GSH remains, necrosis may occur instead of apoptosis (Liu et 
at., 2001). The inhibition ofGSH extrusion in U937 and hepatoma cells with puromycin and 
etoposide prevented apoptosis. The reduced form of GSH was found extracellularly (Ghibelli 
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et at., 1998). The same was observed in Jurkat cells with anti-Fas antibody (Van den 
Dobbelsteen et at., 1996). 
The caspase behaviour found in the TIIP-l cells is much more typical of conventional 
apoptotic behaviour than that of the U937 cells. We cannot tell from this assay whether 
apoptosis is occurring in U937 cells. They may undergo necrosis with oxLDL, or a more 
unusual caspase-independent form of apoptosis, possibly as a result of the critical cysteine 
residue of the caspase enzymes becoming oxidised. Other ways of measuring and defIning 
apoptosis must also be explored. 
B. PHOSPHATIDYLSERINE EXPOSURE 
Another feature of the apoptotic process is the flipping of phosphatidylserine in the 
cell membrane so that it is exposed to the outside of the cell. There it functions as part of the 
recognition process for phagocytes, which clear away apoptotic cells before they reach the 
pro-inflammatory stage of secondary necrosis (Yu et at., 2000). 
Phosphatidylserine exposure has been described as a strictly caspase-dependent 
process (Bomer and Monney, 1999), but it is now known that it may be regulated by caspase-
dependent or -independent pathways (Yu et at., 2000). Experiments with stimulated 
neutrophils have suggested that the flipping of phosphatidylserine might instead depend on 
oxidative stress (Fadeel et al., 1998; Hampton et at., 2002C). 
No indication ofthe process' regulation in THP-l cells has been found, but in U937 
cells exposed to cladribrine, in which caspases-8 and -3 were active, a general caspase 
inhibitor had only a very small effect on phosphatidylserine exposure. A non-caspase factor 
must also contribute (Marzo et al., 2001). 
Phosphatidylserine exposure as a result of incubation with oxLDL has been found in 
Jurkat T cells (Alcouffe et at., 1999), HUVECs (Galle et at., 1999), TIIP-l monocytes (Vicca 
et at., 2000) and human vascular smooth muscle cells (Siow et al., 1999). 
Annexin V is a C~+ -dependent protein that preferentially binds to phosphatidylserine, 
and propidium iodide (PI) is a dye (like trypan blue) that enters cells with damaged cell 
membranes and incorporates itself into the DNA. Since PI differentiates between early and 
CHAPTERS 168 
late apoptotic (necrotic) cells, the assay tends to under- rather than overestimate the level of 
apoptosis (Farber et al., 1999). 
Flow cytometry counts 10,000 cells individually according to fluorescence by 
Annexin V and propidium iodide. The results are presented on a two-dimensional dot 
plot, with PIon the y axis and Annexin V on the x axis. Each graph shows 2,000 cells. 
A cell with very little fluorescence of either sort, in the lower left of the plot, is 
described as being viable. Cells in the lower right quadrant of the graph, binding 
Annexin V but excluding PI, can be said to be apoptotic. Cells that are both PI dye- and 
Annexin V-positive are necrotic and may be undergoing secondary necrosis (Vermes et 
al., 1995; Bacso et al' J 2000). 
The aim was to assign cells to each of these populations. This was originally done 
using quadrants, but this method of dividing up the plot was found to be too rigid, and some 
cells seemed to be assigned to the wrong group. Differences in the position of each cell type's 
viable population were not accounted for. So instead, hand-drawn regions were used, the 
shape of which was more flexible. Each cell type had slightly different regions, based on 
where their control popUlations started out. The same regions were used for analysis of all 
results for that cell type. 
As oxLDL concentration increased the main cell population was seen to shift up and 
to the right in both cell types, as shown in the selection of dot plots in Figures 68 and 69. 
In THP-1 cells, the viable region was the highest bar in the control cells, and as the 
oxLDL concentration increased, it dropped away (Figure 70). There were hardly any cells 
remaining in this region after incubation with l.SmglmL or 3.OmglmL oxLDL. 
All changes between the control and O.SmglmL involved THP-1 cells moving from 
the viable to apoptotic populations, displaying phosphatidylserine on the cell surface. 
Incubation with oxLDL at O.SmglmL resulted in the largest apoptotic sample, but apoptosis 
then decreased with increasing oxLDL concentration, as primary or secondary necrosis 
increased to include most of the cells by l.SmglmL oxLDL. There is no significant difference 
between the results for l.SmglmL and 3.OmglmL oxLDL. 
The THP-1 cells moved from being 78% viable, to 61 % apoptotic, to 80% necrotic by 
l.5mglmL oxLDL. The oxLDL concentrations shown here have no midway point, where half 
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of the cells are apoptotic and half necrotic. This picture fits in well with the caspase activity 
levels at 48 hours for the different concentrations (Figure 62). 
The necrosis would be primary if the cells moved directly from the viable region to 
the necrotic region, or secondary if they reached the necrotic region via the apoptotic region. 
This progression might occur faster for greater oxLDL concentrations, hence the higher 
number of cells in this region for the higher oxLDL concentrations. Secondary necrosis may 
be the most likely possibility, since at 48 hours, caspase activation had already peaked and 
dropped away in cells incubated with 1.5mglrnL and 3.0mglrnL oxLDL. This implies that 
cells had passed through apoptosis at this point. 
78NP at 200ilM was not found to influence phosphatidylserine exposure significantly 
on THP-l cells with oxLDL (p = 1 for each ofthe three populations) (Figure 71). A 
concentration of oxLDL between the apoptotic concentration (0.5mglrnL) and necrotic 
concentration (1.5mglrnL) was used, in anattempt to fmd a point at which a similar 
proportion of apoptotic and necrotic cells were present, perhaps giving the 78NP a better 
chance of having an effect. However, LOmglrnL oxLDL presented a similar profile to 
0.5mglrnL oxLDL. 
The effect of oxLDL on phosphatidylserine exposure in U937 cells (Figure 72) was 
more graduaL The control cells had a similar proportion of viable cells to that found with the 
THP-l cells. At 0.5mglrnL oxLDL, U937 cells had approximately the same amount of 
apoptotic cells as THP-l cells did, but also a higher proportion of viable cells. By 1.5mglmL 
oxLDL, the percentage of viable cells had decreased, although not as drastically as in THP-l 
cells. The rest of the cells were split evenly (p = 0.096) between the apoptotic and necrotic 
regions. By 3.OmglrnL oxLDL the U937 cells had caught up with the THP-l cells again: 
there were almost no viable cells, few apoptotic cells, and a vast majority of cells undergoing 
(secondary) necrosis. 
Both 10ilM and 200ilM 781\lP were able to delay the effects of 1.5mg/rnL oxLDL on 
U937 cells (Figure 73). There was a significant decrease in the number of necrotic cells with 
IOIlM 78NP (p = 0.039) and a very significant decrease for the 200ilM concentration (p 
0.001). For 200/lM 78NP, there appeared to be more viable cells, although this result was not 
significant (p = 0.91). There was no significant change in the number of apoptotic cells (p = 
0.06 for 10ilM and p = 0.13 for 200IlM). 
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Figure 68: Flow cytometry dot plots showing the effect of oxLDL and 78NP on THP-l cells. 
THP-l cells (5 x 1Q5cells/mL) were incubated with increasing concentrations of oxLDL or 78NP for 48 hours in 
RPM! 1640. The cells were washed and incubated with propidium iodide and annexin-V-FITC for 10 minutes 
before analysis by flow cytometry. Regions indicate approximate locations of cells that are viable (Rl), 
undergoing apoptosis (R3) and in the process of (secondary) necrosis (R2). A shows control cells, B shows cells 
with 0.5mg/mL oxLDL, C shows cells with 1.5mglmL oxLDL, D cells with 3.0mg/mL oxLDL, E cells with 
1.0mglmL oxLDL and F cells with 1.0 mglmL oxLDL and 200!JM 78NP. 
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Figure 69: Flow cytometry dot plots showing the effect of oxLDL and 78NP on U937 cells. 
U937 cells (5 x 105ceUs/mL) were incubated with increasing concentrations of oxLDL or 78NP for 48 hours in 
RPMI 1640. The cells were washed and incubated withpropidium iodide and annexin-V-FITC for 10 minutes 
before analysis by flow cytometry. Regions indicate approximate locations of cells that are viable (Rl), 
undergoing apoptosis (R3) and in the process of (secondary) necrosis (R2). A shows control cells, B shows cells 
with 0.5mg/mL oxLDL, C shows cells with L5mg/mL oxLDL, D cells with 3.0mg/mL oxlDL, E cells with 
1.5mg/mL oxLDL and 10ilM 78NP and F cells with 1.5 mg/mL oxLDL and 2001JM 78NP. 
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Figure 70: Effect of oxLDL on THP-l cells' phosphatidylserine exposure and PI uptake. 
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THP-l cells (5 x 105cells/mL) were incubated with increasing concentrations of oxLDL for 48 hours in RPMI 
1640. The cells were washed and incubated with propidium iodide and annexin-V-FITC for 10 minutes before 
analysis by flow cytometry. Regions were drawn on the dot plots to indicate approximate locations of cells that 
were viable, undergoing apoptosis and in the process of (secondary) necrosis. The number of cells in each area 
is expressed as the mean ± SD of triplicates. 
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Figure 71: Effect of oxLDL and 78NP on THP-l cells' phosphatidylserine exposure and PI uptake. 
THP-l cells (5 x 105cells/ruL) were incubated with l.Omg/ruL oxLDL with or without 200l1M 78NP for 48 
hours inRPMI 1640. The cells were washed and incubated withpropidium iodide and annexin-V-FITC for 10 
minutes before analysis by flow cytometry. Regions were drawn on the dot plots to indicate approximate 
locations of cells that were viable, undergoing apoptosis and in the process of (secondary) necrosis. The number 
of cells in each area is expressed as the mean ± SD of triplicates. 
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Figure 72: Effect of oxLDL on U937 cells' phosphatidylserine exposure and PI uptake. 
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U937 cells (5 x 105cells/ruL) were incubated with increasing concentrations of oxLDL for 48 hours in RPMI 
1640. The cells were washed and incubated with propidium iodide and annexin-V-FITC for 10 minutes before 
analysis by flow cytomelry. Regions were drawn on the dot plots to indicate approximate locations of cells that 
were viable, undergoing apoptosis and in the process of (secondary) necrosis. The number of cells in each area 
is expressed as the mean ± SD of triplicates. 
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Figure 73: Effect of oxLDL and 78NP on U937 cells' phosphatidylserine exposure and PI uptake. 
U937 cells (5 x 105cells/mL) were incubated with 1.5mglmL oxLDL with or without 10~ or 200~ 78NP for 
48 hours inRPMI 1640. The cells were washed and incubated with propidiumiodide and annexiu-V-FITC for 
10 minutes before analysis by flow cytometry. Regions were drawn on the dot plot., to indicate approximate 
locations of cells that were viable, undergoing apoptosis and in the process of (secondary) necrosis. The number 
of cells in each area is expressed as the mean ± SD of triplicates. 
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The 78NP effect is relatively small when compared to other 78NP protective effects 
in U937 cells, suggesting that its mechanism of action may be able to influence the 
phosphatidylserine exposure less efficiently than it would other parts of the cell death 
process. If 78NP acts as an antioxidant, as suggested by its thiol protective effect, the less 
significant effect on Annexin V binding may imply that the phosphatidylserine exposure 
process does not completely rely on the oxidative state of the cell. Alternatively, although 
78NP may delay cell death, it may not directly affect phosphatidylserine exposure itself. 
The lack of difference between the protective effects of the 78NP concentrations (p = 
0.999) is in marked contrast to the effects of these concentrations on cell viability. If the 
maximum level of protection is provided by a much lower concentration, either the 78NP is 
much more efficient at this, or there is a maximum level of protection that is possible and 
already provided by the lower concentration. 
By this assay's definition of apoptosis, apoptosis occurs in both cell types with 
oxLDL, as does (secondary) necrosis. The apoptotic process may occur more swiftly in THP-
1 cells, as higher concentrations of oxLDL result in greater levels of (secondary) necrosis, a 
characteristic not picked up by the viability assays used earlier. This may relate to the THP-1 
cells' use of caspases for the process, which are likely to be the most efficient way of 
completing apoptosis (Bomer and Monney, 1999). The speed of conclusion of the death 
process may help to account for the lack of protection provided by 78NP, especially if its 
effect, as suggested here in the U937 cells, is to slow the process down. There is simply less 
of a window in which the 78NP can act. Perhaps the difference is also indicative of other 
dissimilarities in the carrying out of apoptosis, which 78NP cannot influence. 
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C. HOECHST STAIN 
One of the later stages of the apoptotic cascade is the changes in the mOlphology of 
the cell, especially in the nucleus. Hoechst 33342 stains the nucleus of the cell, intercalating 
between the A-T base pairs of DNA, thereby making morphological changes of the nucleus 
visible (Schobersberger et al., 1996). Changes include contraction and condensation of the 
nucleus, chromatin fragmentation, pyknosis (margination of the chromatin) and apoptotic 
body formation (Escargueil et al., 1992; Ok,ado et al., 1996; Brunk et al., 1997; Alcouffe et 
al., 1999; Lizard et al., 1999). Necrotic changes are also visible. These nuclei are described 
as swollen, diffuse and disintegrating (Lizard et al., 1999). 
This method is most suited to a qualitative analysis. The cells are examined until a 
feature of interest comes into view, which can then be photographed and described. Some 
authors attempt to categorise every cell by this method, as apoptotic, necrotic or neither. Cells 
can be difficult to assign to particular categories, so the decision seems likely to be SUbjective 
and less reliable. 
THP-1 or U937 cells (5 x 105 cells/mL) were incubated with varying concentrations 
of oxLDL and 78NP in RPM! 1640 as before, but only for 24 hours, as it was found that 
many cells were too disintegrated after 48 hours to give a clear picture. At the end of the 
incubation, the cells were washed twice with PBS to remove the oxLDL, stained with 
Hoechst 33342 and mounted onto slides. The slides were examined using a fluorescence 
microscope at 40 or 100 times magnification. 
Both cell types showed the traditional signs of apoptosis and necrosis in a similar way 
and to a similar extent. The only difference was in the effect of 78NP, which brought the cells 
closer to an untreated cell phenotype in U937 cells only. 
Figures 74 and 75 show untreated THP-1 and U937 cells respectively. Both cell types 
have relatively rounded nuclei, with the nuclei distributed centrally in the cell. 
Several of the features commonly found in cells undergoing apoptosis and stained 
with Hoechst 33342 are seen in the pictures of cells incubated with oxLDL. The condensation 
of the nucleus is represented by a shrinking in size and increase in stain brightness. Pyknosis 
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is seen by the nucleus moving to the edge of the cell. Fragmentation is also visible, as the 
nucleus breaks up into smaller pieces, while remaining in the cell. This is the beginning of the 
formation of apoptotic bodies. Good examples of each of these are marked in the figures with 
P for pyknosis, C for condensation and F for fragmentation, but there are other examples in 
each picture. Examples of necrotic features are indicated on the figures with S for swelling, 
DF for diffuse, DE for cell debris and DS for disintegrating cells. 
The pictures ofTHP-l and U937 cells incubated with 0.5mglmL oxLDL for 24 hours 
show all the apoptotic features, and have no characteristics of necrosis (Figures 76 and 77). 
The main feature of Figure 77 is the brightness. 
Figures 78-81 are cells incubated with 1.5mglmL oxLDL Figure 78 is ofTHP-l 
cells, showing brightness and good fragmentation. Figure 79 features brightness, 
condensation and fragmentation in THP-l cells, The very large cell appears to contain 
fragmentation in the manner of apoptosis, but the swelling is characteristic of necrosis, 
suggesting that, after 24 hours of incubation with this concentration of oxLDL, some cells 
have moved through apoptosis to secondary necrosis. This is an interesting finding as it 
suggests that condensation and fragmentation, followed by lysis, may be the mechanism of 
secondary necrosis. This has not been previously demonstrated. 
Figure 80 shows two good examples of fragmentation and one of pyknosis in U937 
cells. There are not many cells on the slide, suggesting some may already have undergone 
cell lysis. Figure 81 illustrates the beginnings of necrosis in U937 cells, in a similar way to 
Figure 79. Some cells appear diffuse, and seem to be disintegrating. Others are still 
undergoing apoptosis, as demonstrated by pyknosis and fragmentation. 
Figures 82 and 83 were taken of cells incubated with 20011M 78NP as well as 
l.5mglmL oxLDL The THP-I picture (Figure 82) looks similar to the cells incubated only 
with oxLDL (Figure 79). There is fragmentation and swelling and diffuse cells. In the next 
figure, representing the U937 cells (Figure 83), a definite effect of78NP can be seen. Care 
was taken to ensure the pictures represented what was present on the slides overall. The 
number of cells has markedly increased, suggesting death is slower. A few cells are still 
showing apoptotic features, but many look relatively normal, similar to the cells in the 
untreated population. Although the outcome of incubation with 78NP cannot be quantified 
here, it seems to be one of its more complete effects on apoptosis. This may relate to the fact 
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that these nuclear changes happen relatively late in the apoptotic process, so that, if delayed, 
they may be unlikely to have occurred by this 24 hour timepoint. 
The last three figures show cells incubated with 3,OmglmL oxLDL, the highest 
concentration used. Most cells at this concentration, in both cell types, appear to have passed 
through apoptosis and begun secondary necrosis. Figure 84 shows THP-1 cells. Most cells 
here are swollen, some to a very large size. Plenty of debris is also visible. There are a few 
smaller, brighter cells remaining. The U937 figures are similar. Figure 85 was photographed 
at only 40x magnification, so a greater area can be seen. Many cells have clumped together 
and spilled their contents, and a few bright cells, separate from the others, are still present. 
Figure 86 shows a close-up of a necrotic cell releasing its contents. Many of the other cells 
look diffuse. 
Morphologically, both U937 and THP-l cells appear to be undergoing apoptosis with 
oxLDL. Higher concentrations cause some cells to become necrotic, or to pass through 
apoptosis to secondary necrosis. 78NP appears to be able to inhibit the development of these 
characteristics of apoptosis in U937 cells, but not THP-1 cells. 
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Figure 74: THP-l cells (5 x L05 cells/mL) were incubated in RPMl l640 for 24 hours. The ce lls were 
washed in PBS, fixed and Sl<lined with Hoechst 33342. The picture was taken on a Zeiss Axiocam camera 
attached to a Zeiss tluorescence microscope. 
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Figure 75: U9J7 cells ('i x 10' cell,/mL) were incubated in RPM I l640 for 24 hours. The ceUs were 
washed in PBS, fixed and stained with Hoechst 33342. The picture was taken on a Zl.:iss Axiocam camera 
attached to a Zeiss fluorescence microscope. 
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Figure 76: THP-l cells (5 x LOs cells/mL) were incuhated with 0.5mg/mL oxLDL in RPMI 1640 for 
24 hours. The cells were washed in PBS, fixed and stained with Hoechst 33342. The picture was taken 
using a Zei ss Axiocam camera attached to a Zeiss fluorescence microscope. P indicates an example of 
pyknosis and F fragmentation . 
Figure 77: U)l37 cells (5 x lOs cells/mL) were incuhated with 0 .5mg/ mL ox! ,OL in RPMl L640 for 24 
hours. The cells were washed in PBS , fixed and stained with Hoechst 33342. The picture was taken us ing a 
Zeiss Axiocam camera attached to a Zeiss fluore scence microscope . P indicates examples of pyknosis . 
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Figure 78: THP- I cells (5 x 10' cells/mL) were incubated with 1.5mg/mL oxLDL in RPMI 1640 for 
24 hours. The cell s were washed in PBS, fixed and stained with Hoechst 33342. The picture was taken 
using a Zeiss Axiocam camera attached to a Zeiss fluorescence microscope. F shows an example of 
fra gmentation. 
Figure 79: TIIP-I cells ('1 x 105 cells/mL) were incubated with I .5mg/mL oxLDL in RPM! 1640 for 
24 hours. The cells were washed in PBS, fixed and stained with Hoechst 33342. The picture was taken 
using a Zei:;s Axiocam camera attached to a Zeiss fluorescence microscope. F indicates examples of 
fra gmentation, C rerresents condensation and S shows an example of swelling. 
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Figure 80: U937 cells (S x 10' cells/mL) were incubated with I.Smg/mL oxLDL in RPMI 1640 for 24 
hours. The cells were w<lshed in PBS , fixed and stained with Hocchst 33342. The picture was taken using a 
Zeiss Axiocam camera attached to a Zeiss fluorescence microscope. F indicates examples of fragmentation 
and P shows pyknosis. 
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Figure 81: U937 cells (5 x l05 cells/mL) were incubated with 1.51l1g/1l1L oxLDL in RPyU 1640 fur 24 
hours. The cells were w:1shed in PBS, fixed :1nd stained with Hoechst 33342. The picture was taken us ing :1 
Zei ss Axiocam camera atta 'hed to a Zeiss fluorescence microscope . F indic:1tes examples of fragmentation 
and DF shows diffuse cells. 
CHAPTIR 5 
Figure 82: Tl lP- l cell s (5 x l05 cells/mL) were incubated with Umg/mL oxLDL and 200pM 781 P 
in RPMI 1640 for 24 hours. The cells were washed in PBS, fixed and stained with Hoechst 33342. The 
picture was taken using a Zeiss Axiocam camera attached to a Zeiss fluorescence microscope. F indica tes 
ex:unples of fragmentation and S and OF show a swelling, diffuse cell. 
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Figure 83: 937 cells (5 x LO' cells/mI.) were incubated with l.5mg/mL oxLOL and 200pM 78NP in 
RPMI 1640 for 24 hours. The cells were washed in PBS. fixed and stained with Hoechst 33342 The picture 
was taken using a Zeiss Axiocam camera attached to a :I.eiss fluorescence microscope. 
CHAPTER 5 
Figure 84: THP-l cell;; (S x LO' cdls/mL) were incuhated with 3.0mg/mL oxLDL in RPM! 1640 for 
24 hours. The cells were washed in PBS, fixed and stained with Hoechst .B342. The picture was taken 
lIsing a Ze iss Axiocam camera attached to a Zeiss fluorescence microscope . C indicates an example of 
condensation. Sand DF show swe lling and diffuse ce lls and DE indicates ce ll debri s. 
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Figure 85: U'137 cells (S x 105 cells/mL) were incubated with 3.0mg/mL oxLDL in RPMl 1640 for 24 
hours. The cells were washed in PBS , fixed and stained with Hoechst 33342. The picture was taken at 40x 
magnification using a Zeiss Axiocam camera attached to a Zeiss fluorescence microscope. C indicates an 
example of condensation and DF shows clumps of diffuse cells. 
Figure 86: 937 cells (5 x 105 cells/mL) were incubated with 3.0mg/mL oxLDL in ]{PMI 1640 for 24 
hours . The cells were washed in PBS , fixed and stained with Hocchst 33342. The picture was taken at 100x 
magni fication using a Zeiss Axiocarn camera attached to a Zeiss fluorescence microscope. DS indicates an 
example of a disintegrating cell and DF shows a diffuse cell. 
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THE DEFINITION OF APOPTOSIS 
According to the Hoechst and Annexin V/propidium iodide assays, both U937 and 
THP-l cells are undergoing apoptosis with oxLDL, at least at the two lower concentrations 
tested. The cells then appear to undergo secondary necrosis, which is a possibility given the 
lack of phagocytes to clear the apoptotic monocytes. Some primary necrosis may also be 
present. However, caspase activation, often seen as the cornerstone to a description of 
apoptosis, is not as conclusive. THP-I cells show caspase activation exactly as expected. 
U937 cells, though, have very low levels of caspases, which decrease even further as time of 
incubation or oxLDL concentration increases. 
An issue that is important to consider at this point is which events are required before 
a cell can be said to be undergoing apoptosis, as opposed to necrosis. There are three main 
differences between the apoptotic and necrotic death processes, which may help in pinning 
down their definitions. 
To begin with, apoptosis is a biochemically active metabolic process. The fact that 
some of the apoptotic triggers include changes in concentrations of growth factors and 
cytokines are indications of this (Schobersberger et al., 1996). It requires ATP for chromatin 
condensation and DNA fragmentation, and caspase activation by APAF-l (Lelli If. et al., 
1998; Carmody and Cotter, 200 1). The energy-requiring period of apoptosis after exposure to 
staurosporin or anti-Fas antibody is 90 minutes (Leist and Nicotera, 1997). 
In contrast, necrosis is a passive process, which does not require ATP (Leist and 
Nicotera, 1997). The artificial lowering of A TP results in necrosis, even under conditions 
where apoptosis would usually predominate, such as in the cases ofT cells with etoposide or 
anti-Fas antibody, or endothelial cells with hydrogen peroxide (Lelli Ir. et al., 1998). In liver 
damage by TNFa or Fas, apoptosis occurs early on, but after extended exposure, when ATP 
has been depleted, necrosis is the dominant form (Leist and Nicotera, 1997). 
Secondly, apoptosis is a highly regulated process, initiated intentionally by the cell 
when it considers itself beyond repair. The high degree of regulation is illustrated in human 
endothelial cells upon addition of HOC 1. Half ofthe HOCI is gone in the first minute, but the 
apoptosis not seen until hours later (Vissers et al., 1999). 
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Necrosis is therefore used as a default method of cell death, when apoptotic regulation 
fails, such as when apoptotic signals are blocked or anti-apoptotic proteins over-expressed, as 
well as in cases where cell injury is sudden and severe or too much energy is lost (Leist and 
Nicotera, 1997; Alcouffe et al., 1999). Since necrosis is not a well-regulated process, once 
embarked upon, it cannot be converted back to apoptosis (Palomba et al., 1996). 
The other major difference between apoptosis and necrosis is the implication of death 
on neighbouring cells (Leist and Nicotera, 1997). Apoptotic bodies are tidily phagocytosed, 
whereas necrotic cells lyse, releasing debris which can cause an inflammatory response (Lelli 
Jr, etal., 1998). 
The parts of the apoptotic process responsible for these differences will be important 
in attempting to define apoptosis. DNA fragmentation, which requires ATP, the activation of 
caspase enzymes as part of the regulation and execution, and the extemalization of 
phosphatidylserine to induce phagocytosis are three features that could therefore be 
considered as critical markers of apoptosis. These were all explored in this work. 
The problem with using DNA fragmentation and caspase activity as definitions for 
apoptosis is that they are not always present in every apoptotic-like situation. 
Endonuclease activity and their alterations to the nucleus appear not to be essential for 
apoptosis, since inhibitors of endonucleases such as aurintricarboxylic acid, Zn2+ ions and 
Ca2+ chelators reduce cytotoxicity and retard death, but do not prevent it (Reid et al., 1993B; 
Zarnzami et al., 1995; Escargueil-Blanc et al., 1997). In fact, full DNA fragmentation does 
not feature in all forms of apoptosis, and sometimes only single strand nicking is found. This 
is usually the case in carcinoma cell lines and hepatocytes (Ueda and Shah, 1994). 
Splenocytes, U937 cells and WEHI-231 pre-B cells were found to be irreversibly 
committed to apoptosis, without nuclear damage (Zarnzami et al., 1995).1774 cells with 
oxLDL showed morphological changes associated with apoptosis, but had no DNA 
fragmentation (Hakamata et al., 1998). 
A persistent dogma of apoptosis is that its execution absolutely requires caspases. 
There are many proteins able to act as triggers of apoptosis, but the final trigger, that signals 
the point of no return, has often been described as caspase-3. Caspase inhibitors have usually 
been reported to be successful at completely stopping apoptosis, as they would be expected to 
be if caspases are the only final trigger point. Other cells, incubated with apoptotic stimuli 
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and caspase inhibitors such as ZV AD.fink or p3S, will still undergo apoptosis, but in a fonn 
without caspase cleavage, chromatin condensation or DNA laddering. Some of these inducers 
are puromycin, NO, irradiation and the overexpression ofBax (Borner and Monney, 1999). 
In cells from caspase-3 knockout mice, the requirement for caspase-3 was found to be 
tissue and stimulus specific. It was dispensable in immature T and B cells, but differentiated 
T cells were resistant to UV-irradiation without it, although still susceptible to y-irradiation 
(Woo et al., 1998). In human hepatoma HepG2 cells incubated with Salvia miltiorrhiza, there 
was no procaspase-3 cleavage, and a general caspase inhibitor decreased apoptosis by only 
40% (Uu et al., 2001). Neutrophils undergoing an apoptotic-like process with PMA had no 
DNA fragmentation or caspases (Farleel et at., 1998; Hampton et al., 2002C). Caspase 
inhibitors could not suppress apoptosis in myeloid cells incubated with doxorubicin or 
vincristine (Lotem and Sachs, 1996). 
It is possible that some caspases not yet found may be resistant to the inhibitors, or the 
inhibitors may be unstable and degraded within cells (Borner and Monney, 1999). 
It is more likely that another system may work in place of the caspases, such as the 
events associated with the mitochondria or lysosome. This might involve AlF or serine 
proteases, calpains or cathespins, which also degrade cellular proteins, but in a less efficient 
manner. In MRC-S cells and human lung cells incubated with cadmium, apoptotic 
characteristics including mitochondrial depolarization, chromatin condensation, DNA 
fragmentation and phosphatidylserine exposure were found. There was no caspase activity, 
but AlF was found to be translocated to the nucleus (Shih et al., 2003). Serine proteases have 
been found to have a role in early chromosomal digestion. Inhibition of serine protease AP24 
conferred better protection against UV apoptosis than a caspase-3 inhibitor (Borner and 
Monney, 1999). 
Calpains have been found to be part of apoptosis due to hypoxia in hepatocytes and 
TNFa-induced apoptosis in U937 monocytes, which featured phosphatidylserine exposure, 
plasma membrane blebbing and nuclear fragmentation. It was inhibited by calpain inhibitor 
calpeptin (Vanags et al., 1996). Calpains may be activated by a Ca2+ rise. They are able to 
cleave fodrin and actin-binding proteins such as a-actinin, eliminating anchorage to the 
membrane and leading to blebbing. They also degrade protein kinases and transcription 
factors, as well as each other (Borner and Monney, 1999; Kinoshita et al., 1999). 
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OxLDL-induced leakage of the lysosome would provide DNases and cathespin 
enzymes, which might act as executioners (Brunk et al., 1997; Ishisaka et at., 2001). 
Cathespin D is involved in apoptosis induced by IFNy, Fas and lNFa and provokes apoptosis 
when overexpressed (Bomer and Monney, 1999). Inhibitors of cathespins Band L could 
suppress apoptosis in myeloid cells incubated with p53 or cycloheximide or undergoing y-
irradiation, and adding caspase inhibitors did not have an additional protective effect (Lotem 
and Sachs, 1996). The range of cathespin enzymes may mean they are able to be effective 
under many different conditions. Cathespin B is a thiol protease, which might therefore be 
inactivated by reduced thiolloss, but cathespin D, an aspartic acid protease, might still be 
active (O'Neil et al., 1997). 
OxLDL can induce cathespin D (but not B or L) in human macrophage-derived foam 
cells and in lipid-rich atherosclerotic lesions, and the activity of several of the lysosomal 
hydrolases has been found to increase two-to-four-fold compared to nonnal arteries or 
fibrosed or complicated lesions (Wei et al., 1998). 
In sphingosine-mediated apoptosis in Jurkat and J774 cells, lysosomal protease 
activity preceded caspase activation and changes of mitochondrial membrane potential. 
Lysosomal protease inhibitors inhibited caspase activity (Kagedal et al., 2001). Cathespin B 
activity also preceded apoptotic features in WEHI-S fibrosarcoma cells incubated with mFa. 
Cathespin B inhibitors, but not caspase inhibitors, decreased apoptosis (Foghsgaard et al., 
2001). 
The other feature examined in this chapter as part of apoptosis is the externalisation of 
phosphatidylserine. This is particularly important in considering apoptosis in an in vivo 
context, rather than just in the cell as an individual unit. Phosphatidylserine exposure 
influences how the cell interacts with and affects other cells and components which surround 
it in the body. It can be argued that this is the most important component of apoptosis, since 
cells can be cleared without releasing their inflammatory contents (Leist and Nicotera, 1997; 
Hampton et al., 2002C). If phagocytosis does not occur, the cell will undergo necrosis, and 
the careful regulation of apoptosis will have lost what is perhaps its major function. Necrotic 
cells may also be taken up by phagocytes, but they still cause pro-inflammatory responses 
(Hirt et al., 2000; Cocco and Ucker, 2001). No examples have been located of apoptosis in 
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which phosphatidylserine exposure is not present. However, it is not a feature as often studied 
as DNA fragmentation or caspase activation. 
The boundaries between apoptosis and necrosis are also blurred due to the fact that 
the type of cell death is so very dependent on the exact circlUllstances. The same stimulus can 
induce apoptosis or necrosis or both, even simultaneously in the same cell population. This 
will vary depending on stimulus, the concentration ofthe stimulus, cell type and length of 
incubation. Necrotic features may simply represent the end stages of apoptosis in vitro, as 
phagocytosis cannot usually occur. No consistency is found between cell types, or even 
within the same cell type with different inducers. 
The two processes also have many common features, which makes them less 
distinguishable from one another. Among these are the involvement of Ca2+ -dependent 
enzymes, c-Fos and mitochondrial membrane permeability (Kroemer and Reed, 2000). There 
is limited evidence of caspases-8 and -10 participating in necrosis, and that Bcl-2 
overexpression inhibits necrosis by viruses, oxidative stress and hypoxia (Leist and Nicotera, 
1997; Hetz et al., 2002), in spite of these being considered strict indicators of apoptosis. This 
has not been confirmed independently and is ignored by most authors. 
Annexin V is able to gain access to phosphatidylserine during necrosis as a result of 
membrane fragmentation. The Annexin vlPr assay is based upon distinguishing the two 
forms of cell death by loss of cell membrane integrity (Vermes et al., 1995; Green and 
Steinmetz, 2002). However, it has been suggested that phosphatidylserine may be exposed on 
necrotic cells for a short time before the membrane integrity is lost (Waring et al., 1999; 
Lecoeur et al., 2001). 
A new view is emerging that, instead of completely separate phenomena, apoptosis 
and necrosis are only extremes in a wide range of biochemical and morphological patterns of 
cell death (Lelli Jr. et ai., 1998; Bomer and Monney, 1999). Apoptosis has previously been 
used as a heterogeneous lUllbrella term, to pull together a set of events which often occur 
together, and necrosis was usually defined as the absence of these. The idea of a continulUll 
between two polar forms of cell death, as opposed to a dichotomy, would allow for examples 
missing so-called 'crucial' apoptotic features such as caspases or DNA fragmentation. These 
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forms would therefore be placed somewhere towards the middle of the spectrum, depending 
on what other characteristics the cell death demonstrated. 
The three characteristics tested for in this chapter are all important parts of the death 
process. Together, they would make a strong case for apoptosis, as they look at different parts 
of the process, across the timeframe and different functions that are carried out as part of it. 
From this, it can be concluded that THP-1 cells are undergoing a conventional form of 
apoptosis with oxLDL, and that U937 cells are also likely to become apoptotic, but their 
death with oxLDL is more towards the middle of the scale. 
Perhaps a range of assays like this is required before apoptosis can be diagnosed. So 
many features have been identified as part of apoptosis, most, but not all, of which were 
outlined in the introductory chapter. Many ofthese are not tested for by those undertaking 
apoptotic studies. As a result, many ofthe literature examples of apoptosis may in fact be 
towards the middle, rather than one end, of the spectrum, as they may be missing many 
important apoptotic characteristics. 
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SUMMARY 
Three assays were used to assess the appearance of apoptosis in THP -1 and U937 
cells with oxLDL. The Hoechst 33342 stain was used to examine changes in nuclear 
morphology, and it was found that both cell types showed the same typical apoptotic features. 
Higher concentrations of oxLDL caused either necrosis or secondary necrosis as well. 
The Annexin V Ipropidium iodide assay looked at phosphatidylserine exposure on the 
surface of the cells. Both cell types seemed to undergo apoptosis, with THP-I cells moving 
more swiftly towards (secondary) necrosis. 
A fluorescent caspase assay was used to test for caspase activation. Here the two cell 
types were very different. THP-I cells had an increase in caspase activity over time and with 
oxLDL concentration, although this then dropped away as secondary necrosis began to take 
place. The 3.OmglmL oxLDL concentration was found to cause more necrosis than apoptosis. 
In U937 cells, the caspase levels were very low, and furthcr incubation with oxLDL 
lowered them still further. A correlation of loss of total reduced thiols and loss of caspase 
activity led to an demonstration of oxLDL inactivation of already activated caspases, 
suggesting this may be one of its effects in U937 cells. 
78NP seemed to reduce the appearance of apoptotic features in U937 cells as 
measured by Hoechst 33342 staining and the Annexin V/propidium iodide assay, and 
continued to have no effect on THP-1 cells. It was able to partly decrease the loss of caspase 
activity occurring in U937 cells when the oxLDL was added, bringing them up closer to 
control levels. This may be related to its protection of reduced cellular thiols, shown by the 
DTNB assay in earlier chapters. 
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78NP PRODUCTION BY IFNy IN VWO AND CELL VIABILITY 
INTRODUCTION 
IFNy, generated by T cells in inflammatory conditions such as in the atherosclerotic 
plaque (Wachter et aI., 1989), has important roles throughout atherosclerotic development. 
Some of these effects may be due to the production of 78NP. 
Stimulation of cells with IFNy reduces their ability to oxidise LDL. In mouse 
macrophages, this is via increased NO synthesis, and lipopolysaccharide, which also 
stimulates iNOS, can have the same effect (Bolton et aI., 1994). In human mononuclear cells, 
reduction ofLDL oxidation by IFNy may be due to contributions from 78NP, 3-
hydroxyanthranilic acid (3HAA), a tryptophan metabolite found in mammalian cells 
(Werner-Felmayer et ai., 1989; Christen et ai., 1990; Thomas and Stocker, 1999) or 
unidentified metal ion chelators (Baoutina et ai., 200lA). 3HAA at lO/lM has been reported 
to decrease cell-mediated LDL oxidation when added to cultures. Inhibition of the flavin 
enzyme responsible for 3HAA and lower levels of tryptophan in the medium than required 
for 3HAA formation halted the inhibition by IFNy (Christen et ai., 1994). Addition of 5/lM 
78NP to media inhibited TBARS formation in LDL caused by THP-1 monocytes, whereas 
20/lM was required with THP-1 macrophages to stop lipid oxidation and reduce a-tocopherol 
loss (Gieseg and Cato, 2003). IFNy can also inhibit lipoxygenase activity by around 20%, 
which might reduce its contribution to LDL oxidation (Fong et ai., 1994; Folcik et ai., 1997). 
IFNy can decrease foam cell formation. Stimulation of human monocyte-derived 
macrophages with IFNy for 3 days downregulated scavenger receptor A at the mRNA level, 
modestly reducing the number of receptors on the surface of the cell, with a concomitant 
reduction in acLDL binding and internalization, decreased cholesterol accumulation and 
inhibition of the transformation into foam cells (Fong et al., 1990; Geng and Hansson, 1992). 
IFNy may affect the scavenger receptor by inducing Statl binding to the promoter, 
ant agonising the AP-1 and ets transcription factors, and possibly also destabilising the mRNA 
(Grewal et ai., 2001). IFNy also regulates other oxLDL receptors, such as CD36 (Nicholson 
et ai., 1995A). IFNy affects the metabolism of the modified LDL as well, slowing the 
CHAPTER 6 195 
movement of acLDL to the lysosomes in peritoneal mouse macrophages, by controlling 
microtubules and their regulation of all intracellular movement (Fong et al., 1990). 
IFNy may conversely promote foam cell formation. It has been shown to reduce 
cholesterol efflux by downregulating the ATP-binding-cassette-l transporter gene, which is 
used for apoA-I and apoE mediation of efflux. In human monocyte-derived macrophages it 
decreases apoE production (Garner et aI., 1997A; Panousis and Zuckerman, 2000A). It is 
associated with increased intracellular cholesteryl ester accumulation and induces ACAT 
expression and activity in peritoneal murine macrophages. It also increases lipoprotein 
receptors on smooth muscle cells, enhancing their foam cell formation (Panousis and 
Zuckerman, 2000B). 
IFNy might also delay apoptosis, reducing foam cell death. Three studies showed 
IFNy reducing apoptosis in Ml myeloid leukemic cells transfected with p53, or incubated 
with cycloheximide and doxorubicin. Other cytokines such as IL-6, IL-3 and GM-CSF could 
have the same effect. Intracellular oxidative stress levels were not decreased, but caspase 
activation was. IFNy could also act in synergy with caspase inhibitors, diminishing apoptosis 
levels still further (Lotem et al., 1996; Lotem and Sachs, 1996; Lotem and Sachs, 1998). 
If 78NP acts to protect the monocytes and macrophages in inflammatory situations 
such as the atherosclerotic plaque, the cells must produce 78NP at a high enough 
concentration for it to act as an antioxidant. The production of 78NP by the three cell lines 
used in this work during incubations with IFNy is examined. 
Previous studies (Table 4) have investigated the production of neopterin by IFNy in 
monocytes or macrophages. Troppmair (1988) uses a radioimmunoassay for neopterin, 
whereas all others use the HPLC pterin method. Troppmair's experiments examined only the 
supernatant (amount of neopterin excreted by the cell) and gave results as medians. Most of 
the rest of the studies looked at the neopterin contained within the cell, which was analysed 
after cell lysis and protein determination. 
The cell types all had similar levels of neopterin. All cells produced some neopterin 
without stimulation from IFNy, and this level increased markedly once the IFNy was added. 
Higher levels of IFNy resulted in more neopterin production. Monocytes (both peripheral 
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blood mononuclear cells and THP-1 cells) were found to produce more neopterin before 
stimulation than the macrophages. 
After incubation with IFNy, comparisons between cell types become less clear. From 
Troppmair's measurements, it appears that monocytes produce less neopterin after addition of 
IFNy than macrophages. A similar assessment of the remaining studies is complicated by the 
dissimilarities in THP-1 monocyte measurements by Weiss (1992) and Werner-Felmayer 
(1990). Weiss' value for neopterin after incubation of cells with 300U/rnL IFNy is around 
fourfold more than Werner-Felmayer's result with 250U/rnL IFNy. Therefore macrophages 
may produce more or less neopterin after incubation with IFNy than monocytes, depending 
on whether the values from Weiss or Werner-Felmayer are considered. 
The discrepancy is intriguing, since these results came from closely collaborating 
researchers. This suggests that variation in neopterin levels produced is common in and 
between these experiments. 
A pattern has been found over time in neopterin generation induced by IFNy. The 
production increases and peaks. Troppmair (1988) found this occurred with peripheral blood 
macrophages by 4 days, and in vivo after IFNy injection by 48 hours. The amount of 
neopterin would then level out, or decrease. 
Wemer-F elmayer (1990) showed that THP -1 monocytic cells have the same pteridine 
production patterns as peripheral blood macrophages, producing similar amounts of 
neopterin, monapterin and biopterin. This should make them a suitable model for studying 
neopterin production in vivo. 
I 
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Table 4: Amounts ofneopterin produced by monocytes and macropbages with and without IFNy in 
previously published studies. 
THP-1 monocytes (Weiss et aI., 1992) 
Supernatant (nM, lOt> cells) i Inside cell (pl11ollmg cell 'Qrotein) 
Without IFNy 3.8±0.6 12.6±3.1 
I 
I 300U/mL IFNy 81.7±4.9 206.0±22.3 I 
1 Without IFNy 
250U/mL IFNy 
500U/mL IFNy • 
r-----wOOU/mL 
W 
100 
ithoutIFNy 
U/mLIFNy 
i Without IFNy 
I 250U/mL IFNy 
THP 1 yt (W - monoc es F I I 1990) erner- e mayer et a ., 
Inside cell ('Qmol/mg cell 'Qrotein) 
4.7±4.0 
52.1±0.8 
150.5±9.2 
334.9±14.8 
Peripheral blood mononuclear ! Monocyte-derived macrophages I 
cells (Troppmair et al., 1988) I (Troppmair et al., 1988) i 
Supernatant (pmol/10() cells) I Supernatant (pmoIIl 06 celi~ 
22 i 14 
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Monocyte-derived I Monocyte-derived macrophages 
macrophages (Werner-Felmayer et al., 1990) (Werner et al., 1989) 
Inside cell (pmollmg) Inside cell (pmollmg) 
1.95±1.27 2.8±1.9 
159.63±51.22 131.4±68.0 
In the second part of this chapter, IFNy is added to cells with oxLDL, to test whether 
the 78NP produced might protect the cell from viability loss. However, this may also alter 
viability in other ways, since IFNy is likely to have numerous other effects aside from 78NP 
production. 
In many cases interferons cause differentiation of the cell as part of the activation 
process. For instance, an increase in adherence ofTHP-1 monocyte cells was found after 24 
hours of treatment with IFNy, and HLA-DR and FeRl expression were enhanced. This was 
only a partial effect, however, since the cells did not completely differentiate or enlarge to 
CHAPTER 6 198 
macrophage size (Tominaga et al., 1998). IFNyat 100U/mL was said to differentiate U937 
cells after 48 hours (Nonaka et al., 1999). When incubating cells with IFNy in this research, 
no extra adherence or change in shape which might indicate differentiation was observed, 
although no specific tests for differentiation markers were undertaken. 
IFNy may have slightly different effects on the THP-1 and U937 cell types. IFNy 
induces the HLA-DR gene very strongly in THP-1 cells, and weakly in U937 cells, where it is 
not expressed constitutively. IFNy also induces TNFa , but only in THP-l cells (Arenzana-
Seisdedos et al., 1988). THP-l cells' release of ceruloplasmin is said to be somewhat 
stimulated by IFNy, whereas U937 cells, which may not constitutively release it, are 
stimulated twenty-fold by IFNy (Mazumder et al., 1997). IFNy also decreases CD4 antigen 
levels on cells. In U93 7 cells the reduction was 50%, but the effect was much smaller in 
THP-1 cells (Faltynek et al., 1988). 
In the last part of the chapter, 78NP levels in vivo are examined. During 
inflammation, the metabolites of macrophages and neutrophils damage cells. The resulting 
accumulation of dead cells, cellular debris and fluid at the site is known as pus (Davies, 
1997). Serum neopterin and 78NP is hypothesised to come from such inflammatory lesions, 
which suggests pterins have been diluted from sites of much higher concentrations (Duggan 
et al., 2002). 
Levels of 78NP and neopterin have not been measured in bodily materials other than 
serwn to date. Neopterin has been identified in plaque samples by immunoblotting 
(Reibnegger, personal communication, 2003). Concentrations in serum vary, but stay within 
the low nanomolarrange in healthy subjects (Wachter et al., 1992), in a ratio ofneopterin: 
78NP of 1:2 (Weiss et at., 1993B). One study with 662 subjects reported serum levels in 
healthy subjects which varied by age. Those aged 0-18 had 6.78±0.22nM, those aged 19-75, 
5.34±0.14nM, and those aged older than 75, 0.67±0.79nM (Wachter et al., 1989). Other 
studies showed a nonnal range of6.2-lOnM (Gurfrnkel et al., 1999), 3.8-12.2nM 
(Schumacher et al., 1992) or 5.3±2.7nM (Murr et al., 1999). Some studies reported median 
concentrations of 4. 7nM neopterin and 8.9nM 78NP (Weiss et al., 1994) and 4.85nM 
neopterin and 6.9nM 78NP (Widner et al., 1999). An upper limit for healthy subjects in 
another study was given as 15nM (Mueller et al., 1991). 
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In severely ill patients, serum levels of up tolJ-LM have been reported (Baier-Bitterlich 
et ai., 1996B). This is close to the range required for antioxidant activity, as found for 
prevention ofLDL oxidation (Gieseg and Cato, 2003). 
Serum levels of neopterin have been examined in atherosclerotic patients. Not all 
patients have elevated neopterin levels, and the increase in concentration compared to 
controls is not large, which does not support the contention that 78NP might play an 
important role in plaque development. The lower elevation of neopterin in some patients may 
reflect varying levels of inflammation, and so 78NP production, in the plaque. 
In one study, the average neopterin level was 15.5±19.35nM, close to the upper limit 
of the controls. Half of the patients had elevated levels, with 20% above 20nM and one up to 
113.5nM (Tatzber et al., 1991). Only half of the patients with congestive heart failure 
examined in another study had elevated neopterin levels, and the increase was small (Fuchs et 
aI., 1993). In another group of patients with coronary artery disease or peripheral artery 
disease, elevations were again very small, with only a few up to around 20nM (Erren et al., 
1999). Only 39% of patients with unstable angina had elevated neopterin levels (Gurfinkel et 
ai., 1999). Neopterin was said not to be a specific marker in a group of males with coronary 
artery disease diagnosed angiographically. The average neopterin levels for patients and 
controls were 8.0±2.7nM and 7.6±2.5nM respectively (Schumacher et al., 1992). 
In a larger study with 321 carotid atherosclerosis patients and 240 controls aged 40-
79, those with atherosclerosis had higher neopterin levels. In men, patients had 8.5±2.7nM 
compared to 6,7±2.3nM in controls, and in women the figures were 9.6±3.3nM versus 
7.5±2.3nM. The increase in neopterin was found to be significant in all groups except older 
women. Neopterin was more strongly correlated with atherosclerosis than other risk factors 
studied, such as blood pressure and fibrinogen levels, but the authors state that since the 
difference is small, large study groups are required, and neopterin could not be used as a 
clinical marker for early diagnosis. Its significance was said to be that it adds to the evidence 
ofimmune activation in atherosclerosis (Weiss et ai., 1994). 
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RESULTS AND DISCUSSION 
A. PRODUCTION OF 78NP BY IFNy STIMULATION OF MONOCYTES AND MACROPHAGES 
The amount of neopterin produced by THP-l monocytes, U937 monocytes and 
THP-l macrophage-like cells after 48 hours incubation with IFNy is represented in Table 5. 
The results are presented so as to allow comparison with earlier studies. 
Table 5: The amount ofneopteriu produced by three cell types after stimulation with IFNy for 48 
hours. THP-l or U937 monocytes (5 x 1Q5cells/mL) or 'JHP-l macrophage-like cells (1 x 1Q5cells/mL) were 
incubated in RPMI 1640 with IFNy (specific activity 2 x 107U/mg protein) of 300U/mL or 1500UlmL for 48 
hours. The supernatant was then removed, and the cells washed and lysed in water by sonication. The amount of 
neopterin present was measured using the pterin HPLC assay after oxidation with acidic iodide. Protein 
determinations were carried out for each cell type. Results are expressed as the mean ± SD of triplicates. 
Treatment I U937 monocytes THP-l monocytes THP-l macrophage-like cells 
Supernatant (nM) l6.45±1.08 26.82±4.53 NoIFNy • 20.41±5.50 
Within cells 
I (nmollmg cell protein) 2,97±0.04 
I 
2.36±O.2l 4.73±0.71 
NoIFNy 
· Supernatant (nM) 59.57±1O.55 30.75±0.71 53.03±3.71 300U/mL IFNy 
· Supernatant 
! (pmol/105 cells) 11.91±2.11 6.15±0.14 53.03±3.71 
I 
i 
300U/~IFNy .----T-----------+-----------+------~-----------~ 
Within cells 
i (nmol/mg cell protein) 
\300U/mL IFN] 
Supernatant (nM) 
· 1500U/mL IFNy 
I 
I 
I 
4,45±0.64 
90.61±3.95 
18.12±0.79 
6,05±0.80 
3.64±0.02 1 1. 15±0.93 
55.39±4.05 86.19±13.87 
11.08±0.81 86.19±13.87 
4.56±0.04 18.65±1.1l 
Under all conditions examined, U937 monocytes produced more 78NP than THP-l 
monocytes. This result was unexpected, as the parental U937 cell line was unable to produce 
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78NP, however certain subclones are known to have undergone changes such that 78NP 
production does occur (Wachter et al., 1989; Werner-Felmayer et al., 1990). The U937 cell 
line used in our studies appears to belong to one of these groups. 
The THP -1 macrophage-like cells yield by far the largest amount of 78NP, once the 
number of cells or the amount of cell protein is taken into account. This is not surprising, 
since one of the effects of differentiation is an increase in IFNy receptors (Kosaka et al., 
2001), and an increase in production of substances associated with inflammation, including 
antioxidants (Akeson et ai., 1991B; Gotoh et ai., 1993). 
Before the concentrations of neopterin measured were converted from nM into 
nmollmg cell protein, it was noted that the concentrations found in the celllysates, and hence 
inside the cell, were higher than those in the supernatants. 
Another observation is that the five-fold higher concentration ofIFNy did not yield a 
five-fold higher concentration of 78NP. Instead the increase ranged between around 125% 
and 180%. The results in Table 4 from a similar experiment (Werner-Fe1mayer, 1990) show a 
much more proportional increase. The highest IFNy concentration tested here is much greater 
than the one in the table. Either a threshold is reached, over which extra IFNy has no further 
effect, or the production levels off, becoming less efficient with increasing concentrations. 
Such a high concentration may also have decreased 78NP production, or cell viability. 
The monocyte cell lines showed overall lower levels of78NP increase with higher 
IFNy concentration, and the smallest increases were found within the cell rather than in the 
supernatant. The THP-l macrophage-like cells had approximately even increases both within 
and outside the cell. 
Studies over time, using only 300U/mL IFNy, showed the pattern of an increase in 
neopterin concentration which peaked at 24 hours and tailored off (Figures 87 and 88). This 
trend was also found by Troppmair (1988). The reduction in neopterin concentration may be 
due to both a decrease in Il<'Ny-induced production and the oxidation of the 78NP present to 
products other than neopterin. In Chapter 4, 78NP incubated with cells was shown to oxidise 
almost exclusively to 7,8-dihydroxanthopterin. 
CHAPTER 6 202 
125 
100 
-
.!! 
S 
10 75 II::) 
-
"0 
E Q. 50 
-.-. 
D.. 
Z 
..... 
25 
O~------~--------r-------'--------.------~ 
o 10 20 30 40 50 
Time (hours) 
-- THp·1 cells 
-.- U937 cells 
......... THP-1 macrophage-like cells 
Figure 87: Production of neopterin in IFNy-stimulated cell supernatant over 48 hours. 
cUlP_l or U937 monocytes (5 x 105cells/mL) or THP-l macrophage-like cells (1 x l05cells/mL) were incubated 
in RPMI 1640 with IFNy (specific activity 2 x l07U/mg protein) of300U/mL for up to 48 hours. At 0,2,6,12, 
24 or 48 hours, the supernatant was removed. The amount of neopterin present was measured using the pterin 
HPLC assay after oxidation with acidic iodide. Ibis experiment was repeated twice, and the results presented 
are from a representative experiment. Results are expressed as the mean ± SD of triplicates. 
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Figure 88: Production ofneopterin in IFN'Y-stimulated cell lysate over 48 hours. 
THP-l or U937 monocytes (5 x 105cells/mL) or THP-l macrophage-like cells (1 x 105cells/mL) were incubated 
in RPMI 1640 with IFNy (specific activity 2 x 107U/mg protein) of300U/mL for up to 48 hours. At 0, 2, 6, 12, 
24 or 48 hours, the supernatant was then removed, and the cells washed and lysed in water by sonication. The 
amount of neopterin present was measured using the pterin HPLC assay after oxidation with acidic iodide. 
Protein detenninations were carried out for each cell type. This experiment was repeated twice, and the results 
presented are from a representative experiment Results are expressed as the mean ± SD of triplicates. 
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The relative amounts of 78NP produced by each cell type match those in the 
experiments represented in Table 5. THP-I macrophage-like cells produced the most 78NP, 
relative to cell number or amount of cell protein, and U937 cells generated more than the 
THP-I monocytic cells. The maximum amount of 78NP produced by each cell type, that is, 
the amount measured at the 24 hour timepoint, is given in the table below: 
Table 6: The amount ofneopterin produced by three cell types after stimulation with IFNy for 24 
hours. THP-l or U937 monocytes (5 x 105cells/mL) or THP-l macrophage-like cells (1 x 105cells/mL) were 
incubated in RPMI 1640 with IFNy (specific activity 2 x 107U/mg protein) of300U/mL for 24 hours. The 
supernatant was then removed, and the cells washed and lysed in water by sonication. The amount of neopterin 
present was measured using the pterin HPLC assay after oxidation with acidic iodide. Protein detenninations 
were carried out for each cell type. Results are expressed as the mean ± SD of triplicates. 
Treatment 
Supernatant (nM) I 
· NoIFNy 
Within cells 
(nmollmg cell protein) 
NoIFNy 
· Supernatant (nM) 
300U/mL IFNy 
Supernatant 
I (pmolllO' cells) 
300U/mL IFNy 
Within cells 
· nmollm cell rotein I ( g P 
300U/mL IFNy 
) ! 
U937 monocytes 
25,50±9.83 
2.79±0.36 
160.26±8.29 
32.05±1.66 
16.58±0.60 
I THP-l monocytes i THP-l macrophage-like cells 
16.64±0.68 ! 29.05±3.14 
i 
2.69±0.06 6.23±0.62 
89.61±L06 I 79.94±21.3 
I 
17.92±0.21 79. 94±21.3 
8.21±0.32 30.17±1.51 
The levels of neopterin described in the supernatant were similar, although slightly 
higher, than those found by Werner (1989), Werner-Felmayer (1990) and Weiss (1992). 
However the concentrations expressed relative to cell protein, quantifYing neopterin inside 
the cell, were around twenty-fold greater than those in the earlier studies. 
A number of reasons could account for the differences. The THP -1 monocytes used 
by Werner-Felmayer (1990) were passaged only once weekly, as opposed to two or three 
times for the cells used in these studies. The lower number of cells used here may also have 
resulted in greater production when cell numbers or protein levels are compared. The earlier 
studies presented above used THP-l monocytes at a density of 6 x 105 ImL, compared to 
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5 x 105/mL in this work. Cell density can affect metabolism (Hughes et ai., 1994; Rodriguez 
et ai., 1994). 
Since the greatest discrepancy is in the intracellular concentrations, a difference in 
method used to prepare the celllysates may be a determining factor. In this study, cells were 
resuspended in water, after PBS washes. To ensure lysis was complete, the cells were also 
sonicated for two minutes. A less rigorous protocol, resulting in incomplete cell lysis, would 
result in smaller 78NP concentrations. 
Some 78NP was also produced by unstimulated cells. This level did not increase 
significantly over time. The THP-1 macrophage cells consistently had a higher level of 78NP 
present before stimulation with IFNI', due to their more advanced state of differentiation. This 
differs from the values given in the studies outlined earlier, in which THP-1 monocytes had 
higherlevels of 78NP before stimulation than monocyte-derived macrophages. The relatively 
'undifferentiated' state of the peripheral blood 'macrophages' may have some bearing on 
this. The cells Werner (1989) extracted from donors were experimented on as 'macrophages' 
only three days after removal from blood, and so were probably more monocyte-like in 
nature. 
The level of78NP that was generated is around a thousand-fold lower than that used 
to protect U937 cells in viability studies in earlier chapters. From the evidence here alone, it 
seems unlikely that 78NP is able to protect monocytes and macrophages in vivo. Of course, in 
vivo, many other antioxidants may be present to contribute to the protection, such as 3HAA, 
vitamins and antioxidants formed by other cell types. The period of contact with the oxidant 
will also be much longer, especially in the development of atherosclerosis, which is a slow 
process, spanning years. Possibly low levels of78NP, produced continuously over that time 
due to constant IFNI' stimulation from T cells, are able to aid the cell. Levels of 78NP may 
also be higher in the complex situation of the plaque due to stimulation of the cells by other 
cytokines. Another possibility is that when the cell produces the 78NP itself, as opposed to 
having it exogenously added, it is in a different part of the cell, where it can better act as an 
antioxidant. 
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THE EFFECT OF OxLDL ON IFNY-STIMULATED 78NP PRODUCTION 
The effect of oxLDL on IFNy-induced 78NP production was examined in each of the 
three cell types many times. Since oxLDL influences so many cell signalling pathways, it is 
likely to change signalling patterns resulting from IFNy stimulation. In particular, oxLDL 
affects the pathway activated by IFNy once bound to cell-surface receptors, the Janus tyrosine 
kinases, which phosphorylate Stat factors (Johnson et al., 1994). For example, oxLDL 
activated Jak2, Statl and Stat3 in MRC5 fibroblasts, to a greater degree if it was more 
extensively oxidised. (Maziere et al., 20Ot). In THP-l monocytes, incubation with 
extensively oxLDL upregulates PP ARy, which then downregulates iNOS and the induction of 
inflammatory cytokines (Jang et al., 1999). This might be expected to reduce their 
upregulation by IFNy (Billiau and Dijkmans, 1990; Tatzber et al., 1991; Kuby, 1997). 
The results of adding oxLDL to cells and measuring 78NP production were very 
variable and irreproducible, although there were trends which appeared most of the time. The 
results would have been complicated by the other effects the oxLDL was having on the cells 
at the same time, for instance the decrease in cell viability. 
As a general rule, L5mg/mL oxLDL added to control cells, not incubated with IFNy, 
had no effect on the level of 78NP produced. This was the case even after 48 hours, when a 
large cell viability loss would have occurred. Sometimes a small increase in the supernatant 
fraction was found at the 48 hour timepoint, possibly as the 78NP which would have been 
kept inside the cell was released due to loss of integrity of the cell membrane. 
Trends were also apparent in cells incubated with 300U/mL IFNy when 1.5mg/mL 
oxLDL was also added. In U937 monocytes, a decrease in 78NP concentration occurred in 
the supernatant fraction. By 48 hours, an increase was apparent inside the cells. In THP-1 
monocytes, most values decreased, both intra- and extracellularly. Occasionally, a small 
increase was found. In THP-l macrophage-like cells, any effects seen were very smalL There 
was never a change in the 78NP concentration in the supernatant due to addition of oxLDL. 
At earlier timepoints, up to 12 hours, a small decrease in 78NP was usually found, whereas in 
the later stages ofthe incubation, the concentration increased. 
Similar experiments were performed in an examination ofTHP-l macrophage-like 
cells to which non-oxidised LDL was added. LDL alone, at 40nM, caused an increase in 
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supernatant pterin in IFNI'-stimulated and unstimulated cells, but did not affect intracellular 
levels (Gieseg and Cato, 2003). In a study of human mononuclear cells, the presence of 
native or oxLDL did not affect levels of tryptophan degradation or 3HAA synthesis (Christen 
etai., 1994). 
No real conclusions as to the effect of oxLDL on 78NP induction can be drawn from 
this data. The effect does not appear to be readily reproducible, although general trends can 
be seen. Certainly oxLDL, under these conditions, appears to have no decisive effect on 
78NP production in the cell types studied. It is unlikely, then, that 78NP is being induced in 
the viability studies with oxLDL in earlier chapters, at least not to a level at which it may 
affect viability. 
B. CELL VIABILITY OF MONOCYTES AND MACRO PHAGES WITH IFNy 
In an in vivo situation, cells would have to produce 78NP themselves if it were to act 
as a protectant in an inflammatory environment. The quantity of78NP the three cell types are 
able to produce under stimulation with IFNI' has turned out to be very much lower than the 
concentrations that were used in the earlier chapters to protect cells against oxLDL and 
AAPH. Nevertheless, the fact that the 78NP is produced endogenously may mean that it is 
more efficient as an antioxidant. 
In this section, the effect of adding 300U/mL IFNI' to cells challenged with oxLDL is 
examined. The first set of experiments use both monocyte cell types, and look at what 
happened when the IFNI' was added to the cells at around the same time as the oxLDL, and a 
48 hour incubation was performed. It was found that more precise results were obtained when 
the IFNI' was added to wells containing RPMI 1640 ten minutes before the cells were added, 
to allow it to be distributed evenly around the solution. It was then more likely that all cells 
received equal cytokine stimulation. 
No protective effect of the IFNy was found in THP-l cells when the analysis was 
carried out by MTT assay, but 300U/mL IFNI' alone caused a slight viability loss (Figure 89). 
A protective effect against the oxLDL was evident when the trypan blue assay was used, 
which was very significant at p'::;O.OOl, although also very small (Figure 90). Again a small 
viability loss was caused by the IFNI' by itself. 
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In U937 cells, again no protective effect ofIFNy was apparent with the MIT assay, 
and the viability loss from the IFNy alone was more pronounced (Figure 91). The trypan blue 
assay analysis results (Figure 92) mirrored those of the 1HP-1 cells, with a slight but very 
significant (p:<;0.00l) protective effect ofIFNy, and a cell viability loss with IFNy only. 
The protection against oxLDL shown with the trypan blue assay in monocyte cell 
lines may represent a delaying of apoptosis, slight enough to affect loss of membrane 
permeability, but not the loss of enzyme function measured by the MIT assay. 
78NP may have contributed to this effect, but there is no proof ofthis. Other products 
ofIFNy stimulation may have also played a role or been completely responsible for the 
protection. Although no extra tryptophan was added, evidence has also been presented that 
RPM! 1640 media contains high enough levels, at around 25~M, for 3HAA to be made 
(Christen et at., 1994). IFNI' might also delay apoptosis through the reduction of caspase 
activation and the blocking of cell proliferation (Lotem et ai., 1996; Xaus et ai., 2001). The 
lack of a decrease in intracellular oxidative stress levels may suggest the effect is not 
antioxidant-based, making a contribution by 78NP or 3HAA less likely, but this would need 
to be further investigated (Lotem and Sachs, 1996). 
In THP-l cells differentiated with PMA, scavenger receptor expression and activation 
is inhibited by IFNI' and other cytokines. This may make the cells less susceptible to oxLDL-
induced cytotoxicity, if that toxicity requires uptake of the oxLDL (Hsu et ai., 1996). 
Alternatively, the cells may become more susceptible, if uptake decreases the oxLDL's 
toxicity (Lougheed et ai., 1991). Here, it was found that IFNI' did not change the viability 
loss due to the oxLDL in the THP-l macrophage-like cells, as analysed with the MTT assay, 
but did alter cell viability alone (p:<;O.OI) (Figure 93). 
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Figure 89: Effect of IFNy on oxLDL-induced cell viability loss in TIIP-l cells: MIT assay. 
209 
TIIP-l cells (5 x 105cells/mL) were incubated with 1.5mglmL oxLDL with or without 300U/mL IFNy in RPMI 
1640 for 48 hours. A 300U/mL IFNy-only control was included. The MIT assay was used, and results are 
expressed as mean ± SD of triplicates. 
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Figure 90: Effect ofIFNy on oxLDL-induced cell viability loss in TIIP-l cells: trypan blue assay. 
TIIP-l cells (5 x 105cells/mL) were incubated with 1.5mglmL oxLDL with or without 300U/mL IFNI' in RPMI 
1640 for 48 hours. A 300U/mL IFNy-only control was included. The trypan blue assay was used, and results are 
expressed as mean ± SD of triplicates. 
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Figure 91: Effect ofIFNr on oxLDL-induced cell viability loss in U937 cells: MTT assay. 
210 
U937 cells (5 x 105cells!mL) were incubated with 1.5mglmL oxLDL with or without 300U/mL IFNy in RPMI 
1640 for 48 hours. A 300U/mL IFNy-only control was included. The MIT assay was used, and results are 
expressed as mean ± SD of triplicates. 
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Figure 92: Effect ofIFNr on oxLDL-induced cell viability loss in U937 cells: trypan blue assay. 
U937 cells (5 x 105cells/mL) were incubated with 1.5mglmL oxLDL with or without 300UlmL IFNy in RPMl 
1640 for 48 hours. A 300U!mL IFNy-only control was included. The trypan blue assay was used, and results are 
expressed as mean ± SD of triplicates. 
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Figure 93: .Effect of IFNy 00 oxLDL-induced cell viability loss in THP-l macrophage-like cells: MTT 
assay. 1HP-l macrophage-like cells (1 x 105cells/mL) were incubated with 1.5mg/mL oxLDL with or without 
300U/mL IFNy in RPM! 1640 for 48 hours. A 300U/mL IFNy-only control was included. The MIT assay was 
used, and results are expressed as mean ± SD of triplicates. 
Perhaps a greater protective effect might be found if time for 78NP production was 
allowed before addition of oxLDL. Cells were incubated with IFNy at 300U/mL in a flask for 
24 hours before they were washed and aliquoted into wells for addition of oxLDL. The 
differentiated cells were preincubated in the same way in their wells and washed before the 
start of the experiment. To distinguish between the importance of the 78NP that was 
produced and retained inside the cells, and that which was excreted, the viability part of the 
experiment was performed in two ways. In the first case, the cells were washed after 
incubation with IFNy, and were placed in the wells in a new RPW 1640 solution, with fresh 
IFNy. In the second case, the media used for the 24 hour incubation was reused, being plated 
out into the wells for the viability part of the experiment, so that any 78NP that was excreted 
into the medium during the incubation was still present. No new IFNy was added, since the 
dose used for the incubation was still present and able to be effective. In the differentiated 
cells, new media was used, with fresh IFNy added. 
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In THP-l cells with new media and IFNy, no protective effect oflFNy was found with 
either MIT or trypan blue assays (Figures 94 and 95). The same result was achieved with the 
reused media (Figures 96 and 97). In two cases there was even a decrease in cell viability 
once IFNy was also added, compared with just oxLDL. The decrease was only significant 
(P:SO.001) in Figure 97, THP-l cells in reused media assayed with trypan blue. 
In U937 cells the outcome was identical. No protective effect oflFNy against oxLDL 
was found with either with the new or the reused media, analysed with either assay. These 
results are illustrated in Figures 98-101. The same result was found with the differentiated 
THP-1 cells, in Figure 102. 
Instead of the more pronounced protective effect expected after IFNy preincubation, 
in this set of experiments IFNy does not seem to positively affect oxLDL-induced cell 
viability loss, even when fresh IFNyis added. The protective function found with the trypan 
blue assay in Figures 90 and 92 appears to be lost when cells are preincubated with IFNy. 
This implies the reduction in cell death seen in the earlier figures was not due to 78NP, as its 
concentration does not decrease hugely over this timeframe. 
The cells may become desensitized to IFNy over the 24 hours of preincubation, so 
that the changes the IFNy causes which are seen in a retarding of cell death are reduced over 
time. This phenomenon has been described before. It was found that repeated stimulation 
with LPS caused tolerance to develop, diminishing IL-12 production in human monocyte-
derived macrophages (Monteleone et at., 1999). Macrophages isolated from inflammatory 
sites in the body are desensitized towards LPS and IFNy, producing less TNFa. After ten 
days in culture, cytokine production becomes normalized (Burger et at., 1999). 
Alternatively, the apoptosis-causing effect of the IFNy may become more pronounced 
with longer incubation with IFNy, canceling out the protective effect. For example, 
preincubation with IFNy has been shown to upregulate pro-caspases and downregulate anti-
apoptotic proteins (Varela et at., 2001), and this may take some time to occur to a degree 
where it is measurable as cell viability loss. 
In conclusion, even when allowed time to build up a greater concentration of 78NP, 
monocytes are not able to protect themselves from oxLDL due to stimulation with IFNy. 
IFNy alone causes a loss of viability of around 20-30% relative to the untreated cells. 
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Figure 94: Effect on oxLDL-induced cell viability loss of pre incubating THP~l cells with IFNy, and 
changing the media for incubation witho:xLDL: MIT assay. 
TIIP-1 cells were preincubated with 300U/mL IFNy for 24 hours before being washed and resuspended in new 
RPMI 1640 media (5 x 105cells/mL) and incubated with L5mg/mL oxLDL with or without 300U/mL IFNy for 
48 hours. A 300U/mL IFNy-only control was included. The MIT assay was used, and results are expressed as 
mean± SD of triplicates. 
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Figure 95: Effect on o:xLDL-induced cell viability loss of preincubating THP-l cells with IFNy, and 
changing the media for incubation with o:xLDL: Trypan blue assay. 
TIIP-I cells were preincubated with 300U/mL IFNy for 24 hours before being washed and resuspended in new 
RPMI 1640 media (5 x 105cellslmL) and incubated with L5mg/mL oxLDL with or without 300U/mL IFNy for 
48 hours. A 300U/mL IFNy-only control was included. The trypan blue assay was used, and results are 
expressed as mean ± SD of triplicates. 
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Figure 96: Effect on oxLDL-induced cell viability loss of preincubating THP-l cells with IFNy. and 
reusing the media for incubation with oxLDL: MIT assay. 
TIIP-l cells were preincubated with 300U/mL IFNy for 24 hours before being washed and resuspended in the 
RPMI 1640 media they were preincubated in (5 x 105cellslmL) and incubated with 1.5mglmL oxLDL for 48 
hours. A 300U/mL IFNy-only control was included. The MIT assay was used, and results are expressed as 
mean ± SD of triplicates. 
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Figure 97: Effect on oxLDL-induced cell viability loss of preincubating THP-l cells with IFNy, and 
reusing the media for incubation with oxLDL: Trypan blue assay. 
TIIP-l cells were preincubated with 300U/mL IFNy for 24 hours before being washed and resuspended in the 
RPMI 1640 media they were preincubated in (5 x 105cells/mL) and incubated with 1.5mg/mL oxLDL for 48 
hours. A 300U/mL IFNy-only control was included. The trypan blue assay was used, and results are expressed 
as mean ± SD of triplicates. 
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Figure 98: Effect on oxLDL-induced cell viability loss of preincubating U937 cells with IFNy, and 
changing the media for incubation with oxLDL: MTT assay. 
U937 cells were preincubated with 300U/mL IFNy for 24 hours before being washed and resuspended in new 
RPMI 1640 media (5 x 105cells/mL) and incubated with l.5mg/mL oxLDL with or without 300U/mL IFNy for 
48 hours. A 300U/mL IFNy-onIy control was included. The MIT assay was used, and results are expressed as 
mean ± SD of triplicates. 
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Figure 99: Effect on oxLDL-induced cell viability loss of preincubating U937 cells with IFNy, and 
changing the media for incubation with oxLDL: Trypan blue assay. 
U937 cells were preincubated with 300U/mL IFNI' for 24 hours before being washed and resuspended in new 
RPMl1640 media (5 x 105cells/mL) and incubated with 1.5mg/mL oxLDL with or without 300U/mL IFNy for 
48 hours. A 300U/mL IFNy-only control was included. The trypan blue assay was used, and results are 
expressed as mean ± SD of triplicates. 
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Figure 100: Effect on oxLDL-induced cell viability loss of preincubating U937 cells with IFNy, and 
rensing the media for incubation with oxLDL: MTT assay. 
U937 cells were preincubated with 300U/mL IFNy for 24 hours before being washed and resuspended in the 
RPM! 1640 media they were preincubated in (5 x 105cells/mL) and incubated with 1.5mg/mL oxlDL for 48 
hours. A 300U/mL IFNy-only control was included. The MIT assay was used, and results are expressed as 
mean ± SD of triplicates. 
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Figure 101: Effect on oxLDL-induced cell viability loss of pre incubating U937 cells with IFNy, and 
reusing the media for incubation with oxLDL: Trypan blue assay. 
U937 cells were preincubated with 300U/mL IFNy for 24 hours before being washed and resuspended in the 
RPM! 1640 media they were preincubated in (5 x lOscells/mL) and incubated with LSmg/mL oxlDL for 48 
hours. A 300U/mL IFNy-only control was included. The trypan blue assay was used, and results are expressed 
as mean ± SD of triplicates. 
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Figure 102: Effect on oxLDL-induced cell viability loss of preincubating THP-l macrophage-like 
cells with IFNy. and changing the media for incubation with oxLDL: MIT assay. 
nIP-I macrophage-like cells (1 x 105cells/mL) were preincubated with 300U/mL IFNy for 24 hours before 
being washed and incubated in new RPMI 1640 media and l.5mg/mL oxLDL with or without 300U/mL IFNy 
for 48 hours. A 300U/mL IFNy-only control was included. The MTT assay was used, and results are expressed 
as mean ± SD of triplicates. 
IFNY-MEDIATED APOPTOSIS 
As well as being able in some cases to reduce apoptosis, as outlined above, it has 
previously been reported that IFNy may cause cell viability loss. IFNy brought about 
apoptosis in human erythroid progenitor cells by downregulating their protective mechanisms 
and upregulating FLICE and various caspases (Dai and Krantz, 1999). IFNy could cause 
apoptosis in human peripheral blood monocytes and macrophages through cell activation, 
with secondary necrosis following rapidly, as measured by trypan blue exclusion. No reactive 
oxygen species scavengers were able to protect against IFNy, but protein kinase C was found 
to be activated before apoptosis (Munn et al., 1995). IFNy induced the expression of caspases 
-1 and in U937 and THP-I cells (Lin et al., 2000) and caused apoptosis ofT cells in vitro 
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via NO production by macrophages, completing a negative feedback loop (Dalton et ai., 
2000). IFNy could upregulate FasL in U937 cells (Sumimoto et ai., 1994). 
IFNy is also known to make cells more sensitive to apoptosis (Chinetti et al., 1998). 
This appears to occur with the THP-1 cells and oxLDL (Figure 97). In HUVECs, IFNy alone 
did not cause viability loss, but in combination with TNFa or LPS, it did, possibly by 
induction of NO production (Wemer-Felmayer et al., 1993). In a similar manner, IFNy made 
U937 cells more sensitive to Fas and TNFa-mediated apoptosis (Matsuda et ai., 1991; 
Nonaka et al., 1999), and to y-irradiation and etoposide (Tamura et al., 1996). IFNy also 
sensitised THP-l and HL-60 cells to Fas and TRAIL-mediated apoptosis. Procaspase-8 was 
upregulated, and Bcl-2 downregulated by the IFNy-preincubation (Varela et al., 2001). 
A short investigation was carried out to fmd out the way in which IFNy may be 
causing this viability loss in THP-l and U937 cells. Two avenues of inquiry were examined. 
Thiolloss in both monocyte cell types was looked at, as a change in cellular thiol redox 
potential could affect viability. A small thiol10ss was found after incubating THP-l (Figure 
103) or U937 cells (Figure 104) with 300U/mL or 1500U/mL IFNy. There was about the 
same amount ofthio1 oxidation as viability loss. The thiolloss was concentration-dependent, 
in that more occurred with the higher IFNy concentration, but in U937 cells the difference 
between the IFNy doses was barely significant (p::;0.05), and it was not significant at all in 
THP-l cells. This does not reflect the five-fold increase in IFNy concentration. Just as with 
78NP production in the earlier work, the effect of IF Ny plateaus, reaching its maximum 
effectiveness between 300U/mL and 1500U/mL, after which no further additions influence 
the effect. IFNy receptors may be saturated at this point. The small drop in thiols, or change 
in intracellular thiol redox potential this indicates, may well contribute to the viability loss. 
The thiol drop might also be a consequence, rather than a cause, of viability loss. The two 
cannot be differentiated from this data. 
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Figure 103: Effect of U'Ny on reduced thiolloss in THP-l cells: DTNB assay. 
TIIP-l cells (5 x 105cells/mL) were incubated with two concentrations ofIFNy in RPM! 1640 for 48 hours. The 
analysis was done using the DTNB assay. Results are expressed as the mean SD of triplicates. 
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Figure 104: Effect oflFNy on reduced thiolloss in U937 cells: DTNB assay. 
U937 cells (5 x lOscells/mL) were incubated with two concentrations ofIFNy in RPM! 1640 for 48 hours. The 
analysis was done using the DTNB assay. Results are expressed as the mean ± SD of triplicates. 
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The other factor investigated as a possible cause of the IFNy-mediated cell viability 
loss was the biological messenger nitric oxide, NO. iNOS is found in human blood 
monocyte-derived macrophages after stimulation with IFNy (Reiling et al., 1994). The 
induction can be blocked by antioxidants such as N-acetylcysteine (Pahan et al., 1998). 
NO's derivatives are mutagenic (Lewis et al., 1995), and can be cytotoxic through the 
inhibition of enzymes (Mullet et al., 1997; Wang et al., 1997; Halliwell and Gutteridge, 
1999). Part ofthe inhibition is due to its interactions with protein thiol groups (Messmer et 
al., 1996). It can also nitrosyl ate the thiol group of glutathione (Bemdji et al., 1999). 
Several cell types, including RA W264.7 macrophages, rat alveolar epithelial cells and 
human T cells, undergo apoptosis as a result of IFNy-stimulated NO production. Hepatocytes 
are resistant to NO-induced apoptosis (Messmer and Bruene, 1995; Schobersberger et al., 
1996; Bruene et al., 1997; Okada et al., 1998; Dalton et al., 2000; Tendler et al., 2001). 
U937 cells undergo p53-independent apoptosis in the presence of NO (Messmer and 
Bruene, 1995). However, NO can also inhibit TNF-a-mediated apoptosis in this cell type. At 
a late stage of apoptosis, this occurs by a cGMP-independent mechanism involving S-
nitrosylation and inactivation of caspases. At an early stage, ceramide generation, which 
potentiates this apoptosis, is inhibited (De Nadai et al., 2000). 
NO's production in human macrophages, in spite of the presence of iNOS, is 
somewhat controversiaL Around half the studies attempting to measure it do not find it, 
although procedures used in other papers are followed exactly (Reiling et al., 1994). Studies 
which do detect it find that the production rate is low and rather slow. The highest reported 
human monocyte-macrophage level was found after stimulation of the cells with M avium 
and TNF a. After 7 days, 211 ±20IlMil 06 cells was achieved. This result is very much the 
exception, most concentrations being in the very low nanomolar range. The highest result 
with IFNy was 26nmoV106cells over 24 hours (Albina, 1995). Using the Ca2+ ionophore 
ionomycin, values for NO production over 10 minutes with 5 x 105 cells/mL were obtained 
for THP-l cells (30.9±1.8nM), U937 cells (26.2±2.0nM) and peripheral blood monocytes 
(32.1±8.7nM) (King et al., 1997). Apoptosis of human monocytes and macrophages by IFNI' 
is therefore not necessarily due to NO (Munn et al., 1995). 
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NO concentration in THP-l monocytes incubated with 300U/rnL IFNy for up to 48 
hours is shown in Figure 105. RPM! 1640 gave a slight absorbance alone, so a reading was 
carried out for incubated media only at each timepoint and subtracted from the value of the 
ce111ysate or supernatant sample. It was found that there was no further nitrite in the cell 
lysate, so the graphed results represent the values obtained from the supernatant. 
There was no difference in NO production between cells with or without IFNy. In 
both cases, the levels were much lower than those reported in the studies outlined above. NO 
is therefore not the cause of the low levels of cell death resulting from IFNy in the 
experiments here. 
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Figure 105: Production of NO in THP-l cells with and without IFNy. 
THP-l cells (5 x 105cells/mL) were incubated with or without 300U/mL IFNy in RPMI 1640 for up to 48 hours. 
At certain timepoints, cells were removed, washed twice with PBS, lysed by sonication and analysed for NO 
production with the Griess reagent at 540nm. NO concentration was found from a standard curve constructed 
using sodium nitrite. Results are expressed as the mean SD of triplicates. 
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IFNy might be causing a loss of cell viability by upregulating caspases, or 
downregulating antiapoptotic factors such as Bcl-2, as was reported above. The small drop in 
reduced thiols found in Figures 103 and 104 may be affecting the cell viability. Another 
possibility is that IFNy is in fact beginning to cause a partial differentiation of the cells by 48 
hours, slowing cell growth. If growth was therefore occurring faster in the untreated cells, the 
impression of a slight loss of viability might be given. It is unlikely though, that much growth 
is occurring, as the cells are deprived of the nutrients required for growth which are contained 
insemm. 
Since there was a drop in cell viability during incubation with IFNy, it was 
investigated whether 78NP could improve the levels of viability. Greater concentrations of 
the antioxidant induced by IFNy could perhaps balance the deleterious effects it is creating. 
However, this was not found to be the case when THP-l cells (Figure 106) and U937 cells 
(Figure 107) were incubated with 300U/mL IFNy with or without 200jlM 78NP. Both cell 
types gave the same result, showing no significant decrease in viability loss due to the 
addition of the 78NP. 
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Figure 106: Effect of 78NP on IFNr-mediated THP-l cell viability loss: MTT assay. 
1HP-I cells (5 x lOscells/mL) were incubated in RPM! 1640 with 300U/mL IFNy with or without 200f1M 78NP 
for 48 hours. The MTT assay was used for analysis. A 200f1M 78NP only control was included. Results are 
expressed as the mean ± SD of triplicates. 
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Figure 107: Effect of 78NP on IFNy-mediated U937 cell viability loss: MTT assay. 
U937 cells (5 x 105cells/mL) were incubated in RPMl1640 with 300U/mL IFNy with or without 200ilM 78NP 
for 48 hours. The MIT assay was used for analysis. A 200J1M 78NP only control was included. Results are 
expressed as the mean ± SD of triplicates. 
1bis result offers no support for the idea that 78NP might reduce the cell viability 
decreasing effects ofIFNy. It is possible that the 78NP produced may indeed be working this 
way, but at a location the exogenously added 78NP cannot reach, or else in such a way that it 
is already carrying out its maximum possible protective effect, and no extra 78NP will be 
able to affect this. 1bis could be tested by knocking out an enzyme responsible for 78NP, but 
this would be complicated as the enzymes specific for this pathway, for example GTP 
cyclohydrolase I, lead to other pteridine products such as 5,6, 7, 8-tetrahydrobiopterin. 
Higher levels of78NP might be produced in vivo. Direct cell-to-cell contact may 
favour accumulation of higher concentrations in the microenvironments of cells, which could 
be further augmented in concert with other cytokines acting upon cells with IFNy, such as 
IL-l and TNFa (Wirleitner et at., 2001). 
CHAPTER 6 224 
C. LEVELS OF 78NP AND NEOPTERlN IN VIVO 
Inflammatory material was gathered from consenting patients at the DSA Unit in the 
Radiography department of Christchurch Hospital. Samples of other fluids, such as plasma, 
could not be obtained from patients, as it was inappropriate to subject such ill patients to 
further invasive sampling. 
All pus samples were found to contain pterin. A comparison of the levels of pterin and 
78NP in each revealed that inflammatory material, as expected, contained much more pterin 
than reported in serum. 
In several cases, the amount of78NP in pus appeared to be negative. The 78NP 
concentration was calculated by measuring pterin fluorescence with and without acidic iodide 
oxidation of the sample. Oxidation was used for total pterin, to show both 78NP and 
neopterin. Only neopterin will showup before oxidation. Where 78NP seemed negative, 
more fluorescence was found in the samples before oxidation than afterwards, total neopterin 
having been lost This may be a result of reaction with other substances present in the pus, 
which may only be present after reaction with acidic iodide. The addition of acidic iodide 
greatly changed the size of every peak in pus samples, but to varying extents in each sample, 
suggesting different constituents. 
The level of pterin, although measurable, was not at all close to the range required in 
experiments in earlier chapters to protect cells from viability loss and apoptosis caused by 
AAPH or oxLDL. Higher 78NP concentrations might be necessary to see an effect in cells in 
this type of experiment, since the dose is only added once, whereas in vivo high levels of 
neopterin persist in body fluids of patients. It could be argued that the 78NP may be more 
concentrated in the microenvironment surrounding the cell that produces it (Gieseg et al., 
2000). Levels of78NP may also have been higher than they appeared if78NP had oxidised to 
78XP, which was not measured. Since the development of an inflammatory, or particularly an 
atherosclerotic site, is a far longer process than any of the experiments undertaken here, a 
lower concentration of78NP might be sufficient to protect the cell. It seems unlikely, 
however, that these situations will be able to be verified. 
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Table 7: Pterin measurements in pus. 
Inflammatory material was brought to the laboratory on ice and frozen at -80°C until use. Samples were 
prepared by addition of nanopure water, BHT and EDTA under aseptic conditions, followed by homogenization 
for one minute. Samples were analysed immediately by the HPLC pterin method with and without acidic iodine 
solution, and protein determinations were carried out for each sample. Results are expressed as the mean ± SD 
of triplicates. 
I Patient Sex I Age Origin of pus I Total pterin Total pterin %78NP I [78NP] (nM)1 
code 
i I (prool/rog (nM) 
protein) i I 
DE F : 43 . Gallbladder S.7±L2 46.9±4.0 -56.1 -25.8±5.9 
fossa 
NM M 61 Peripancreatic 19.1±3.0 419.0±5.0 -17.9 -74.9±9.7 
PM M 44 i RHS plural ! 6.9±0.3 365.5±11.0 -9.6 -35.1±17.6 
i I space 
i 
ME F 49 i Paracoli region 16.5±2.3 517.2±18.0 45.9 237.1±0.1 
RB M 51 i Gallbladder 8.7±1.6 67.2±3.0 -22.2 ,-15.1±3.6 . 
i fossa 
NH IF 69 i Anterior 1.7±1.2 I 68.0±4.0 -16.2 r-1L0±5.ol 
. ¥a0minal wal 
LM F 34 elvis 6.8±0.6 i 496.6±46.0 -3.82 I -19.0±0.02 
VL F 89 Gallbladder ! 10.4±0.4 • 692.0±26.0 13.5 93.4±0.003 
!HGlO F 62 Subphrenic 16.3±0.9 543.6±29.0 • 11.6 ·63.4±0.02 
i DJ M 68 RHS flank 10.2±0.3 692.0±21.0 77.0 533.7±0.01 
I i NP ! F 41 . RHS anterior 9.8±1.2 580.0±71.0 41.8 . 242.2±0.04 I plural space i i 
AC F ! 24 • Fistulalabcess 15.6±05 1 651.6±19.0 12.1 178.7±0.01 
! RHS 
MG F i 74 Pelvis 16.7±1.9 860.0±99.0 52.3 . 449.8±0.1 
BC F 64 Pelvis 19.9±3.5 889.0±157.0 35.3 314.1±0.09 
. HG8 F i 62 Subphrenic 17.0±1.6 i 639.0±61.0 37.4 I 238.9±0.05 I 
• PE M 53 Lower 14.4±1.1 . 1281.0±96.0 . 15.7 1 200.7±0.04 
I abdomen I 
i 
. CB M 89 ! Abdominal 9.6±1.9 96.0±2.0 I -15.0 ! -14.4±2.4 i 
i cavity L 
GM 'M i 48 Pararectal, i 7.8±0.6 1 304.0±22.0 ·43.1 i 131.2±0.01 
lower pelvic 
i 
i 17.3±O.O04 WI 'M 73 Paracoli, lower' 16.9±0.8 ! 403.2±20.0 I 4.3 I i pelvic I 
I 
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CORRELATIONS 
An examination of the various pterin measurements grouped according to sex 
suggested that females may have a slightly higher concentration of pterin in their 
inflammatory material, and that this material might contain a greater proportion of 78NP, 
however these correlations were not statistically significant (Table 8). 
Table 8: Comparison of pterin measurements between male and female patients. 
I 
All (Mean±SD) Female (Mean±SD) Male (Mean±SD) 
~Total pterin(pmol/mg) 12.l1±5.20 12.40±5.84 11.70±4.52 
• %78NP 29.56±22.07 31.67±20.37 26.66±25.35 
I [78NP] (nM) 178.83±159.60 196.68±155.00 154.29±173.16 
... -1 
Possible correlations between pterin and 78NP concentrations, pterin or 78NP and 
protein concentration, and the age of the patient, pterin, 78NP or protein were also examined, 
using the Prism program. Correlations were assessed using the Pearson correlation co-
efficient, r, r2, and two-tailed p-values. 
Significant correlations were only found for the comparison of 78NP and pterin. 
When measured in pmol/mg, r was 0.4221, Pearson r was 0.6497 and p was 0.0026 (** in 
the system used on the earlier graphs). When the pterin value was expressed as 11M, and the 
78NP value as nM, ? was 0.4042, Pearson r was 0.6358 and p was 0.0034 (also **). This 
means that a patient with more pterin overall is likely to also have more 78NP. The 
correlation is not at the greatest level of significance, suggesting that other factors, such as 
the extent and type of inflammatory reaction, for example, will impact on how much 78NP is 
oxidised in the site. 
OTHER PARAMETERS 
The same inflammatory material was also used for measurements oflevels of vitamin 
E, as another representative antioxidant, and two markers of protein oxidation, PB-DOP A 
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and dityrosine, by other members of the laboratory (Table 9) (Gieseg et al., 1993; Gieseg et 
al., 2000; Hawkins and Davies, 2001). 
Abstraction of hydrogen from tyrosine's hydroxyl group by radicals such as hydroxyl, 
alkoxyl or peroxyl radicals gives the phenoxyl radical TyrO', which often crosslinks to give 
dityrosine. This has been found in atherosclerotic lesions (Halliwell and Gutteridge, 1999; 
Hawkins and Davies, 2001). It can be formed from reactions caused by myeloperoxidase, or 
from a metal-catalysed Fenton system in vitro (Huggins et ai., 1993). 
The hydroxide 3,4-dihydroxyphenylalanine (DOPA) is formed through the reaction of 
a hydroxyl radical with the aromatic ring of tyrosine, followed by addition of oxygen and 
elimination of the hydroperoxide (Hawkins and Davies, 2001). 
It was hoped that correlations would be found among the different pterin 
measurements and vitamin E, PB-DOP A and dityrosine, however this was largely not the 
case. A significant positive correlation was found between the concentration of total pterin 
and vitamin E (?=0.2283, Pearson r=OA778, p=0.0385, *), and 78NP and vitamin E 
(?=0.3751, Pearson r=0.6125, p=0.0069, **). This may reflect the oxidative conditions of the 
particular inflammatory site the material was drawn from. The two antioxidants might be 
'used up' at a similar pace, or the amount of vitamin E available might influence the level of 
78NP production. 
The lack of correlation between the two antioxidants and the two markers of oxidation 
allow no conclusions to be drawn about pterins or vitamin E acting as antioxidants in vivo to 
suppress oxidation resulting in PB-DOP A or dityrosine. 
Highly significant positive correlations were found between the amount of protein 
found in the inflammatory material, and the amount of dityrosine or PB-DOP A measured. 
Both are protein oxidation products, so this would be expected. In the case of protein 
compared to PB-DOP A, ? was 0.8216, Pearson r was 0.9064 and p < 0.0001 (***). For 
dityrosine and protein, r2 was 0.7177, Pearson r was 0.8472 and p < 0.0001 (***). 
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Table 9: Vitamin E, PH-DOPA and dityrosine measured in pus. These were determined by HPLC 
(Gieseg et al., 1993; Gieseg et al., 2000). The results are presented as mean ± SEM. 
~P_a_tie_n_t_co_d_e----,-__ ~ ___ ------>!~_--"",--+-P_B_-_D_O_P_A--",-m_ol_/m-,g"",-)-I-_D_i-,,--os.ine (pmol/mg) 
DE 109.68±17.17 O.OO±O.OO 
NM 225.31±26.94 12.15±1.97 
PM i 421.47±8.03 86.58±7.12 5.04±O.18 
MH I 1009.25±57.51 166.59±24.86 154.13±5.06 
RB 
I 
31O.21±17.82 104.47±6.58 O.OO±O.OO 
i NH 12.49±O.O89 409.52±18.16 81.46±12.87 f--
LM 290.05±19.74 70.60±1.56 2.28±O.23 
VL 240.34±25.85 92.31±1O.22 69.40±12.69 
HGIO 1148.12±28.31 75.12±3.71 3.65±O.24 
DJ 79.09±6.04 262. 54±20.53 1.96±O.32 
NP 252.29±3.85 523.52±46.39 1.48±O.15 
AC I 714.04±15.78· 115.09±1O.28 1.2O±O.O72 I--- MG i 542.84±4.97 54. 13±2.62 7.99±O.60 
.. -
BC 252.91±16.41 580.51±21.73 1.93±O.18 
HG8 i 1056.53±22.24 49.68±3.31 7.79±O.37 
• PE I 337.43±7.72 297.47±25.87 4.4O±O.39 ~CB 439.34±19.91 288.43±38.38 3.05±O.17 
, GM I 241.27±17.22 333.20±42.70 23.94±1.06 
WT 1470.37±57.52 203.77±31.30 6.93±O.64 
i 
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SUMMARY 
All three cell types tested produced 78NP under stimulation from IFNy. A higher 
level was produced with a greater IFNy concentration, but the increase was not proportional 
to the increase in IFNy concentration. THP-l macrophage-like cells produced the most 78NP 
relative to cell number and protein concentration, and U937 monocyte cells generated more 
than THP-l monocytes. The maximum amount produced was a thousand-fold less than the 
concentrations used in viability assays to protect U937 cells. All three cell types showed the 
same trends over time, with an increase until 24 hours, after which the 78NP concentration 
tailed off 
IFNy incubated with cells could not protect U937 monocytes, TIIP-l monocytes or 
THP-l macrophage-like cells from cell viability loss caused by oxLDL, even if preincubated 
with the cells to allow time for 78NP to be produced. It caused a small loss of viability itself, 
which was not due to NO production, but may relate to a slight loss of reduced thio1s, caspase 
upregulation or downregu1ation of anti-apoptotic proteins. 78NP at 200llM was unable to 
protect the cells from IFNy-mediated cell viability loss. 
78NP and neopterin levels measured in inflammatory material were higher than those 
found in serum. However, the levels were still a thousand-fold lower than those required to 
protect cells from oxLDL or AAPH-mediated viability loss in in vitro experiments. 
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SUMMARY AND CONCLUSIONS 
The primary focus of this study was to investigate whether 7,8-dihydroneopterin 
could protect monocytes and macrophages from the cytotoxic effects of biologically relevant 
concentrations of oxLDL in vitro. It has been hypothesised that 78NP is synthesised in vivo 
as a macrophage protectant and thus may be important in plaque fonnation and stability 
during atherosclerosis. During this research, a second focus developed, describing the process 
of cell death induced by the oxLDL and how it differed between the two monocyte cell types 
examined. 
EFFECT OF OxLDL ON CELLS 
Both THP-l and U937 monocytes were found to undergo concentration-dependent 
viability loss in the presence of oxLDL (Figures 29 and 34), which occurred to a similar 
degree in each cell type. The oxLDL concentrations tested were comparable with those found 
in vivo in the intima. However, while THP-l cells showed a gradual loss of reduced thiols, 
similar to the level of cell viability loss, U937 cell thiols were suddenly and completely 
depleted with 1.5mglmL oxLDL (Figures 39 and 40). A critical point for this oxLDL 
concentration was reached after six hours of incubation, after which time it appeared that 
maintenance of reduced thiols was not possible (Figure 42). Potential mechanisms of 
glutathione loss reported previously in U937 cells include efflux, oxidation and 
downregulation of synthesis. A small proportion of the reduced thiols may also be lost from 
proteins, including important enzymes and transcription factors such as NFKB. 
The difference between the two monocyte cell types may relate to the way the oxLDL 
interacts with the cells. The monocytes are unlikely to have scavenger receptors (Akeson et 
al., 1991A), although these may be induced during incubation with oxLDL (Lei et al., 2002). 
U937 cells have higher CD36 levels than THP-l cells (Nguyen-Khoa et al., 1999) and THP-l 
cells a greater ability to phagocytose than U937 cells (Sundstrom and Nilsson, 1976). 
However, the differing loss of caspase activity in each cell type during the incubation of cell 
lysates with oxLDL (Figure 72) suggested that oxLDL's access to the cell was not a factor. 
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The cell type difference is more likely to be part of the oxidative response to oxLDL-
initiated stress. The U937 cell thiol response may be specific to oxLDL, as the sudden drop in 
thiols was not observed with AAPH treatment. The two cell types have different antioxidant 
profiles: U937 cells have less GSH, thioredoxin, thioredoxin reductase and ceruloplasmin and 
more MnSOD than TIIP-1 cells (Mazumder et al., 1997; Ferret et al., 2000), which may 
result in the cell types being differently equipped to deal with various stresses. The cell types 
may also have different signalling pathways altered by oxLDL. U937 cells are reported to 
have no PPARy (Inoue et al., 2001), which has an anti-inflammatory effect in cells during 
longer incubations with oxLDL (Jang et al., 1999). This may result in a greater level of 
intracellular oxidative stress over the incubation time and a more extensive loss of reduced 
thiols. 
The loss ofthiols in U937 cells may be important for the induction of apoptosis 
during incubation with oxLDL. A lowering ofthiollevels has been suggested to be essential 
for apoptosis in some cell types (Lizard et at., 1998). In U937 cells, the loss resulted in the 
inactivation of caspase enzymes, which have a catalytic cysteine residue (Boggs et at., 1998). 
A comparison of the loss of cell viability, thiols and caspase activity in U937 cells over time 
(Figure 71) showed that thiols and caspase activity decreased in parallel, whereas loss in 
viability was slower. Hydrogen peroxide, protein hydroperoxides, NO, selenium and zinc 
ions have been reported to inhibit activated caspases in a manner reversible by DIT, 
demonstrating thiol-dependence (Hampton and Orrenius, 1997; Stennicke and Salveson, 
1997; Boggs et at., 1998; Park et al., 2000; Borutaite and Brown, 2001; Hampton et at., 
2002A; Hampton et al., 2002B). OxLDL was shown to lower caspase activity in celllysates 
over ten minutes (Figure 72) to a much greater extent in U937 cells than in THP-1 cells, in 
line with the overall effect of oxLDL on reduced thiols in these cell types. This result 
emphasises the specific nature of this reponse in the U937 cell type for oxLDL, as other 
studies have shown that U937 cells can have active caspase enzymes (Galan et at., 2001). 
Caspases were activated in a much more conventional fashion in THP-1 cells, which 
did not undergo the same extensive loss of reduced thiols. Caspase activity increased over 
time with increasing concentrations of oxLDL and decreased again as secondary necrosis 
began (Figure 67). 
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An alternative mechanism of apoptosis is required by the U937 cells with oxLDL. 
This may involve other enzymes, such as cathespins and DNases, which might be released 
from the lysosome if oxLDL were to accumulate inside it (Brunk et at., 1997; Bomer and 
Monney, 1999). Oxidative stress might itself be an important part of the apoptotic 
mechanism. Loss of reduced thiols is a passive, indirect form of oxidative stress (Ghibelli et 
at., 1998). A lowering of glutathione levels may open the mitochondrial pore, allowing 
apoptosis to proceed by this route (Lizard et al., 1998). 
In other respects, oxLDL induced similar forms of apoptosis in U937 and THP-l 
monocytes. The Hoechst 33342 stain showed both cell types to have typical apoptotic nuclear 
morphology, including condensation, pyknosis and fragmentation. Higher concentrations of 
oxLDL induced primary and secondary necrosis as well as apoptosis over 24 hours. 
The Annexin V /propidium iodide assay looked at phosphatidylserine exposure on the 
surface of the cells. Both cell types appeared to undergo apoptosis, with THP-l cells moving 
more swiftly towards (secondary) necrosis. The process would not have been caspase-
dependent in U937 cells (Figures 73-78). 
To confirm that apoptosis is taking place, the fmdings of all three assays need to be 
combined. From this it appears that apoptosis is likely to be occurring in both cell types, but 
on a continuum scale from apoptosis to necrosis, THP-l cells undergo a more conventional 
form of apoptosis, whereas the U937 cells' apoptosis is more towards the centre of the scale. 
PMA-differentiated THP-l macrophage-like cells were resistant to cell viability loss 
with AAPH and oxLDL, even at high concentrations and over long periods of time (Figures 
96, 97, 100-102). This may be due to the changes in cell metabolism that occur as a result of 
differentiation. For example, lipid metabolism genes and the scavenger receptor are activated 
(Kritharides et al., 1998; Liao et ai., 2000), which would result in more degradation of 
oxLDL and less toxicity. Macrophage secondary products are also generated (Via et ai., 
1989) and the cells'antioxidant profile changes, to include more GSH, thioredoxin, 
thioredoxin reductase and SOD (Gotoh et at., 1993; Ferret et al., 2000). PMA-induced 
changes also counteract some of those mediated by oxLDL. PP ARy, TNFa and PKC, the 
expression of which oxLDL incubation increases in monocytes, will decrease as a result of 
incubation with PMA (Schwende, 1996; Girona et at., 1997; Jang et al., 1999). 
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EFFECT OF 78NP ON CELLS 
78NP was tested as an antioxidant or protectant in THP-1 and U937 monocytes and 
THP-1 macrophage-like cells with two inducers of cell viability loss: AAPH, which produces 
peroxyl radicals and oxLDL, thought to be the main source of cell damage and death in the 
plaque. The contrasts in the effect of78NP on the THP-1 and U937 cell types allowed 
conclusions to be drawn regarding the nature of cellular protection by 78NP. 
It has previously been shown in chemical systems that 78NP is able to scavenge a 
wide range of radicals very efficiently, including peroxyl radicals (Duggan et at., 2002). 
Therefore AAPH was a logical ftrst step in testing the response of cells to 78NP. 78NP 
prevented loss of cell viability and lowered reduced thiolloss in U937 cells in RPMI 1640 
and EBSS media, and slightly lowered THP-1 cell viability loss in the EBSS medium only 
(Figures 13, 14, 19-22, 25, 26). It had no effect on THP-1 macrophage-like cells (Figure 98). 
78NP has also been reported to protect cells and cellular membranes from oxidative 
stimuli. 78NP shielded red blood cells from haemolysis initiated by AAPH, hydrogen 
peroxide and HOCI (Gieseg et at., 2000B) and could partially protect U937 cells from 
hydrogen peroxide, HOCI and Fe-mediated damage (Gieseg et at., 2001). In some situations, 
such as when it was at millimolar concentrations, 78NP has been reported to act as a pro-
oxidant or pro-apoptotic factor (Schobersberger et at., 1996; OettI2000B). 
The hypothesis was that these previously reported properties would allow 78NP to 
protect cells against oxLDL. 78NP reduced loss of cell viability and reduced thiols in U937 
cells and had no effect on THP-1 monocyte or macrophage-like cells (Figures 32, 37,44,45, 
103). It is possible that antioxidant activities were responsible for the protection, as the 
lowering ofthiolloss in U937 cells appeared crucial. 
The studies using AAPH led to the conclusion that while 78NP could scavenge 
peroxyl radicals in cell solutions, scavenging may not be the only mechanism protecting cells 
from viability loss. The level of protection against cell viability loss provided by scavenging 
was shown by the small amount of protection provided to THP-1 cells in EBSS media against 
AAPH. In U937 cells, lowering ofthiolloss and perhaps othermechanisrns also contributed, 
resulting in a more effective protection against cell viability overall. 
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The main mechanism of78NP's protection in U937 cells may therefore be redox 
modulation. Lowering the loss of reduced thiols has been shown to improve U937 cell 
viability in previous studies (Lizard et ai., 1998; Nardini et ai., 1998). 78NP may, directly or 
indirectly, be able to prevent loss of protein and non-protein thiols. It was able to diminish 
caspase inactivation caused by oxLDL in U937 cells, raising caspase activation levels back to 
those of the untreated cells (Figure 70). 
78NP may lower U937 cell thiolloss by preventing the thiols from becoming 
oxidised, by either decreasing the cell's signal or means of oxidising the thiols. It might also 
enhance thiol synthesis, so that those oxidised could be replaced, or decrease efflux of thiols 
from the cell. However, 78NP cannot regenerate reduced thiols after oxidation on BSA, 
making this mechanism less likely (Platt, 2002). 
The effect of time of78NP addition to an oxLDL assay system revealed details ofthe 
mechanisms of both 78NP and oxLDL. 78NP had the same protective effect in U937 cells 
when added to cells two hours before oxLDL as when it was added two hours afterwards. It 
still had some protective effect if added six hours after the oxLDL, but from 12 hours, no 
protective capacity was evident. Twelve hours was also the time at which the oxLDL had first 
caused the maximum amount ofthiolloss, and at which the process resulting in the maximum 
amount of cell viability loss had irreversibly begun. Commitment to cell death must have 
occurred by this point. The effect of the time of addition of 78NP therefore depended on the 
timeline of effects caused by the oxidant (Figures 62-66). 
78NP may also affect cell signalling. Studies have shown that 78NP can increase 
cGMP and Ca2+ and that neopterin can activate NFKB (Woell et ai., 1993; Hoffinan et ai., 
1996; Murr et ai., 1999). Neopterin is unlikely to play an important role in the studies here, as 
most of the 78NP was found to oxidise to 78XP rather than neopterin (Figure 47). 
Importantly, 200j.tM 78NP or neopterin did not increase caspase activation in THP-1 
cells (Figure 68), contrary to previously reported findings in other cell types (Baier-Bitterlich 
et ai., 1995; Schobersberger et ai., 1996). 
In contrast to those results, 78NP appeared to reduce the appearance of apoptotic 
features in U937 cells as measured by Hoechst 33342 staining and the Annexin V/propidium 
iodide assay, and continued to have no effect on THP-l cells (Figures 76 and 78). The nature 
of the effect on U937 cells in these two assays suggests 78NP is delaying the apoptotic 
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process. Phosphatidylserine exposure itself was not reduced at the 48-hour timepoint, but the 
number of cells reaching necrosis or entering apoptosis was decreased. The results with the 
Hoechst 33342 stain appeared more absolute, the oxLDL-treated cells retaining the 
appearance of untreated cells. As the nuclear morphological changes viewed with this assay 
are late apoptotic changes, a delay in the apoptotic process would ensure they had not 
occurred by the 24-hour point at which they were measured. 
The difference in cell types may relate to the extra differentiation of the THP-1 
monocyte and macrophage-like cell type. They may interact with 78NP differently, as THP-1 
cells are better able to phagocytose than U937 cells, and have different cell membrane 
receptors (Tsuchiya et at., 1980). 78NP was able to interact with both THP-1 and U937 
monocyte cell types (up to 400nM), although to a different degree with each over time. The 
actual amount of78NP which became associated with the cells was not itself enough to 
protect cells, so it is difficult to detelmineifthis interaction was important for the survival of 
the cells (Figures 49-51). 
The cell types' different reactions to oxidative stress (as discussed above) may mean 
78NP can have a protective effect in only one cell type when they are incubated with cell 
death mediators such as oxLD L. The idea is supported by the fact that THP-1 cells have not 
yet been shown to be protected against oxLDL-induced oxidative stress by any antioxidant. 
The difference in cellular oxidative stress may not be so great without the stressor, as 78NP 
controls were able to increase THP-1 cell viability, 
These studies showed that 78NP is able to act as an antioxidant or protectant for cells 
against oxidative stress and the reactive oxygen species of oxLDL under some conditions. It 
can delay or reduce apoptosis and the following secondary necrosis. 
PROTECTION OF CELLS BY 78NP IN THE ATHEROSCLEROTIC PLAQUE 
In Chapter 6, it was established that although all three cell types produced 78NP as a 
result of stimulation with IFNy (Table 5), the levels were not high enough to protect the cells 
against oxLDL or IFNy-mediated cell death (Figures 106-119, 123-124). This may or may 
not reflect the in vivo situation. The presence of a more complex environment of cytokines 
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and cell types may increase, as well as decrease, the quantity of 78NP generated. 78NP and 
neopterin levels measured in inflammatory material were higher than those reported in serum 
(Table 7), but were still lower than those required to protect cells from oxLDL or AAPH-
mediated viability loss. 
Higher levels of exogenous 78NP were able to protect some monocyte cell types in 
some situations, suggesting the hypothesis that 78NP might protect cells from cell death in 
vivo may be possible. 78NP, however, could not protect all monocyte cell types under all the 
conditions that were tested and did not protect macrophage-like cells, reinforcing the theory 
that results cannot be extrapolated to other cell types. 78NP was not active as a protectant at 
levels generated by cells treated with IFNy, or found in vivo. The evidence from these model 
systems does not support the hypothesis that 78NP would have a protective effect on cells in 
the atherosclerotic plaque. 
FuRTHER RESEARCH 
The investigations presented in this thesis suggest a variety of directions for future 
studies. In vitro, studies using 78NP may provide interesting and useful information, possibly 
helping to elucidate cells' responses to oxidative stress and their pathways of apoptosis. 
The THP-l and U937 monocyte systems are useful for studying the ways in which 
oxLDL can affect the cell in terms of oxidative stress, due to the differences in their reduced 
thiolloss, an area which could be studied further. The mechanism ofthiolloss in each cell 
type, and the identification of the types of thiols lost as protein or glutathione, would provide 
some interesting information about the effect of oxLDL on cellular thiols. 
These experiments would also allow some evaluation of the hypothesis that a major 
difference between the THP-l and U937 cell types is the form and modulation of their 
intracellular redox state. This could be substantiated by measurement of intracellular 
oxidative stress, such as the level of superoxide, and intracellular antioxidants other than 
glutathione, including thioredoxin, SOD and catalase. The effectiveness of these antioxidants 
under different conditions could be examined after exposure of the cells to other types of 
oxidants and measurement of other types of oxidative damage, such as oxidised products of 
DNA, or levels of nitrated proteins after peroxynitrite treatment. This would enable a profile 
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to be built for each cell type outlining how they respond to a variety of conditions. Redox 
responses could also be examined in terms of how important they are to each cell types' 
apoptotic pathways. For example, cytochrome c released from mitochondria and Bcl-2 
activity could be investigated, and the possible regulation of various features in U937 cells, 
such as phosphatidylserine exposure, which are often under caspase control, by redox 
modulation could be examined. 
The differences in the two monocyte cell types' apoptotic mechanisms with oxLDL 
could be further studied to provide general information about possible apoptotic pathways. 
The effect of oxLDL on the lysosome or mitochondria of each cell type, and the release of 
proteolytic enzymes, could be investigated. Also, the different mechanisms of 
phosphatidylserine exposure may be of interest. The flipping of phosphatidylserine may be 
caspase-dependent in THP-l monocytes and oxidative stress-dependent in U937 monocytes. 
Modulation of apoptotic pathways by oxidative stress, through Bcl-2 or cerami de for 
example, may replace caspase regulation of events. 
The interaction between reduced thiols and caspase enzymes is one that could be 
further explored. The study using celllysates and oxLDL, examining loss of caspase activity 
over time, could be extended. A more pronounced effect on caspases might be expected over 
a greater timeframe. It might also be interesting to add DTT after the oxLDL, to investigate 
whether the reduction in caspase activity could be reversed. A solution of purified caspase 
enzyme(s) could be used to test whether the effect of the oxLDL is direct or via effects on 
upstream molecules. Fractions of oxLDL could be added to this or celllysates to elucidate 
which component of oxLDL is most important for carrying out this function. 
In continuing to examine the development of the atherosclerotic plaque, 78NP should 
be tested as a protectant for human monocyte-macrophages and foam cells, and also a 
mixture of cell types, such human monocyte-macrophages and T cells, or human monocyte-
macrophages and smooth muscle cells. This may provide a model more relevant to the in vivo 
situation, although the quality of the results obtained in these more complex systems may be 
lower. The level of 78NP in plaque could be determined, including in which areas and stages 
of plaque 78NP is present. 
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78NP may protect other cell types in the lesion, such as smooth muscle or endothelial 
cells. These cell types may require a lower concentration of 78NP for an antioxidant effect, 
since they do not produce 78NP themselves. 78NP would be likely to have a greater 
stabilising effect on plaque if it could prevent loss of the smooth muscle cell cap of the 
acellular lipid core. 
While the focus ofthis thesis has been on examining the macrophage death which 
contributes to the formation of the core, 78NP might affect other stages of plaque 
development. A possible influence on the oxidation ofLDL by monocytes and macrophages 
has already been explored (Gieseg and Cato, 2003). 
Initiation -+ recruitment -+ inflammation -+ oxidation ofLDL-+ 
foam cell formation -+ foam cell death -+ rupture 
i 
78NPx 
i 
78NP-.J 
Figure 108: 78NP and the development of atherosclerosis. 
Other ideas for functions for 78NP could also be tested. The fact that 78NP and 
neopterin are made from nucleotide bases may have some significance. Adenine can 
form a complex with two eu2+ ions, which then has a catalase effect, disproportionating 
hydrogen peroxide to oxygen and water, while the complex itself slowly oxidises over 
around forty reactions (Bruston et aI., 1999). 78NP or neopterin may be able to interact 
with bases within DNA, perhaps protecting them from oxidative damage. 
The possibility that 78NP might heighten macrophage immune response, 
suggested in the introduction, could also be tested. In this case, 78NP would encourage 
plaque and inflammation development. 
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